CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><title>Investor Events and Presentations | Takeda Pharmaceuticals</title><meta name="robots" content="index,follow"/><meta name="description" content="Find information and relevant documents on past and upcoming investor-related events, including the Annual Shareholders Meeting and broker conferences."/><meta name="twitter:card" content="summary_large_image"/><meta property="og:title" content="Investor Events and Presentations | Takeda Pharmaceuticals"/><meta property="og:description" content="Find information and relevant documents on past and upcoming investor-related events, including the Annual Shareholders Meeting and broker conferences."/><meta property="og:url" content="https://www.takeda.com/investors/events/"/><meta property="og:image" content="http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg"/><meta property="og:image:alt" content="Investor Events and Presentations | Takeda Pharmaceuticals"/><meta property="og:image:secure_url" content="https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg"/><meta property="og:image:type" content="image"/><meta property="og:image:width" content="1200"/><meta property="og:image:height" content="627"/><meta property="og:locale" content="en"/><link rel="canonical" href="https://www.takeda.com/investors/events/"/><link rel="alternate" href="https://www.takeda.com/investors/events/" hrefLang="x-default"/><link rel="alternate" href="https://www.takeda.com/investors/events/" hrefLang="en"/><link rel="alternate" href="https://www.takeda.com/jp/investors/events/" hrefLang="ja"/><link rel="preload" as="image" imageSrcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" imageSizes="100vw" fetchpriority="high"/><meta name="viewport" content="user-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover"/><style> :root { --bodyBlock-fontLineHeight: 1.625rem; --bodyBlock-fontLineHeightMobile: 1.625rem; --bodyBlock-fontSize: 1rem; --bodyBlock-fontSizeMobile: 1rem; --bodyBlock-fontWeight: 400; --bodyBlock-fontWeightMobile: 400; --buttonPrimary-backgroundColor: #BD120A; --buttonPrimary-borderRadiusBottomLeft: 1.25rem; --buttonPrimary-hoverBackgroundColor: #891515; --buttonPrimary-textColor: #ffffff; --buttonSecondary-textColor: #333333; --colorDarkGrey: #333333; --colorDarkGreyContrast: #ffffff; --colorHoverGrey: #DCE6E9; --colorLightGrey: #edf2f4; --colorLightGreyContrast: #333333; --colorMediumGrey: #a1a4ac; --colorMediumGreyContrast: #ffffff; --colorPrimary: #BD120A; --colorPrimaryActive: #891515; --colorPrimaryActiveContrast: #ffffff; --colorPrimaryContrast: #ffffff; --colorSecondary: #891515; --colorSecondaryContrast: #ffffff; --cta-fontLineHeight: 1.625rem; --cta-fontLineHeightMobile: 1.625rem; --cta-fontSize: 1rem; --cta-fontSizeMobile: 1rem; --cta-fontWeight: 700; --cta-fontWeightMobile: 700; --globalImages-borderRadiusBottomLeft: 1.875rem; --h1-fontLineHeight: 2.875rem; --h1-fontSize: 2.625rem; --h1-fontSizeMobile: 1.875rem; --h1-fontWeight: 300; --h1-fontWeightMobile: 300; --h2-fontLineHeight: 2.6875rem; --h2-fontLineHeightMobile: 2rem; --h2-fontSize: 2.25rem; --h2-fontSizeMobile: 1.5rem; --h2-fontWeight: 300; --h2-fontWeightMobile: 300; --h3-fontLineHeight: 2rem; --h3-fontLineHeightMobile: 1.75rem; --h3-fontSize: 1.5rem; --h3-fontSizeMobile: 1.25rem; --h3-fontWeight: 500; --h3-fontWeightMobile: 500; --h4-fontLineHeight: 1.75rem; --h4-fontLineHeightMobile: 1.75rem; --h4-fontSize: 1.25rem; --h4-fontSizeMobile: 1.125rem; --h4-fontWeight: 500; --h4-fontWeightMobile: 500; --h5-fontLineHeight: 1.75rem; --h5-fontLineHeightMobile: 1.75rem; --h5-fontSize: 1rem; --h5-fontSizeMobile: 1rem; --h5-fontWeight: 700; --h5-fontWeightMobile: 700; --quote-fontLineHeight: 2.75rem; --quote-fontLineHeightMobile: 1.625rem; --quote-fontSize: 2rem; --quote-fontSizeMobile: 1.25rem; --quote-fontWeight: 400; --quote-fontWeightMobile: 400; --spacings-marginBottom: 3.125rem; --spacings-marginBottomMobile: 2.5rem; --spacings-marginTop: 0rem; --spacings-marginTopFirstComponent: 3.125rem; --spacings-marginTopFirstComponentMobile: 2.5rem; --spacings-marginTopMobile: 0rem; --spacings-paddingBottom: 0rem; --spacings-paddingBottomMobile: 0rem; --spacings-paddingTop: 0rem; --spacings-paddingTopMobile: 0rem; --subHeading-fontLineHeight: 1.25rem; --subHeading-fontLineHeightMobile: 1.5rem; --subHeading-fontSize: 1.125rem; --subHeading-fontSizeMobile: 1rem; --subHeading-fontWeight: 500; --subHeading-fontWeightMobile: 700; --textColor: #333333; }</style><meta name="robots" content="noindex, nofollow"/><link rel="preload" href="/fonts/woff2/GothamSSm-Book_Web.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="shortcut icon" href="/favicon.ico"/><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png"/><meta name="next-head-count" content="26"/><script type="text/javascript" data-nscript="beforeInteractive"> function OptanonWrapper() {} </script><script type="application/ld+json" data-nscript="beforeInteractive">{"@context": "https://schema.org","@type":"Organization","name": "Takeda Pharmaceutical Company Limited","url": "https://www.takeda.com","logo": "https://www.takeda.com/4ab4e2/siteassets/system/top/howwework_logo_1600x900.jpg","address": {"@type": "PostalAddress","streetAddress": "2-ch?me-1-1 Nihonbashihonch?","addressLocality": "Chuo City","addressRegion": "Tokyo","postalCode": "103-0023","addressCountry": "Japan"},"contactPoint": {"@type": "ContactPoint","contactType": "contact","telephone": "+81 3-3278-2111","email": "Media_Relations@takeda.com"},"sameAs":["https://www.linkedin.com/company/takeda-pharmaceuticals/","https://twitter.com/takedapharma","https://www.youtube.com/takeda-pharmaceuticals"]} </script><script data-nscript="beforeInteractive">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-5XBTH5B');</script><script data-nscript="beforeInteractive"> var _mtm = window._mtm = window._mtm || []; _mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'}); var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_rTZNKGIx.js'; s.parentNode.insertBefore(g,s); </script><script id="disable-nextjs-error-overlay-with-stackbit" data-nscript="beforeInteractive"> window.addEventListener('error', event => { if (undefined) { event.stopImmediatePropagation() } }) window.addEventListener('unhandledrejection', event => { if (undefined) { event.stopImmediatePropagation() } }) </script><link rel="preload" href="/_next/static/css/7533054d188a10d6.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/7533054d188a10d6.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" data-n-g=""/><link rel="preload" href="/_next/static/css/a922c742a726cef7.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/a922c742a726cef7.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/87c3f8f483ce4091.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/87c3f8f483ce4091.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/26430052bc48db76.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/26430052bc48db76.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/5555a79d213559e3.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/5555a79d213559e3.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/866211ae5b7b3fd6.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/866211ae5b7b3fd6.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/8ab1d4e268d724f7.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/8ab1d4e268d724f7.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/91883d28c6383bb9.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/91883d28c6383bb9.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/31a520c29de47217.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/31a520c29de47217.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/60d34407aa623387.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/60d34407aa623387.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/18032995e82b606a.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/18032995e82b606a.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/6c3f34e833f5040c.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/6c3f34e833f5040c.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/0b44fecd0eec4de8.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/0b44fecd0eec4de8.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/6990858c423ee821.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/6990858c423ee821.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/cba2f9c9ec0a5795.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/cba2f9c9ec0a5795.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/3b991331d49717f9.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/3b991331d49717f9.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/a15d58106978cae5.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/a15d58106978cae5.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/dce6181ab6db2625.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/dce6181ab6db2625.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/08d2a1344cce186a.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/08d2a1344cce186a.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/4aac65a614f7abdb.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/4aac65a614f7abdb.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/53b35532ace5d7c5.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/53b35532ace5d7c5.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/1809626d49d0dff1.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/1809626d49d0dff1.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/70b84961cb691abf.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/70b84961cb691abf.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/bc093205626f1295.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/bc093205626f1295.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/688c8defe98da2f3.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/688c8defe98da2f3.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/b583288dccd95558.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/b583288dccd95558.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/998df76f0a5a5526.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/998df76f0a5a5526.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><link rel="preload" href="/_next/static/css/6a557515b5a4036b.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" as="style"/><link rel="stylesheet" href="/_next/static/css/6a557515b5a4036b.css?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-78c92fac7aa8fdd8.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script src="https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js" type="text/javascript" defer="" data-nscript="beforeInteractive"></script><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-document-language="true" type="text/javascript" charSet="UTF-8" data-domain-script="3625bb82-8e0e-4be8-80d3-257e4f469168" defer="" data-nscript="beforeInteractive"></script><script defer="" src="/_next/static/chunks/40481.0e9441455ae33c4f.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/53270.cbf1bf77bd9f27c7.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/60823.c76067985a2e11a4.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/39202.8c4d6f60bc7e3b36.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/38870.bdda886772ba84f8.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/48909.e8b9df13274fe05a.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/3480.fa475f868d2fb3aa.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/53780.b7b531389f9de946.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/14442.24b2e6bfd4fc5259.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/8560.bc05adbb7986189a.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/3981.18de88a4db84cc9a.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/1711.bae4ab957ce62043.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/30213.2b97328fb5a450ea.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/62197.f5e9221cab34696c.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/62590.dd4cb6e9016f2746.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/20611.2a718518e3116634.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/27192.812b8bc8335ddf58.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/80663.abc610c4148f3128.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/827.4c11cd9d5067adab.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/73539.2d83f4303c9e4b30.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/68622-e44baf361494f562.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/93109.8d3deb8362277954.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/89686.726402bf6be2a867.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/67296.2994b60af9df1ddb.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/46359.8454c396458251de.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/74386.e9d262108b4d77a0.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/87037.892262c9dd42cfeb.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/25174.35d9cc3e6858c6c1.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/87730.d1348cd1f65c142c.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/33079.58b5fead16fab234.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/55137.5d98ed6ddcba7036.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/48437.7f1d06d2ee4cfa5e.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/39964.20727f96997d49b5.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/71572.ac35e9aa67c810aa.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/35288.24c815434449b45b.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/87758.05cde5a65fb14c81.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/57959.6f0790802e46f140.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/41305.3c01308b3534bca7.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/64460.4d5792fb894d532d.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/24969.d17db629032fe089.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/62788.75932ae0efa5b868.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/43501.00cce99c5655e2ce.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/16233.434ec912f385b09e.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/37310.75a39bb2c04b19d7.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/83519.dab810db2f4be42d.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/55524.6344b1658ac59f37.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/72045.0f834aee87da8363.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/45162.7eb5aa968481588a.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/72438.7edb31aa817146b4.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/60598.cddb61a01062f74a.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/29291.a6ef5692a451f612.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/77809.4f9d6f42cce54100.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/93781.4b5a68bc2703db5d.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/98859.ca12ca43986840bc.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/3730.72f8ca2580b2bb27.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/19482.f6338748eeccc580.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/16823.5b1805ce8be658c1.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/69805.f66ef5ff015149b9.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/32737.816ac553c10d13d1.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/23885.0e5fba4578dddd2e.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/77093.d3dafcdd7ee55ff6.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/57299.fb4496e2905118ef.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/27002.6fe2ff0fc1d89938.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/80885.1bccc36c0e38a8a8.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/72955.a4d2684fb1436d45.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script defer="" src="/_next/static/chunks/83715.3c05d559696f782d.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP"></script><script src="/_next/static/chunks/webpack-c1ed23fc39a93ea8.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/chunks/framework-903f078a461de64d.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/chunks/main-35483e0f71eada81.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/chunks/pages/_app-1866fa2a1f877dde.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/chunks/57606-17d8894511c45703.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/chunks/pages/%5B%5B...slug%5D%5D-77db6b6c7d38c8b3.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/sbbqT0Rrdp-Nb378BFVQE/_buildManifest.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script><script src="/_next/static/sbbqT0Rrdp-Nb378BFVQE/_ssgManifest.js?dpl=dpl_4ijJEVBigUBEwh2RpW86MbgmVGzP" defer=""></script></head><body><div id="__next"><div class="body-wrapper" data-lang="en"><div id="root" data-sb-object-id="cOAqlEEzQiJUPTqIF5MboP">          <style type="text/css"> #onetrust-consent-sdk svg {display: inline;} </style><header data-sb-field-path="siteSettings:header" class="Header_root__hz_yL h-[90px] sticky z-[100] top-0 !py-0 h-[71px] relative !px-0" data-testid="root"><div class="crawled-navigation sr-only"><ul role="list"><li role="listitem">About<ul role="list"><li role="listitem"><a href="/about/our-company/" tabindex="-1">Our Company</a></li><li role="listitem"><a href="/about/leadership" tabindex="-1">Leadership</a></li><li role="listitem">Corporate Responsibility<ul role="list"><li role="listitem">Corporate Sustainability<ul role="list"><li role="listitem"><a href="/about/corporate-responsibility/corporate-sustainability/sustainability-approach" tabindex="-1">Sustainability Approach</a></li><li role="listitem"><a href="/about/corporate-responsibility/corporate-sustainability/access-to-medicine" tabindex="-1">Access to Medicines</a></li><li role="listitem"><a href="/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/" tabindex="-1">Sustainability Disclosures</a></li></ul></li><li role="listitem">Ethics & Disclosures<ul role="list"><li role="listitem"><a href="/about/corporate-responsibility/ethics-disclosures/ethics" tabindex="-1">Ethics</a></li><li role="listitem"><a href="/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/" tabindex="-1">Transparency Disclosures</a></li></ul></li><li role="listitem"><a href="/about/corporate-responsibility/positions/" tabindex="-1">Positions</a></li><li role="listitem"><a href="/about/corporate-responsibility/corporate-giving" tabindex="-1">Corporate Giving</a></li></ul></li><li role="listitem">Corporate Governance<ul role="list"><li role="listitem"><a href="/about/corporate-governance/strategy/" tabindex="-1">Governance Strategy</a></li><li role="listitem"><a href="/about/corporate-governance/governance-structure" tabindex="-1">Governance Structure</a></li><li role="listitem"><a href="/about/corporate-governance/charters-and-reports" tabindex="-1">Charters and Reports</a></li></ul></li></ul></li><li role="listitem">Science<ul role="list"><li role="listitem"><a href="/science/areas-of-focus/" tabindex="-1">Areas of Focus</a></li><li role="listitem"><a href="/science/research-and-development" tabindex="-1">Research and Development</a></li><li role="listitem"><a href="/science/pipeline" tabindex="-1">Pipeline</a></li><li role="listitem">Products<ul role="list"><li role="listitem"><a href="/science/products" tabindex="-1">Our Products</a></li><li role="listitem"><a href="/science/products/manufacturing" tabindex="-1">Manufacturing</a></li><li role="listitem"><a href="/science/products/suppliers" tabindex="-1">Suppliers</a></li></ul></li><li role="listitem"><a href="/science/clinical-trials" tabindex="-1">Clinical Trials</a></li></ul></li><li role="listitem">Our Impact<ul role="list"><li role="listitem"><a href="/our-impact/our-stories" tabindex="-1">Our Stories</a></li></ul></li><li role="listitem">Newsroom<ul role="list"><li role="listitem"><a href="/newsroom/press-releases" tabindex="-1">Press Releases</a></li><li role="listitem"><a href="/newsroom/statements" tabindex="-1">Statements</a></li><li role="listitem"><a href="/newsroom/media-resources" tabindex="-1">Media Resources</a></li></ul></li><li role="listitem">Investors<ul role="list"><li role="listitem"><a href="/investors/overview" tabindex="-1">Overview </a></li><li role="listitem"><a href="/investors/financial-results/quarterly-results" tabindex="-1">Financial Results</a></li><li role="listitem"><a href="/investors/events" tabindex="-1">Investor Events</a></li><li role="listitem"><a href="/investors/contact" tabindex="-1">Investor Contact</a></li></ul></li><li role="listitem"><a href="/careers" tabindex="-1">Careers</a></li></ul></div><div class="Container_root__5fKNx flex items-center h-full"><div class="flex-none w-[121px] max-sm:w-[56px] -ml-0.5"><a class="flex items-center justify-center min-w-[44px] min-h-[44px]" aria-label="Takeda - Global" data-sb-link-ignore="false" data-sb-field-path=".logo" href="/"><span class="ImageBlock_root__p_rMO ImageBlock_rootFill__ts5qS ImageBlock_rootLimitWidth__EMprg" data-testid="root" style="aspect-ratio:720 / 256"><img alt="Takeda logo" __metadata="[object Object]" fetchpriority="high" loading="eager" decoding="async" data-nimg="fill" class="ImageBlock_image__sHiB_ rounded-none" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;object-fit:cover;color:transparent;aspect-ratio:720 / 256" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257"/></span></a></div><nav class="relative items-center justify-start hidden h-full mr-5 lg:flex pt-1 invisible"><ul class="relative flex pl-10 overflow-x-auto xl:pl-20 no-scrollbar"><li class="relative z-[100] min-w-fit mr-10 font-bold uppercase text-text-color text-sm leading-4 mb-1 min-h-[24px] pt-1"><button tabindex="0" class="cursor-default min-w-[44px] min-h-[44px]"><span class="transition-colors duration-300 ease-in-out font-bold uppercase my-underline link-underline">About</span></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg" style="left:undefinedpx"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/our-company/">Our Company</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/leadership/">Leadership</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><button tabindex="-1" class="flex justify-between w-full cursor-default"><span>Corporate Responsibility</span><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="18" height="24" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Chevron right</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg animate-grow-from-bottom-left absolute min-h-full !top-0 overflow-x-auto xl:overflow-x-visible" style="left:300px"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><button tabindex="-1" class="flex justify-between w-full cursor-default"><span>Corporate Sustainability</span><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="18" height="24" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Chevron right</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg animate-grow-from-bottom-left !top-0 absolute min-h-full" style="left:300px"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/corporate-sustainability/sustainability-approach/">Sustainability Approach</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/corporate-sustainability/access-to-medicine/">Access to Medicines</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/">Sustainability Disclosures</a></li></ul></div></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><button tabindex="-1" class="flex justify-between w-full cursor-default"><span>Ethics & Disclosures</span><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="18" height="24" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Chevron right</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg animate-grow-from-bottom-left !top-0 absolute min-h-full" style="left:300px"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/ethics-disclosures/ethics/">Ethics</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/">Transparency Disclosures</a></li></ul></div></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/positions/">Positions</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-responsibility/corporate-giving/">Corporate Giving</a></li></ul></div></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><button tabindex="-1" class="flex justify-between w-full cursor-default"><span>Corporate Governance</span><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="18" height="24" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Chevron right</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg animate-grow-from-bottom-left absolute min-h-full !top-0 overflow-x-auto xl:overflow-x-visible" style="left:300px"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-governance/strategy/">Governance Strategy</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-governance/governance-structure/">Governance Structure</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/about/corporate-governance/charters-and-reports/">Charters and Reports</a></li></ul></div></li></ul></div></li><li class="relative z-[100] min-w-fit mr-10 font-bold uppercase text-text-color text-sm leading-4 mb-1 min-h-[24px] pt-1"><button tabindex="0" class="cursor-default min-w-[44px] min-h-[44px]"><span class="transition-colors duration-300 ease-in-out font-bold uppercase my-underline link-underline">Science</span></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg" style="left:undefinedpx"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/areas-of-focus/">Areas of Focus</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/research-and-development/">Research and Development</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/pipeline/">Pipeline</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><button tabindex="-1" class="flex justify-between w-full cursor-default"><span>Products</span><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="18" height="24" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Chevron right</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg animate-grow-from-bottom-left absolute min-h-full !top-0 overflow-x-auto xl:overflow-x-visible" style="left:300px"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/products/">Our Products</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/products/manufacturing/">Manufacturing</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/products/suppliers/">Suppliers</a></li></ul></div></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/science/clinical-trials/">Clinical Trials</a></li></ul></div></li><li class="relative z-[100] min-w-fit mr-10 font-bold uppercase text-text-color text-sm leading-4 mb-1 min-h-[24px] pt-1"><button tabindex="0" class="cursor-default min-w-[44px] min-h-[44px]"><span class="transition-colors duration-300 ease-in-out font-bold uppercase my-underline link-underline">Our Impact</span></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg" style="left:undefinedpx"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/our-impact/our-stories/">Our Stories</a></li></ul></div></li><li class="relative z-[100] min-w-fit mr-10 font-bold uppercase text-text-color text-sm leading-4 mb-1 min-h-[24px] pt-1"><button tabindex="0" class="cursor-default min-w-[44px] min-h-[44px]"><span class="transition-colors duration-300 ease-in-out font-bold uppercase my-underline link-underline">Newsroom</span></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg" style="left:undefinedpx"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/newsroom/press-releases/">Press Releases</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/newsroom/statements/">Statements</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/newsroom/media-resources/">Media Resources</a></li></ul></div></li><li class="relative z-[100] min-w-fit mr-10 font-bold uppercase text-text-color text-sm leading-4 mb-1 min-h-[24px] pt-1"><button tabindex="0" class="cursor-default min-w-[44px] min-h-[44px]"><span class="transition-colors duration-300 ease-in-out font-bold uppercase my-underline link-underline link-underline--active">Investors</span></button><div class="hidden fixed no-scrollbar min-w-[300px] p-7 top-16 bg-white shadow-lg" style="left:undefinedpx"><ul class="flex flex-col"><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/investors/overview/">Overview </a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/investors/financial-results/quarterly-results/">Financial Results</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case !font-bold" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/investors/events/">Investor Events</a></li><li class="flex justify-between transition-all duration-300 [&:not(:last-child)]:mb-9 text-text-color hover:font-bold font-[400] text-[16px] leading-[19px] normal-case" role="listitem"><a class="w-full" data-sb-link-ignore="false" tabindex="-1" href="/investors/contact/">Investor Contact</a></li></ul></div></li><li class="relative z-[100] min-w-fit mr-10 font-bold uppercase text-text-color text-sm leading-4 mb-1 min-h-[24px] pt-1"><a class="flex items-center justify-center min-w-[44px] min-h-[44px]" data-sb-link-ignore="false" href="/careers/"><span class="transition-colors duration-300 ease-in-out font-bold uppercase my-underline link-underline">Careers</span></a></li></ul></nav><div class="flex items-center h-full ml-auto"><div class="h-full hidden lg:flex lg:relative items-center justify-end font-bold 2xl:min-w-[280px] "><div class="z-10 flex-col flex-1 truncate"><form><div class="z-10 flex flex-row items-center group"><button title="Search..." aria-label="Search..." class="flex justify-start items-center align-middle search-close-ignored-element truncate m-px min-w-[44px] min-h-[44px]" type="button" tabindex="0"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="flex-none block w-5 group-hover:text-primary" role="img" aria-hidden="true" data-testid="icon-Search"><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg><span class="uppercase hidden ml-2 text-sm truncate 2xl:block">Search...</span></button><input title="Search..." aria-label="Search..." type="text" class="flex flex-col ml-[26px] 2xl:ml-[28px] mt-[-3px] absolute opacity-0 max-w-[135px] 2xl:max-w-[235px] outline-none placeholder:uppercase placeholder:text-medium-grey text-sm xl:text-base placeholder:text-sm w-[20px] 2xl:w-[80px]" tabindex="-1" value=""/><button aria-label="Clear Search Input" class="search-close-ignored-element absolute right-10 transition-opacity hidden p-1 opacity-0 pointer-events-none !right-0" type="button" tabindex="-1"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="22" height="23" viewBox="0 0 22 23" class="w-[14px] h-[14px]" role="img" aria-hidden="true" data-testid="icon-dotcom/Close"><path d="M21.3937 3.28314C21.7036 2.97313 21.8777 2.55273 21.8777 2.11439C21.8777 1.67604 21.7036 1.25564 21.3937 0.945639C21.0842 0.639753 20.6667 0.468204 20.2315 0.468204C19.7964 0.468204 19.3788 0.639753 19.0694 0.945639L10.9907 9.02438L2.91852 0.952251C2.76493 0.798055 2.58241 0.675704 2.38142 0.592219C2.18043 0.508735 1.96493 0.465759 1.7473 0.465759C1.52966 0.465759 1.31416 0.508735 1.11317 0.592219C0.912183 0.675704 0.729657 0.798055 0.576068 0.952251C0.270181 1.2617 0.0986328 1.67927 0.0986328 2.11439C0.0986328 2.5495 0.270181 2.96707 0.576068 3.27652L8.65977 11.3553L0.587639 19.4274C0.277729 19.7374 0.103631 20.1578 0.103631 20.5961C0.103631 21.0345 0.277729 21.4549 0.587639 21.7649C0.897089 22.0708 1.31466 22.2423 1.74977 22.2423C2.18489 22.2423 2.60246 22.0708 2.91191 21.7649L10.9907 13.6862L19.0628 21.7583C19.3728 22.0682 19.7932 22.2423 20.2315 22.2423C20.6699 22.2423 21.0903 22.0682 21.4003 21.7583C21.7062 21.4488 21.8777 21.0313 21.8777 20.5961C21.8777 20.161 21.7062 19.7435 21.4003 19.434L13.3215 11.3553L21.3937 3.28314Z"></path></svg></button></div><span class="w-[0px] h-[1px] hidden lg:block absolute bottom-[14px] bg-medium-grey transition-[width] duration-200"></span></form></div><div class="items-center h-full transition-opacity hidden"><div class="NavigatorMenu_root__ezqGa" data-testid="root"><div class="flex items-center h-full gap-2.5 px-3 py-5 lg:py-0 2xl:px-5 text-sm"><button class="flex items-center justify-center gap-2.5 hover:text-primary min-w-[44px] min-h-[44px]"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 20 20" class="w-5" role="img" aria-hidden="false" data-testid="icon-Globe"><title>Open Location Finder</title><path d="M 7.3388671875 0.3564453125 C 8.188476562500002 0.11881510416666666 9.075520833333336 0 10 0 C 10.91796875 0 11.803385416666668 0.11881510416666666 12.65625 0.3564453125 C 13.509114583333336 0.5940755208333334 14.306640625 0.9293619791666667 15.048828125 1.3623046875 C 15.791015625 1.7952473958333335 16.466471354166668 2.316080729166667 17.0751953125 2.9248046875 C 17.683919270833336 3.533528645833334 18.20475260416667 4.208984375000001 18.6376953125 4.951171875 C 19.070638020833336 5.693359375 19.405924479166668 6.490885416666668 19.6435546875 7.34375 C 19.881184895833336 8.196614583333334 20 9.08203125 20 10 C 20 10.91796875 19.881184895833336 11.803385416666668 19.6435546875 12.65625 C 19.405924479166668 13.509114583333336 19.070638020833336 14.306640625 18.6376953125 15.048828125 C 18.20475260416667 15.791015625 17.683919270833336 16.466471354166668 17.0751953125 17.0751953125 C 16.466471354166668 17.683919270833336 15.791015625 18.20475260416667 15.048828125 18.6376953125 C 14.306640625 19.070638020833336 13.509114583333336 19.405924479166668 12.65625 19.6435546875 C 11.803385416666668 19.881184895833336 10.91796875 20 10 20 C 9.08203125 20 8.196614583333334 19.881184895833336 7.34375 19.6435546875 C 6.490885416666668 19.405924479166668 5.693359375 19.070638020833336 4.951171875 18.6376953125 C 4.208984375000001 18.20475260416667 3.533528645833334 17.683919270833336 2.9248046875 17.0751953125 C 2.316080729166667 16.466471354166668 1.7952473958333335 15.791015625 1.3623046875 15.048828125 C 0.9293619791666667 14.306640625 0.5940755208333334 13.5107421875 0.3564453125 12.6611328125 C 0.11881510416666666 11.8115234375 0 10.924479166666668 0 10 C 0 9.08203125 0.11881510416666666 8.196614583333334 0.3564453125 7.34375 C 0.5940755208333334 6.490885416666668 0.9293619791666667 5.693359375 1.3623046875 4.951171875 C 1.7952473958333335 4.208984375000001 2.316080729166667 3.533528645833334 2.9248046875 2.9248046875 C 3.533528645833334 2.316080729166667 4.208984375000001 1.7952473958333335 4.951171875 1.3623046875 C 5.693359375 0.9293619791666667 6.4892578125 0.5940755208333334 7.3388671875 0.3564453125 Z M 14.6484375 6.25 L 17.900390625 6.25 C 17.652994791666668 5.72265625 17.353515625 5.226236979166668 17.001953125 4.7607421875 C 16.650390625 4.295247395833334 16.259765625 3.870442708333334 15.830078125 3.486328125 C 15.400390625 3.102213541666667 14.934895833333336 2.760416666666667 14.43359375 2.4609375 C 13.932291666666668 2.1614583333333335 13.408203125 1.9173177083333335 12.861328125 1.728515625 C 13.095703125 2.0540364583333335 13.307291666666668 2.399088541666667 13.49609375 2.763671875 C 13.684895833333336 3.128255208333334 13.8525390625 3.504231770833334 13.9990234375 3.8916015625 C 14.1455078125 4.278971354166667 14.270833333333336 4.671223958333334 14.375 5.068359375 C 14.479166666666668 5.465494791666668 14.5703125 5.859375 14.6484375 6.25 Z M 18.388671875 12.5 C 18.62955729166667 11.69921875 18.750000000000004 10.865885416666668 18.75 10 C 18.750000000000004 9.134114583333336 18.62955729166667 8.300781250000002 18.388671875 7.5 L 14.84375 7.5 C 14.895833333333336 7.916666666666668 14.934895833333336 8.331705729166668 14.9609375 8.7451171875 C 14.986979166666664 9.158528645833334 15 9.576822916666668 15 10 C 15 10.423177083333336 14.986979166666664 10.841471354166668 14.9609375 11.2548828125 C 14.934895833333336 11.668294270833336 14.895833333333336 12.083333333333336 14.84375 12.5 L 18.388671875 12.5 Z M 9.1064453125 18.486328125 C 9.383138020833336 18.662109375000004 9.680989583333336 18.750000000000004 10 18.75 C 10.319010416666668 18.750000000000004 10.616861979166668 18.662109375000004 10.8935546875 18.486328125 C 11.170247395833336 18.310546875000004 11.42578125 18.079427083333336 11.66015625 17.79296875 C 11.89453125 17.506510416666668 12.1044921875 17.1826171875 12.2900390625 16.8212890625 C 12.4755859375 16.4599609375 12.639973958333336 16.09375 12.783203125 15.72265625 C 12.926432291666668 15.3515625 13.046875 14.993489583333336 13.14453125 14.6484375 C 13.2421875 14.303385416666668 13.317057291666668 14.00390625 13.369140625 13.75 L 6.630859375 13.75 C 6.682942708333334 14.00390625 6.7578125 14.303385416666668 6.85546875 14.6484375 C 6.953125 14.993489583333336 7.073567708333334 15.3515625 7.216796875 15.72265625 C 7.360026041666668 16.09375 7.5244140625 16.4599609375 7.7099609375 16.8212890625 C 7.8955078125 17.1826171875 8.10546875 17.506510416666668 8.33984375 17.79296875 C 8.57421875 18.079427083333336 8.829752604166668 18.310546875000004 9.1064453125 18.486328125 Z M 6.416015625 12.5 L 13.583984375 12.5 C 13.636067708333336 12.083333333333336 13.6767578125 11.668294270833336 13.7060546875 11.2548828125 C 13.7353515625 10.841471354166668 13.75 10.423177083333336 13.75 10 C 13.75 9.576822916666668 13.7353515625 9.158528645833334 13.7060546875 8.7451171875 C 13.6767578125 8.331705729166668 13.636067708333336 7.916666666666668 13.583984375 7.5 L 6.416015625 7.5 C 6.363932291666668 7.916666666666668 6.3232421875 8.331705729166668 6.2939453125 8.7451171875 C 6.2646484375 9.158528645833334 6.25 9.576822916666668 6.25 10 C 6.25 10.423177083333336 6.2646484375 10.841471354166668 6.2939453125 11.2548828125 C 6.3232421875 11.668294270833336 6.363932291666668 12.083333333333336 6.416015625 12.5 Z M 1.611328125 7.5 C 1.3704427083333335 8.300781250000002 1.25 9.134114583333336 1.25 10 C 1.25 10.865885416666668 1.3704427083333335 11.69921875 1.611328125 12.5 L 5.15625 12.5 C 5.104166666666668 12.083333333333336 5.065104166666668 11.668294270833336 5.0390625 11.2548828125 C 5.013020833333334 10.841471354166668 5 10.423177083333336 5 10 C 5 9.576822916666668 5.013020833333334 9.158528645833334 5.0390625 8.7451171875 C 5.065104166666668 8.331705729166668 5.104166666666668 7.916666666666668 5.15625 7.5 L 1.611328125 7.5 Z M 10.8935546875 1.513671875 C 10.616861979166668 1.337890625 10.319010416666668 1.25 10 1.25 C 9.680989583333336 1.25 9.383138020833336 1.337890625 9.1064453125 1.513671875 C 8.829752604166668 1.689453125 8.57421875 1.920572916666667 8.33984375 2.20703125 C 8.10546875 2.493489583333334 7.8955078125 2.8173828125 7.7099609375 3.1787109375 C 7.5244140625 3.5400390625 7.360026041666668 3.90625 7.216796875 4.27734375 C 7.073567708333334 4.648437500000001 6.953125 5.006510416666668 6.85546875 5.3515625 C 6.7578125 5.696614583333334 6.682942708333334 5.99609375 6.630859375 6.25 L 13.369140625 6.25 C 13.317057291666668 5.99609375 13.2421875 5.696614583333334 13.14453125 5.3515625 C 13.046875 5.006510416666668 12.926432291666668 4.648437500000001 12.783203125 4.27734375 C 12.639973958333336 3.90625 12.4755859375 3.5400390625 12.2900390625 3.1787109375 C 12.1044921875 2.8173828125 11.89453125 2.493489583333334 11.66015625 2.20703125 C 11.42578125 1.920572916666667 11.170247395833336 1.689453125 10.8935546875 1.513671875 Z M 6.50390625 2.763671875 C 6.692708333333334 2.399088541666667 6.904296875 2.0540364583333335 7.138671875 1.728515625 C 6.591796875 1.9173177083333335 6.067708333333334 2.1614583333333335 5.56640625 2.4609375 C 5.065104166666668 2.760416666666667 4.599609375 3.102213541666667 4.169921875 3.486328125 C 3.740234375 3.870442708333334 3.349609375 4.295247395833334 2.998046875 4.7607421875 C 2.646484375 5.226236979166668 2.3470052083333335 5.72265625 2.099609375 6.25 L 5.3515625 6.25 C 5.4296875 5.859375 5.520833333333334 5.465494791666668 5.625 5.068359375 C 5.729166666666668 4.671223958333334 5.8544921875 4.278971354166667 6.0009765625 3.8916015625 C 6.1474609375 3.504231770833334 6.315104166666668 3.128255208333334 6.50390625 2.763671875 Z M 5.3515625 13.75 L 2.099609375 13.75 C 2.3470052083333335 14.27734375 2.646484375 14.773763020833336 2.998046875 15.2392578125 C 3.349609375 15.70475260416667 3.740234375 16.12955729166667 4.169921875 16.513671875 C 4.599609375 16.897786458333336 5.065104166666668 17.239583333333336 5.56640625 17.5390625 C 6.067708333333334 17.83854166666667 6.591796875 18.08268229166667 7.138671875 18.271484375 C 6.904296875 17.94596354166667 6.692708333333334 17.600911458333336 6.50390625 17.236328125 C 6.315104166666668 16.871744791666668 6.1474609375 16.495768229166668 6.0009765625 16.1083984375 C 5.8544921875 15.721028645833336 5.729166666666668 15.32877604166667 5.625 14.931640625 C 5.520833333333334 14.534505208333336 5.4296875 14.140625 5.3515625 13.75 Z M 13.49609375 17.236328125 C 13.307291666666668 17.600911458333336 13.095703125 17.94596354166667 12.861328125 18.271484375 C 13.408203125 18.08268229166667 13.932291666666668 17.83854166666667 14.43359375 17.5390625 C 14.934895833333336 17.239583333333336 15.400390625 16.897786458333336 15.830078125 16.513671875 C 16.259765625 16.12955729166667 16.650390625 15.70475260416667 17.001953125 15.2392578125 C 17.353515625 14.773763020833336 17.652994791666668 14.27734375 17.900390625 13.75 L 14.6484375 13.75 C 14.5703125 14.140625 14.479166666666668 14.534505208333336 14.375 14.931640625 C 14.270833333333336 15.32877604166667 14.1455078125 15.721028645833336 13.9990234375 16.1083984375 C 13.8525390625 16.495768229166668 13.684895833333336 16.871744791666668 13.49609375 17.236328125 Z"></path></svg><span class="uppercase">GLOBAL</span></button><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" width="1" height="15" aria-hidden="false" class="" role="img" data-testid="icon-dotcom/VerticalLine"><title>VerticalLine</title><path stroke="#000" stroke-width=".5" d="M.533.512v14"></path></svg><span>EN</span></div></div></div></div><div class="flex leading-[0]"><input aria-label="Search" type="text" class="absolute h-0 w-0 opacity-0"/><div class="NavigatorMenu_root__ezqGa" data-testid="root"><button aria-label="open search menu"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="none" viewBox="0 0 24 24" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="block w-6 lg:hidden" role="img" aria-hidden="false" data-testid="icon-Search"><title>Search</title><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg></button></div><div class="NavigatorMenu_root__ezqGa" data-testid="root"><button aria-label="Open mobile menu" type="button" class="HamButton_root__hNTHT ml-3"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="28" height="24" class="HamButton_icon__6HRf9" role="img" aria-hidden="true" viewBox="0 0 28 24" data-testid="icon-Hamburger"><rect width="100%" height="1"></rect><rect y="10.5" width="100%" height="1"></rect><rect y="21" width="100%" height="1"></rect></svg></button></div></div></div></div></header><main><h1 class="sr-only">Investor Events and Presentations | Takeda Pharmaceuticals</h1><div dir="ltr"><div></div><div data-sb-field-path="sections"><section data-section-position="0" data-sb-field-path="sections.0" data-section-name="# Investor Events " data-exclude-from-nav="false" class="global-pt global-pb mt-0 global-mb !pb-4 !mb-0 max-sm:h-auto"><div class="relative"><div class="relative inset-0 min-h-[500px] max-sm:min-h-[200px]"><div class="relative h-[500px] max-sm:h-[200px] opacity-90 bg-white"><span class="ImageBlock_root__p_rMO ImageBlock_rootFill__ts5qS ImageBlock_rootLimitWidth__EMprg" data-testid="root" style="aspect-ratio:1600 / 900"><img alt="Glasses on newspaper" loading="lazy" decoding="async" data-nimg="fill" class="ImageBlock_image__sHiB_ rounded-none" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;object-fit:cover;object-position:center;color:transparent;aspect-ratio:1600 / 900" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/q_auto:eco/f_auto/v1/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/q_auto:eco/f_auto/v1/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/q_auto:eco/f_auto/v1/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/q_auto:eco/f_auto/v1/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/q_auto:eco/f_auto/v1/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900"/></span><div class="absolute inset-0 bg-black" style="opacity:0%"></div></div><div class="absolute bottom-0 left-0 w-11/12 px-14 pt-10 pb-8 bg-black/80 max-sm:relative max-sm:w-full max-sm:p-6 max-lg:px-8 max-lg:py-8"><hr class="absolute w-36 max-md:w-28 top-0 left-0 h-[6px] bg-primary border-none"/><div class="space-y-4"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><h2 id="Investor_Events" class="!m-0 !font-light normal-case tracking-normal md:line-clamp-3 text-white !mr-10 sm:!m-0 title" data-sb-field-path=".title">Investor Events</h2></div></div></div></div><div class="w-full max-sm:absolute max-sm:bottom-0 max-sm:pb-4 sm:bg-light-grey text-3xl font-medium" data-sb-field-path=".navigationGroup"><div class="NavigationGroupRedesign_root__AjnpQ" data-testid="root"><ul data-sb-field-path=".links" class="NavigationGroupRedesign_list__mE15P" data-testid="list"><li data-sb-field-path=".0" class="NavigationGroupRedesign_listItem__nDx4a NavigationGroupRedesign_listItemHidden__HBYqB" data-testid="listItem"><a class="LinkWithIcon_root__5ncib NavigationLink_link__x5UcW NavigationGroupRedesign_link__sXCqC" aria-label="Overview" data-sb-link-ignore="false" data-active="false" __metadata="[object Object]" type="Link" tabindex="-1" href="/investors/overview/"><span data-testid="label">Overview</span></a></li><li data-sb-field-path=".1" class="NavigationGroupRedesign_listItem__nDx4a NavigationGroupRedesign_listItemHidden__HBYqB" data-testid="listItem"><a class="LinkWithIcon_root__5ncib NavigationLink_link__x5UcW NavigationGroupRedesign_link__sXCqC" aria-label="Financial Highlights" data-sb-link-ignore="false" data-active="false" __metadata="[object Object]" type="Link" tabindex="-1" href="/investors/financial-highlights/"><span data-testid="label">Financial Highlights</span></a></li><li data-sb-field-path=".2" class="NavigationGroupRedesign_listItem__nDx4a NavigationGroupRedesign_listItemHidden__HBYqB" data-testid="listItem"><a class="LinkWithIcon_root__5ncib NavigationLink_link__x5UcW NavigationGroupRedesign_link__sXCqC" aria-label="Quarterly Results" data-sb-link-ignore="false" data-active="false" __metadata="[object Object]" type="Link" tabindex="-1" href="/investors/financial-results/quarterly-results/"><span data-testid="label">Quarterly Results</span></a></li><li data-sb-field-path=".3" class="NavigationGroupRedesign_listItem__nDx4a NavigationGroupRedesign_listItemHidden__HBYqB" data-testid="listItem"><a class="LinkWithIcon_root__5ncib NavigationLink_link__x5UcW NavigationGroupRedesign_link__sXCqC" aria-label="Stock Information & Shareholder Returns" data-sb-link-ignore="false" data-active="false" __metadata="[object Object]" type="Link" tabindex="-1" href="/investors/stock-information/"><span data-testid="label">Stock Information & Shareholder Returns</span></a></li><li data-sb-field-path=".4" class="NavigationGroupRedesign_listItem__nDx4a NavigationGroupRedesign_listItemHidden__HBYqB" data-testid="listItem"><a class="LinkWithIcon_root__5ncib NavigationLink_link__x5UcW NavigationGroupRedesign_link__sXCqC" aria-label="Securities Report & Form 20-F " data-sb-link-ignore="false" data-active="false" __metadata="[object Object]" type="Link" tabindex="-1" href="/investors/sec-filings-and-security-reports/"><span data-testid="label">Securities Report & Form 20-F </span></a></li><li data-sb-field-path=".5" class="NavigationGroupRedesign_listItem__nDx4a NavigationGroupRedesign_listItemHidden__HBYqB" data-testid="listItem"><a class="LinkWithIcon_root__5ncib NavigationLink_link__x5UcW NavigationLink_currentPageLink__9tZyg NavigationGroupRedesign_link__sXCqC" aria-label="IR Events" data-sb-link-ignore="false" data-active="true" __metadata="[object Object]" type="Link" tabindex="-1" href="/investors/events/"><span data-testid="label">IR Events</span></a></li></ul></div></div></div></section><section data-section-position="1" data-sb-field-path="sections.1" data-section-name="Divider Section Redesign" data-exclude-from-nav="true" class="global-pt global-pb global-mt global-mb !pt-4 !mt-0 !mb-0 bg-white"><div class="Container_root__5fKNx"><hr data-sb-field-path=".divider" class="Divider_root__damfW bg-dark-grey"/></div></section><section data-section-position="2" data-sb-field-path="sections.2" data-section-name="## Contents " data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb !pt-4 !pb-0 !mt-0 !mb-0 bg-white"><div class="Container_root__5fKNx"><header class="SectionTitleContainer_root__XGH__ text-dark-grey" data-testid="sectionTitleContainer"><div class="Markdown_root__pKQ5I" data-testid="root"><h2 id="Contents" class="SectionWrapperWithTitle_title__pmQu0" data-sb-field-path=".title">Contents</h2></div></header><div data-sb-field-path=".items" class="" data-testid="root"><div class="Grid_grid__UAr5E QuickLinksSection_grid__QDRGI" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 22%), 1fr))" data-testid="grid"></div></div></div></section><section data-section-position="3" data-sb-field-path="sections.3" data-section-name="" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb !mb-0 !mt-0 bg-white"><div class="Container_root__5fKNx"><div data-sb-field-path=".rows" data-testid="rows"><div class="ColumnsRowsSection_row__jRYNK ColumnsRowsSection_row1-1-1__9DvCc" style="gap:20px 5%" data-sb-field-path=".0" data-testid="row"><div data-sb-field-path=".cell.0" data-testid="cellWrapper"><div data-sb-field-path=".components" data-testid="cell"><section data-sb-field-path=".0" class="global-pt global-pb global-mt global-mb !mb-0 !mr-14 bg-white"><div class="Container_root__5fKNx"><div data-sb-field-path=".items" class="" data-testid="root"><div class="Grid_grid__UAr5E QuickLinksSection_grid__QDRGI" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 22%), 1fr))" data-testid="grid"><div class="Grid_gridItemWrapper__3STn4" data-testid="gridItemWrapper"><div data-sb-field-path=".0" class="QuickLinksItemNormal_root__QaYc1" data-testid="root"><div class="QuickLinksItemNormal_quickLinksMediaWrapper__z6dk8 border-transparent" data-testid="quickLinksMediaWrapper"><span class="ImageBlock_root__p_rMO ImageBlock_rootFill__ts5qS ImageBlock_rootLimitWidth__EMprg ImageBlock_rootGlobalBorderRadius__HvsBo QuickLinksItemNormal_quickLinksMedia__7PJM1 text-primary" data-testid="root" style="aspect-ratio:42 / 41"><img data-sb-field-path=".media.0.url" alt="chevron down" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" class="ImageBlock_image__sHiB_" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;object-fit:cover;color:transparent;aspect-ratio:42 / 41;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' %3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3CfeColorMatrix values='1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 100 -1' result='s'/%3E%3CfeFlood x='0' y='0' width='100%25' height='100%25'/%3E%3CfeComposite operator='out' in='s'/%3E%3CfeComposite in2='SourceGraphic'/%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage width='100%25' height='100%25' x='0' y='0' preserveAspectRatio='xMidYMid slice' style='filter: url(%23b);' href='data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAElBMVEXAIBnAIBnAIBnAIBnAIBnAIBm4tKS0AAAABnRSTlMjMBkMPROE4iCeAAAAPElEQVQIHRXBgQnAMAgAwdcJFDKACJlAOkDACSzZf5XSO+rHZOYmAAV3B1l9DOluI1YfZcRt8wT6UpO3PsI9BuYftIYnAAAAAElFTkSuQmCC'/%3E%3C/svg%3E")" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/Global/Investor/Chevron 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/Global/Investor/Chevron 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/Global/Investor/Chevron 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/Global/Investor/Chevron 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/Global/Investor/Chevron 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/Global/Investor/Chevron"/></span></div><div data-testid="linkDescriptionWrapper"><a class="QuickLinksItemNormal_link__cILmU text-primary" data-sb-link-ignore="false" href="/investors/events/#earnings-announcement-meetings--ir-events--broker-conferences">Earnings Announcement Meetings / IR Events / Broker Conferences</a></div></div></div></div></div></div></section></div></div><div data-sb-field-path=".cell.1" data-testid="cellWrapper"><div data-sb-field-path=".components" data-testid="cell"><section data-sb-field-path=".0" class="global-pt global-pb global-mt global-mb !mb-0 bg-white"><div class="Container_root__5fKNx"><div data-sb-field-path=".items" class="" data-testid="root"><div class="Grid_grid__UAr5E QuickLinksSection_grid__QDRGI" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 22%), 1fr))" data-testid="grid"><div class="Grid_gridItemWrapper__3STn4" data-testid="gridItemWrapper"><div data-sb-field-path=".0" class="QuickLinksItemNormal_root__QaYc1" data-testid="root"><div class="QuickLinksItemNormal_quickLinksMediaWrapper__z6dk8 border-transparent" data-testid="quickLinksMediaWrapper"><span class="ImageBlock_root__p_rMO ImageBlock_rootFill__ts5qS ImageBlock_rootLimitWidth__EMprg ImageBlock_rootGlobalBorderRadius__HvsBo QuickLinksItemNormal_quickLinksMedia__7PJM1 text-primary" data-testid="root" style="aspect-ratio:42 / 41"><img data-sb-field-path=".media.0.url" alt="chevron down" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" class="ImageBlock_image__sHiB_" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;object-fit:cover;color:transparent;aspect-ratio:42 / 41;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' %3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3CfeColorMatrix values='1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 100 -1' result='s'/%3E%3CfeFlood x='0' y='0' width='100%25' height='100%25'/%3E%3CfeComposite operator='out' in='s'/%3E%3CfeComposite in2='SourceGraphic'/%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage width='100%25' height='100%25' x='0' y='0' preserveAspectRatio='xMidYMid slice' style='filter: url(%23b);' href='data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAElBMVEXAIBnAIBnAIBnAIBnAIBnAIBm4tKS0AAAABnRSTlMjMBkMPROE4iCeAAAAPElEQVQIHRXBgQnAMAgAwdcJFDKACJlAOkDACSzZf5XSO+rHZOYmAAV3B1l9DOluI1YfZcRt8wT6UpO3PsI9BuYftIYnAAAAAElFTkSuQmCC'/%3E%3C/svg%3E")" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/Global/Investor/Chevron 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/Global/Investor/Chevron 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/Global/Investor/Chevron 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/Global/Investor/Chevron 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/Global/Investor/Chevron 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/Global/Investor/Chevron"/></span></div><div data-testid="linkDescriptionWrapper"><a class="QuickLinksItemNormal_link__cILmU text-primary" data-sb-link-ignore="false" href="/investors/events/#annual-shareholders-meetings">Annual Shareholders Meetings</a></div></div></div></div></div></div></section></div></div><div data-sb-field-path=".cell.2" data-testid="cellWrapper"><div data-sb-field-path=".components" data-testid="cell"><section data-sb-field-path=".0" class="global-pt global-pb global-mt global-mb !mb-0 bg-white"><div class="Container_root__5fKNx"><div data-sb-field-path=".items" class="" data-testid="root"><div class="Grid_grid__UAr5E QuickLinksSection_grid__QDRGI" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 22%), 1fr))" data-testid="grid"><div class="Grid_gridItemWrapper__3STn4" data-testid="gridItemWrapper"><div data-sb-field-path=".0" class="QuickLinksItemNormal_root__QaYc1" data-testid="root"><div class="QuickLinksItemNormal_quickLinksMediaWrapper__z6dk8 border-transparent" data-testid="quickLinksMediaWrapper"><span class="ImageBlock_root__p_rMO ImageBlock_rootFill__ts5qS ImageBlock_rootLimitWidth__EMprg ImageBlock_rootGlobalBorderRadius__HvsBo QuickLinksItemNormal_quickLinksMedia__7PJM1 text-primary" data-testid="root" style="aspect-ratio:42 / 41"><img data-sb-field-path=".media.0.url" alt="chevron down" __metadata="[object Object]" loading="lazy" decoding="async" data-nimg="fill" class="ImageBlock_image__sHiB_" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;object-fit:cover;color:transparent;aspect-ratio:42 / 41;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' %3E%3Cfilter id='b' color-interpolation-filters='sRGB'%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3CfeColorMatrix values='1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 100 -1' result='s'/%3E%3CfeFlood x='0' y='0' width='100%25' height='100%25'/%3E%3CfeComposite operator='out' in='s'/%3E%3CfeComposite in2='SourceGraphic'/%3E%3CfeGaussianBlur stdDeviation='20'/%3E%3C/filter%3E%3Cimage width='100%25' height='100%25' x='0' y='0' preserveAspectRatio='xMidYMid slice' style='filter: url(%23b);' href='data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAElBMVEXAIBnAIBnAIBnAIBnAIBnAIBm4tKS0AAAABnRSTlMjMBkMPROE4iCeAAAAPElEQVQIHRXBgQnAMAgAwdcJFDKACJlAOkDACSzZf5XSO+rHZOYmAAV3B1l9DOluI1YfZcRt8wT6UpO3PsI9BuYftIYnAAAAAElFTkSuQmCC'/%3E%3C/svg%3E")" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/Global/Investor/Chevron 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/Global/Investor/Chevron 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/Global/Investor/Chevron 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/Global/Investor/Chevron 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/Global/Investor/Chevron 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/Global/Investor/Chevron"/></span></div><div data-testid="linkDescriptionWrapper"><a class="QuickLinksItemNormal_link__cILmU text-primary" data-sb-link-ignore="false" href="/investors/events/#retail-investor-events">Retail Investor Events</a></div></div></div></div></div></div></section></div></div></div></div></div></section><section data-section-position="4" data-sb-field-path="sections.4" data-section-name="Divider Section Redesign" data-exclude-from-nav="true" class="global-pt global-pb global-mt global-mb !mt-4 bg-white"><div class="Container_root__5fKNx"><hr data-sb-field-path=".divider" class="Divider_root__damfW bg-dark-grey"/></div></section><section data-section-position="5" data-sb-field-path="sections.5" data-section-name="<div id="earnings-announcement-meetings--ir-events--broker-conferences">## Earnings Announcement Meetings / IR Events / Broker Conferences" data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__5fKNx"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="mb-5" data-sb-field-path="title"><div id="earnings-announcement-meetings--ir-events--broker-conferences"></div><h2 id="Earnings_Announcement_Meetings_IR_Events_Broker_Conferences">Earnings Announcement Meetings / IR Events / Broker Conferences</h2></div></div><ul data-sb-field-path=".tabs" class="flex justify-start items-center gap-4" role="list"><li class="w-1/2" role="listitem"><button id="tab-1" data-sb-field-path=".[0]" data-active="true" class="whitespace-nowrap text-base text-center relative w-full bg-primary text-white border border-primary border-b-0 after:content-[''] after:absolute after:left-[calc(50%_-_0.4rem)] after:-bottom-2 after:text-primary after:bg-primary after:rotate-45 after:w-4 after:h-4 py-2 "><span data-sb-field-path=".title" class="pb-[1px] text-white">Upcoming Events</span></button></li><li class="w-1/2" role="listitem"><button id="tab-2" data-sb-field-path=".[1]" data-active="false" class="whitespace-nowrap text-base text-center relative w-full bg-white text-dark-grey border border-medium-grey border-b-0 py-2 "><span data-sb-field-path=".title" class="pb-[1px] text-dark-grey">FY2024 Past Events</span></button></li></ul><hr class="border-2 border-primary"/><div data-sb-field-path=".tabs.0" class="flex flex-col gap-12 max-md:gap-8"><div data-sb-field-path=".content.0"><div class="RTE_root__IAyax bg-white pt-6 p-4" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="R_D_Day_Focus_on_Late_Stage_Pipeline_and_Market_Opportunity">R&D Day: Focus on Late-Stage Pipeline and Market Opportunity</h3><p>(6:30pm ~ EST on December 12, 2024)<br/>*Duration: Approximately 5 hours</p><p>Presentation material will be posted at 5:30pm EST on December 12th. (7:30am JST on December 13th)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://zoom.us/webinar/register/WN_outURVqXT-aImrwATSefJw">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://zoom.us/webinar/register/WN_outURVqXT-aImrwATSefJw</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/Global/Investor/events/2024/ics/r_d-day-focus-on-late-stage-pipeline-and-market-opportunity-en.ics">Add to Calender</a></p></li></ul><hr/><h4 id="Quarterly_Results_Quarter_3_FY2024">Quarterly Results - Quarter 3 FY2024</h4><p>(January 30, 2025)</p><hr/><h4 id="Quarterly_Results_Quarter_4_FY2024">Quarterly Results - Quarter 4 FY2024</h4><p>(May 8, 2025)</p><hr/></div></div></div></div></div><div data-sb-field-path=".tabs.1" class="flex flex-col gap-12 max-md:gap-8 hidden"><div data-sb-field-path=".content.0"><div class="RTE_root__IAyax bg-white pt-6 p-4" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><div id="tab-3"></div><h4 id="Quarterly_Results_Quarter_2_FY2024">Quarterly Results - Quarter 2 FY2024</h4><p>(October 31, 2024)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" data-sb-link-ignore="false" href="/investors/financial-results/quarterly-results/">Read more</a></li></ul><hr/><h4 id="Quarterly_Results_Quarter_1_FY2024">Quarterly Results - Quarter 1 FY2024</h4><p>(July 31, 2024)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results/">Read more</a></li></ul><hr/><h4 id="TAK_861_Investor_Call_on_Phase_2b_Narcolepsy_Type_1_Data">TAK-861 Investor Call on Phase 2b Narcolepsy Type 1 Data</h4><p>(7:30pm- 8:30pm CDT, 8:30pm - 9:30pm EDT on June 3, 2024)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20240604/4/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20240604/4/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1717400991/Global/Investor/events/2024/tak-861-investor-call-en.pdf">Presentation</a></p></li></ul><hr/><h4 id="Quarterly_Results_Quarter_4_FY2023">Quarterly Results - Quarter 4 FY2023</h4><p>(May 9, 2024)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2023/">Read more</a></li></ul><hr/></div></div></div></div></div></div></section><section data-section-position="6" data-sb-field-path="sections.6" data-section-name="## Event Archive " data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__5fKNx"><header class="SectionTitleContainer_root__XGH__ text-dark-grey" data-testid="sectionTitleContainer"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><h2 id="Event_Archive" class="SectionWrapperWithTitle_title__pmQu0" data-sb-field-path=".title">Event Archive</h2></div><hr class="Divider_root__damfW bg-primary SectionWrapperWithTitle_titleBottomBorder__Gd46k"/></header><div data-sb-field-path=".accordions"><div id="afa44aad7eb523e4b18d228a9e799ce2" data-sb-field-path=".[0]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2023 (April 2023-March 2024)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><span class="text-primary" data-sb-field-path=".title"></span></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h4 id="Cowen_44_sup_th_sup_Health_Care_Conference">Cowen 44<sup>th</sup> Health Care Conference</h4><p>(9:50am – 10:20am EST on March 6, 2024)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_3_FY2023">Quarterly Results - Quarter 3 FY2023</h4><p>(February 1, 2024)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2023/">Read more</a></li></ul><hr/><h4 id="42nd_Annual_J_P_Morgan_Healthcare_Conference">42nd Annual J.P. Morgan Healthcare Conference</h4><p>(5:15pm – 5:55pm PST on January 8, 2024)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Plasma_Derived_Therapies_Investor_Event">Plasma-Derived Therapies Investor Event</h4><p>(6:00 – 7:00pm EST on December 5, 2023)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20231206/3/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20231206/3/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></li><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1701756390/Global/Investor/events/2023/PDT_Presentation_2023_EN.pdf">Presentation</a></li></ul><hr/><h4 id="Jefferies_London_Healthcare_Conference">Jefferies London Healthcare Conference</h4><p>(4:00 – 4:25am EST on November 14, 2023)</p><p>(9:00 – 9:25am GMT on November 14, 2023)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_2_FY2023">Quarterly Results - Quarter 2 FY2023</h4><p>(October 26, 2023)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2023/">Read more</a></li></ul><hr/><h4 id="Morgan_Stanley_Healthcare_Conference">Morgan Stanley Healthcare Conference</h4><p>(3:35 – 4:05pm EDT on September 11, 2023)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_1_FY2023">Quarterly Results - Quarter 1 FY2023</h4><p>(July 27, 2023)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2023/">Read more</a></li></ul><hr/><h4 id="Quarterly_Results_Quarter_4_FY2022">Quarterly Results - Quarter 4 FY2022</h4><p>(May 11, 2023)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2022/">Read more</a></li></ul><hr/></div></div></div></div></div><div id="71f40cf2-a8dc-457a-a955-57f74eaac6ce" data-sb-field-path=".[1]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2022 (April 2022-March 2023)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><span class="text-primary" data-sb-field-path=".title"></span></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h4 id="TAK_279_TYK2_inhibitor_Investor_Call_on_Phase_2b_Psoriasis_Data">TAK-279 (TYK2 inhibitor) Investor Call on Phase 2b Psoriasis Data</h4><p>(March 18, 2023)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20230319/2/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20230319/2/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1679175992/siteassets/system/investors/investor--events/TAK-279%20Investor%20Call_EN.pdf">Presentation</a></p></li></ul><hr/><h4 id="QDENGA_Investor_call">QDENGA Investor call</h4><p>(March 15, 2023)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20230316/2/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20230316/2/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1679624806/siteassets/system/investors/investor--events/Qdenga%20Presentation_EN.pdf">Presentation</a></p></li></ul><hr/><h4 id="Cowen_43rd_Health_Care_Conference">Cowen 43rd Health Care Conference</h4><p>(March 6, 2023)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_3_FY2022">Quarterly Results - Quarter 3 FY2022</h4><p>(February 2, 2023)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2022/">Read more</a></li></ul><hr/><h4 id="41st_Annual_J_P_Morgan_Healthcare_Conference">41st Annual J.P. Morgan Healthcare Conference</h4><p>(January 9, 2023)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192363/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc23_presentation.pdf">Presentation</a></li></ul><hr/><h4 id="Conference_call_regarding_acquisition_of_NDI_034858_From_Nimbus_Therapeutics">Conference call regarding acquisition of NDI-034858 From Nimbus Therapeutics</h4><p>(December 13, 2022)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4af01e/siteassets/system/investors/investor--events/takeda-ir-call_en.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20221214/3/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20221214/3/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li></ul><hr/><h4 id="Jefferies_London_Healthcare_Conference">Jefferies London Healthcare Conference</h4><p>(November 15, 2022)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_2_FY2022">Quarterly Results - Quarter 2 FY2022</h4><p>(October 27, 2022)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2022/">Read more</a></li></ul><hr/><h4 id="Seminar_Investors_and_Analysts_on_Lysosomal_Storage_Diseases_LSD">Seminar: Investors and Analysts on Lysosomal Storage Diseases (LSD)</h4><p>(October 4, 2022)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4a7c83/siteassets/system/investors/investor--events/en_lsd-ir-disease-seminar.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20221004/2/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20221004/2/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li></ul><hr/><h4 id="Morgan_Stanley_Healthcare_Conference">Morgan Stanley Healthcare Conference</h4><p>(September 12, 2022)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_1_FY2022">Quarterly Results - Quarter 1 FY2022</h4><p>(July 28, 2022)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2022/">Read more</a></li></ul><hr/><h4 id="Jefferies_Healthcare_Conference">Jefferies Healthcare Conference</h4><p>(June 9, 2022)</p><ul><li>This event was closed.</li></ul><hr/><h4 id="Quarterly_Results_Quarter_4_FY2021">Quarterly Results - Quarter 4 FY2021</h4><p>(May 11, 2022)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2021/">Read more</a></li></ul></div></div></div></div></div><div id="c2e000a4-a4a3-4580-99bf-5787d4483829" data-sb-field-path=".[2]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2021 (April 2021-March 2022)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Cowen_42_sup_nd_sup_Health_Care_Conference">Cowen 42<sup>nd</sup> Health Care Conference</h3><p>(2:50pm – 3:20pm EST on March 8, 2022)</p><ul><li>This event was closed.</li></ul><hr/><h3 id="Seminar_Investors_and_Analysts_on_Short_Bowel_Syndrome_SBS_and_Complex_Crohn_s_Perianal_Fistulas_CPF">Seminar: Investors and Analysts on Short Bowel Syndrome (SBS) and Complex Crohn’s Perianal Fistulas (CPF)</h3><p>(1:00pm JST on February 24, 2022)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_ir-disease-seminar_gi.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://www.irwebcasting.com/20220224/2/index.html">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://www.irwebcasting.com/20220224/2/index.html</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li></ul><hr/><h3 id="Quarterly_Results_Quarter_3_FY2021">Quarterly Results - Quarter 3 FY2021</h3><p>(Held on February 3, 2022)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2021/">Read more</a></li></ul><hr/><h3 id="40_sup_th_sup_Annual_J_P_Morgan_Healthcare_Conference">40<sup>th </sup>Annual J.P. Morgan Healthcare Conference</h3><p>(4:30pm – 5:10pm EST on January 10, 2022)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192362/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc-presentation_2022.pdf">Presentation</a></li></ul><hr/><h3 id="Takeda_Management_Call">Takeda Management Call</h3><p>(6:00pm – 7:00pm EST on January 10, 2022)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_takeda-mgmt-call_jan-11.pdf">Presentation</a></li></ul><hr/><h3 id="Plasma_Derived_Therapies_Investor_Event">Plasma-Derived Therapies Investor Event</h3><p>(5:30pm – 7:30pm EST on November 17, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727524/legacy-dotcom/siteassets/system/investors/investor--events/IRDayPresentation_EN.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2021">Quarterly Results - Quarter 2 FY2021</h3><p>(Held on October 28, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2021/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2021">Quarterly Results - Quarter 1 FY2021</h3><p>(Held on July 30, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2021/">Read more</a></li></ul><hr/><h3 id="Finance_Investor_Day">Finance Investor Day</h3><p>(7:00pm – 9:00pm EDT on July 12, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192361/legacy-dotcom/siteassets/system/investors/investor--events/finance-investor-day_en.pdf">Presentation</a></li></ul><hr/><h3 id="Oncology_Strategic_Update_Call">Oncology Strategic Update Call</h3><p>(6:30pm – 7:45pm EDT on June 8, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/asco-2021-ir-event_en.pdf">Presentation</a></li></ul><hr/><h3 id="2021_Biopharma_CEO_Investor_Forum">2021 Biopharma CEO Investor Forum</h3><p>(8:00am – 8:50am EDT on June 7, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727530/legacy-dotcom/siteassets/system/investors/investor--events/Takeda_CECP_CEO.pdf">Presentation</a></li></ul><hr/><h3 id="Wave_1_Pipeline_Market_Opportunity_Call_Part_2">Wave 1 Pipeline Market Opportunity Call Part 2</h3><p>(8:00am – 10:30am EDT on April 6, 2021)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/Wave1MarketEventPart2_EN.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727534/legacy-dotcom/siteassets/system/what-we-do/research-and-development-rd-in-takeda/our-pipeline/PipelineFactsheet_Apr_2021.pdf">R&D Pipeline Factsheet</a></p></li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2020">Quarterly Results - Quarter 4 FY2020</h3><p>(Held on May 11, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2020/">Read more</a></li></ul></div></div></div></div></div><div id="b9e3a5e1-c426-4199-b636-cff97d1f9655" data-sb-field-path=".[3]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2020 (April 2020-March 2021)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Growth_and_Emerging_Markets_Strategic_Update_Call">Growth and Emerging Markets Strategic Update Call</h3><p>(6:30am-8:15am EST on March 11, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/GEM-IR-Day-Presentation.pdf">Presentation</a></li></ul><hr/><h3 id="Seminar_Investors_and_Analysts_on_Takeda_s_Japan_Oncology_Business_and_its_oncology_products_and_disease_in_Japan">Seminar: Investors and Analysts on Takeda’s Japan Oncology Business and its oncology products and disease in Japan</h3><p>(1:00pm-2:45pm JST on February 25, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192359/legacy-dotcom/siteassets/system/investors/investor--events/20210225_japan-_oncology-event_en.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_3_FY2020">Quarterly Results - Quarter 3 FY2020</h3><p>(Held on February 4, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2020/">Read more</a></li></ul><hr/><h3 id="World_Conference_on_Lung_Cancer_WCLC_Investor_Event">World Conference on Lung Cancer (WCLC) Investor Event</h3><p>(5:00pm-6:00pm EST on January 29, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/investor--events/WCLC-2021-IR-Event.pdf">Presentation</a></li></ul><hr/><h3 id="39_sup_th_sup_Annual_J_P_Morgan_Healthcare_Conference">39<sup>th </sup>Annual J.P. Morgan Healthcare Conference</h3><p>(5:20pm-6:00pm EST on January 11, 2021)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/investor--events/JPMHC2021.pdf">Presentation</a></li></ul><hr/><h3 id="Wave_1_Pipeline_Market_Opportunity_Call">Wave 1 Pipeline Market Opportunity Call</h3><p>(5:00pm-7:15pm EST on December 8, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727539/legacy-dotcom/siteassets/system/investors/investor--events/Wave1presentation_en.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2020">Quarterly Results - Quarter 2 FY2020</h3><p>(Held on October 29, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2020/">Read more</a></li></ul><hr/><h3 id="Seminar_Investors_and_Analysts_on_Inflammatory_Bowel_Disease">Seminar: Investors and Analysts on Inflammatory Bowel Disease</h3><p>(1:00pm JST on September 2, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4ab563/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200902_ibd_en.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2020">Quarterly Results - Quarter 1 FY2020</h3><p>(Held on July 31, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2020/">Read more</a></li></ul><hr/><h3 id="Seminar_Investors_and_Analysts_on_Hereditary_Angioedema_HAE">Seminar: Investors and Analysts on Hereditary Angioedema (HAE)</h3><p>(1:00pm JST on June 30, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4ab54d/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200630_p01_en.pdf">Presentation</a></li></ul><hr/><h3 id="Oncology_Focused_Investor_Call">Oncology Focused Investor Call</h3><p>(8:00am EDT / 9:00pm JST on June 8, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192591/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2020/june-8-onc-investor-event-presentation-06.02.20-final.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2019">Quarterly Results - Quarter 4 FY2019</h3><p>(Held on May 13, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2019/">Read more</a></li></ul></div></div></div></div></div><div id="d45a2a09-a8de-4f58-ba97-10981bed037e" data-sb-field-path=".[4]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2019 (April 2019-March 2020)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Quarterly_Results_Quarter_3_FY2019">Quarterly Results - Quarter 3 FY2019</h3><p>(Held on February 4, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2019/">Read more</a></li></ul><hr/><h3 id="38_sup_th_sup_Annual_J_P_Morgan_Healthcare_Conference">38<sup>th </sup>Annual J.P. Morgan Healthcare Conference</h3><p>(4:00pm-4:55pm PST on January 14, 2020)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/JPMHC_2020.pdf">Presentation</a></li></ul><hr/><h3 id="R_D_Day_and_Plasma_Derived_Therapies_Day_in_Tokyo">R&D Day and Plasma-Derived Therapies Day in Tokyo</h3><p>(11:00am-5:00pm JST on November 21, 2019)</p><h4 id="Plasma_Derived_Therapies">Plasma-Derived Therapies</h4><ul><li><p>Plasma-Derived Therapies Overview: Julie Kim, President, Plasma-Derived Therapies Business Unit</p></li><li><p>Plasma-Derived Therapies R&D: Christopher Morabito, Head, R&D, Plasma-Derived Therapies</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1729283799/Global/Investor/events/2019/pdt_day_tokyo.pdf">Click to Download</a></p></li></ul><h4 id="R_D_Day">R&D Day</h4><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_tokyo-rd-day_all-slides_final_20191121.pdf">Click to Download the slides</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_0---takeda_rdday_intro_final.pdf">Takeda: A Global Values-Based, R&D-Driven Biopharmaceutical Leader: </a>Christophe Weber, President & CEO</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_1---andy-rd-day_final.pdf">Translating Science into Highly Innovative, Life-changing Medicines: </a>Andy Plump, President, R&D</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_2---io-rd-day_final.pdf">Oncology and Cell Therapies with Spotlight on CAR-NK: </a>Chris Arendt, Head, Oncology Drug Discovery Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192575/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_3---tak-788-rd-day_final.pdf">Spotlight on Oncology Opportunities TAK-788: </a>Rachael Brake, Global Program Leader, Oncology</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_4---tak-924-rd-day_final.pdf">Spotlight on Oncology Opportunities Pevonedistat: </a>Phil Rowlands, Head, Oncology Therapeutic Area Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_5---rare-disease-rd-day_final.pdf">Rare Diseases & Gene Therapy: </a>Dan Curran, Head, Rare Disease Therapeutic Area Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_6---ox2r-rd-day_final.pdf">Spotlight on Orexin2R agonists: </a>Deborah Hartman, Global Program Leader, Neuroscience</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_7---gi-rd-days_final.pdf">Therapeutic Area Focus in GI with Spotlight on Celiac Disease: </a>Asit Parikh, Head, GI Therapeutic Area Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf">Takeda R&D Pipeline Narrative</a></p></li></ul><hr/><h3 id="Plasma_Derived_Therapies_Day_in_Covington_Georgia">Plasma-Derived Therapies Day in Covington, Georgia</h3><p>(11:15am-3:45pm EST on November 15, 2019)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/PDT_20191115.pdf">All slides</a></p></li><li><p>Plasma-Derived Therapies Overview: Julie Kim, President, Plasma-Derived Therapies Business Unit</p></li><li><p>Plasma-Derived Therapies R&D: Christopher Morabito, Head, R&D, Plasma-Derived Therapies</p></li><li><p>Covington Site Introduction: Carlos Soto, Covington Site Head</p></li></ul><hr/><h3 id="R_D_Day_in_New_York">R&D Day in New York</h3><p>(12:30pm-4:00pm EST on November 14, 2019)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/all-slides_20191114_vf.pdf">All slides</a></p></li><li><p>Welcome and Opening Remarks: Sheelagh Cawley-Knopf, Head, R&D Global Portfolio Strategy</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192572/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/0---christophe--slide-20191114_vf.pdf">Takeda: A Global Values-Based, R&D-Driven Biopharmaceutical Leader</a>: Christophe Weber, President & CEO</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/1_Andy_20191114.pdf">Translating Science into Highly Innovative, Life-changing Medicines</a>: Andy Plump, President, R&D</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/2_IO_20191114.pdf">Oncology and Cell Therapies with Spotlight on CAR-NK</a>: Chris Arendt, Head, Oncology Drug Discovery Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727598/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/3_TAK788_20191114.pdf">Spotlight on Oncology Opportunities TAK-788</a>: Rachael Brake, Global Program Leader, Oncology</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/4_TAK924_20191114.pdf">Spotlight on Oncology Opportunities Pevonedistat</a>: Phil Rowlands, Head, Oncology Therapeutic Area Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192574/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/5_rare-disease_20191114_2.pdf">Rare Diseases & Gene Therapy</a>: Dan Curran, Head, Rare Disease Therapeutic Area Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/6_OX2R_20191114.pdf">Spotlight on Orexin2R agonists</a>: Deborah Hartman, Global Program Leader, Neuroscience</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/7_GI_20191114.pdf">Therapeutic Area Focus in GI with Spotlight on Celiac Disease</a>: Asit Parikh, Head, GI Therapeutic Area Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf">Takeda R&D Pipeline Narrative</a></p></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2019">Quarterly Results - Quarter 2 FY2019</h3><p>(Held on October 31, 2019)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2019/">Read more</a></li></ul><hr/><h3 id="IR_meeting_with_analysts_and_investors_with_Julie_Kim_President_of_Takeda_s_Plasma_Derived_Therapies_Business_Unit">IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit</h3><p>(Held on October 10, 2019)</p><ul><li>This event was closed.</li></ul><hr/><h3 id="Morgan_Stanley_Healthcare_Conference">Morgan Stanley Healthcare Conference</h3><p>(Held on September 10, 2019 ET)</p><ul><li>This event was closed.</li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2019">Quarterly Results - Quarter 1 FY2019</h3><p>(Held on July 31, 2019)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2019/">Read more</a></li></ul><hr/><h3 id="IR_Seminar_Plasma_Derived_Therapies_Business">IR Seminar “Plasma-Derived Therapies Business”</h3><p>(Held on July 12, 2019)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192570/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/20190712-ir-presentation-on-pdt_final_e.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2018">Quarterly Results - Quarter 4 FY2018</h3><p>(Held on May 14, 2019)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2018/">Read more</a></li></ul></div></div></div></div></div><div id="b25dbc57-bc42-44fb-93bc-5005f99a117c" data-sb-field-path=".[5]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2018 (April 2018-March 2019)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Quarterly_Results_Quarter_3_FY2018">Quarterly Results - Quarter 3 FY2018</h3><p>(Held on February 1, 2019)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2018/">Read more</a></li></ul><hr/><h3 id="37_sup_th_sup_Annual_J_P_Morgan_Healthcare_Conference">37<sup>th </sup>Annual J.P. Morgan Healthcare Conference</h3><p>(Held on January 8, 2019 PST)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727541/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/JPMHC2019-E.pdf">Presentation</a></li></ul><hr/><h3 id="Meeting_regarding_Acquisition_of_Shire_plc_by_Takeda">Meeting regarding Acquisition of Shire plc by Takeda</h3><p>(Held on January 7, 2019)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192566/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/shire-deal-close-announcement_en.pdf">Presentation</a>: A Global, Values-based, R&D-driven Biopharmaceutical Leader</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/offer-for-shire/">More details on Takeda's offer to acquire Shire Plc.</a></p></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2018">Quarterly Results - Quarter 2 FY2018</h3><p>(Held on October 31, 2018)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2018/">Read more</a></li></ul><hr/><h3 id="Takeda_s_R_D_Investor_Day_Boston">Takeda’s R&D Investor Day (Boston)</h3><p>(October 11, 2018)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727546/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULL_DECK_Boston_E.pdf">Presentation</a>: Delivering on our R&D vision</p></li><li><p>Andy Plump, Chief Medical and Scientific Officer</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_Oncology_Boston_E.pdf">Oncology</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_DECK_Boston_E.pdf">Gastroenterology</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727551/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_DECK_Boston_E.pdf">Neuroscience</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727552/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VBU_DECK_Boston_E.pdf">Vaccines</a></p></li></ul></li></ul><hr/><h3 id="Takeda_s_R_D_Investor_Day_Tokyo">Takeda’s R&D Investor Day (Tokyo)</h3><p>(September 27, 2018)</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULLDECK_E_rd_day.pdf">Presentation</a>: Delivering on our R&D vision</p></li><li><p>Andy Plump, Chief Medical and Scientific Officer</p><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_ONCOLOGY_E.pdf">Oncology</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727557/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_E.pdf">Gastroenterology</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727558/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_E.pdf">Neuroscience</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727559/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VACCINE_E.pdf">Vaccines</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727560/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/5_IPARK_E.pdf">Shonan iPark</a></p></li></ul></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2018">Quarterly Results - Quarter 1 FY2018</h3><p>(Held on July 31, 2018)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2018/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2017">Quarterly Results - Quarter 4 FY2017</h3><p>(Held on May 14, 2018)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2017/">Read more</a></li></ul><hr/><h3 id="Conference_Call_Regarding_Proposed_Acquisition_of_Shire_plc_by_Takeda">Conference Call Regarding Proposed Acquisition of Shire plc by Takeda</h3><p>(Held on May 8/9, 2018)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192569/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/takeda-to-acquire-shire-accelerating-takeda_s-transformation-to-deliver-more-for-patients.pdf">Presentation</a>: Takeda to Acquire Shire-Accelerating Takeda’s Transformation to Deliver More for Patients</li></ul></div></div></div></div></div><div id="d4c06805-6a70-4d42-90ee-8528937fcf32" data-sb-field-path=".[6]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2017 (April 2017-March 2018)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Quarterly_Results_Quarter_3_FY2017">Quarterly Results - Quarter 3 FY2017</h3><p>(Held on February 1, 2018)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2017/">Read more</a></li></ul><hr/><h3 id="36_sup_th_sup_Annual_J_P_Morgan_Healthcare_Conference">36<sup>th </sup>Annual J.P. Morgan Healthcare Conference</h3><p>(Held on January 8, 2018 PST)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727540/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2017/36th-annual-j.p.-morgan-healthcare-conference-held-on-january-8-2018-pst/qr2017_q3_p01_en.pdf">Presentation</a></li></ul><hr/><h3 id="Jefferies_2017_Global_Healthcare_Conference">Jefferies 2017 Global Healthcare Conference</h3><p>(Presented November 16, 2017, 10:00 GMT)</p><ul><li>This event was closed.</li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2017">Quarterly Results - Quarter 2 FY2017</h3><p>(Held on November 1, 2017)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2017/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2017">Quarterly Results - Quarter 1 FY2017</h3><p>(Held on July 28, 2017)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2017/">Read more</a></li></ul><hr/><h3 id="UBS_Global_Healthcare_Conference">UBS Global Healthcare Conference</h3><p>(Released on May 23, 2017, 9:30 EDT)</p><ul><li>This event was closed.</li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2016">Quarterly Results - Quarter 4 FY2016</h3><p>(Held on May 10, 2017)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2016/">Read more</a></li></ul></div></div></div></div></div><div id="43ea30193f66" data-sb-field-path=".[7]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2016 (April 2016-March 2017)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Quarterly_Results_Quarter_3_FY2016">Quarterly Results - Quarter 3 FY2016</h3><p>(Held on February 1, 2017)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2016/">Read more</a></li></ul><hr/><h3 id="Conference_Call_on_the_Acquisition_of_ARIAD_Pharmaceuticals">Conference Call on the Acquisition of ARIAD Pharmaceuticals</h3><p>(Released on January 10, 2017)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/conference-call-on-the-acquisition-of-ariad-pharmaceuticals-released-on-january-10-2017/takeda-to-acquire-ariad-pharmaceuticals.pdf">Presentation</a></li></ul><hr/><h3 id="35_sup_th_sup_Annual_J_P_Morgan_Healthcare_Conference">35<sup>th</sup>Annual J.P. Morgan Healthcare Conference</h3><p>(Held on January 9, 2017)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/35thannual-j.p.-morgan-healthcare-conference-held-on-january-9-2017/j.p.-morgan-healthcare-conference-presentation.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2016">Quarterly Results - Quarter 2 FY2016</h3><p>(Held on October 28, 2016)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2016/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2016">Quarterly Results - Quarter 1 FY2016</h3><p>(Held on July 29, 2016)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2016/">Read more</a></li></ul><hr/><h3 id="Takeda_IR_Day">Takeda IR Day</h3><p>(Held on June 9, 2016)</p><ol start="1"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/1.-takeda-oncology.pdf">Takeda Oncology: </a>Christophe Bianchi, President, Global Oncology Business Unit</p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/2.-focused-world-class-r_d.pdf">Focused World Class R&D New approaches to innovation: </a>Andrew Plump, Chief Medical & Scientific Officer</p></li></ol><hr/><h3 id="Quarterly_Results_Quarter_4_FY2015">Quarterly Results - Quarter 4 FY2015</h3><p>(Held on May 10, 2016)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2015/">Read more</a></li></ul></div></div></div></div></div><div id="93cad3cd0d2b" data-sb-field-path=".[8]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2015 (April 2015-March 2016)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Quarterly_Results_Quarter_3_FY2015">Quarterly Results - Quarter 3 FY2015</h3><p>(Held on February 3, 2016)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2015/">Read more</a></li></ul><hr/><h3 id="34th_Annual_J_P_Morgan_Healthcare_Conference">34th Annual J.P. Morgan Healthcare Conference</h3><p>(Held on January 12, 2016)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2015/34th-annual-j.p.-morgan-healthcare-conference-held-on-january-12-2016/qr2015_q3_p01_en.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2015">Quarterly Results - Quarter 2 FY2015</h3><p>(Held on October 30, 2015)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2015/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2015">Quarterly Results - Quarter 1 FY2015</h3><p>(Held on July 30, 2015)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2015/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2014">Quarterly Results - Quarter 4 FY2014</h3><p>(Held on May 15, 2015)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2014/">Read more</a></li></ul></div></div></div></div></div><div id="c320bf2b58fb" data-sb-field-path=".[9]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2014 (April 2014-March 2015)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Takeda_IR_Event_A_Global_Leader_in_Gastroenterology">Takeda IR Event: A Global Leader in Gastroenterology</h3><p>(Held on March 9, 2015)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/takeda-ir-event--a-global-leader-in-gastroenterology-held-on-march-9-2015/qr2014_q3_p_en.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_3_FY2014">Quarterly Results - Quarter 3 FY2014</h3><p>(Held on February 5, 2015)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2014/">Read more</a></li></ul><hr/><h3 id="33_sup_rd_sup_Annual_J_P_Morgan_Healthcare_Conference">33<sup>rd</sup> Annual J.P. Morgan Healthcare Conference</h3><p>(Held on January 13, 2015)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/33rd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2015/qr2014_q3_e01_en.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2014">Quarterly Results - Quarter 2 FY2014</h3><p>(Held on October 30, 2014)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2014/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2014">Quarterly Results - Quarter 1 FY2014</h3><p>(Held on August 1, 2014)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2014/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_4_FY2013">Quarterly Results - Quarter 4 FY2013</h3><p>(Held on May 8, 2014)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2013/">Read more</a></li></ul></div></div></div></div></div><div id="cf7ad452a151" data-sb-field-path=".[10]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">FY2013 (April 2013-March 2014)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="RTE_text__cqJOV" data-sb-field-path=".text"><h3 id="Quarterly_Results_Quarter_3_FY2013">Quarterly Results - Quarter 3 FY2013</h3><p>(Held on February 5, 2014)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2013/">Read more</a></li></ul><hr/><h3 id="32_sup_nd_sup_Annual_J_P_Morgan_Healthcare_Conference">32<sup>nd</sup> Annual J.P. Morgan Healthcare Conference</h3><p>(Held on January 13, 2014)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2013/32nd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2014/j.p.-morgan-healthcare-conference-presentation.pdf">Presentation</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_2_FY2013">Quarterly Results - Quarter 2 FY2013</h3><p>(Held on October 31, 2013)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2013/">Read more</a></li></ul><hr/><h3 id="Quarterly_Results_Quarter_1_FY2013">Quarterly Results - Quarter 1 FY2013</h3><p>(Held on July 31, 2013)</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results-2013/">Read more</a></li></ul></div></div></div></div></div></div></div></section><section data-section-position="7" data-sb-field-path="sections.7" data-section-name="<div id="annual-shareholders-meetings">## Annual Shareholders Meetings</div> " data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white flex flex-col justify-center border-none"><div class="Container_root__5fKNx"><div class="flex w-full max-w-screen-xl"><div class="w-1/1"><div data-sb-field-path=".title" class="TextBody_markdownTitleWrapper___IjAs"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="TextBody_markdownTitle__Qu08o text-dark-grey"><div id="annual-shareholders-meetings"><h2 id="Annual_Shareholders_Meetings">Annual Shareholders Meetings</h2></div></div></div><hr class="Divider_root__damfW bg-primary TextBody_divider__1W9pV"/></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="TextBody_markdownText__NAlzY" data-sb-field-path=".text"><h3 id="148th_Ordinary_General_Meeting_of_Shareholders_June_26_2024">148th Ordinary General Meeting of Shareholders (June 26, 2024)</h3><ul><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1716784771/Global/Investor/events/shareholders-meetings/2024/sm_148_01_en.pdf">Notice of Convocation of the 148th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1716771549/Global/Investor/events/shareholders-meetings/2024/sm_148_02_en.pdf">Other items which are provided electronically</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/events/shareholder-letter-2024">Message from Christophe Weber, President & CEO</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1716782703/Global/Investor/events/shareholders-meetings/2024/sm_148_04_en.pdf">Takeda’s executive compensation overview</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results/">FY2023 Q4 Financial Results</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1717730187/Global/Investor/events/shareholders-meetings/2024/iss-reactive-statement_en.pdf">Statement from Masami Iijima, Chair of the Board of Directors Meeting of Takeda, in Response to Institutional Shareholder Services Inc.’s Voting Recommendations Ahead of the 148th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1717986546/Global/Investor/events/shareholders-meetings/2024/sm_148_05_en.pdf">Partial Correction to the Notice of Convocation of the 148th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1719479941/Global/Investor/events/shareholders-meetings/2024/sm_148_07_en.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1718759459/Global/Investor/events/shareholders-meetings/2024/sm_148_06_en.pdf">Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1719808017/Global/Investor/events/shareholders-meetings/2024/sm_148_08_en.pdf">Results of the Exercise of Voting Rights of the 148th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://bcove.video/3XNRk4n">The 148th Ordinary General Meeting of Shareholders (Video Recording)<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://bcove.video/3XNRk4n</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></p></li></ul></div></div></div></div></div></section><section data-section-position="8" data-sb-field-path="sections.8" data-section-name="## Past Shareholder Events & Reports " data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__5fKNx"><header class="SectionTitleContainer_root__XGH__ text-dark-grey" data-testid="sectionTitleContainer"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><h2 id="Past_Shareholder_Events_Reports" class="SectionWrapperWithTitle_title__pmQu0" data-sb-field-path=".title">Past Shareholder Events & Reports</h2></div><hr class="Divider_root__damfW bg-primary SectionWrapperWithTitle_titleBottomBorder__Gd46k"/></header><div data-sb-field-path=".accordions"><div id="32199af8ccc0bc31aad7a0a1d8b58a97" data-sb-field-path=".[0]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">147th Ordinary General Meeting of Shareholders(June 28, 2023)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><span class="text-primary" data-sb-field-path=".title"></span></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1687414710/Global/Investor/events/shareholders-meetings/2023/sm_147_01-2_en.pdf">Notice of Convocation of the 147th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_02_en.pdf">Other items which are provided electronically</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_03_en.pdf">Message from Christophe Weber, President & CEO</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_04_en.pdf">Takeda’s executive compensation overview</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/investors/financial-results/quarterly-results/">FY2022 Q4 Financial Results</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1687409671/Global/Investor/events/shareholders-meetings/2023/Notice_of_Amendment_to_be_posted_on_the_WEB.pdf">Partial Correction to the Notice of Convocation of 147th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1688013747/Global/Investor/events/shareholders-meetings/2023/sm_147_07_en.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1687488561/Global/Investor/events/shareholders-meetings/2023/sm_147_06_en.pdf">Notice of Resolutions</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1688114712/Global/Investor/events/shareholders-meetings/2023/sm_147_08_en.pdf">Results of the Exercise of Voting Rights</a></p></li></ul></div></div></div></div><div id="057d576b8bc0424837a40689333a399b" data-sb-field-path=".[1]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">147th Interim Report</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><span class="text-primary" data-sb-field-path=".title"></span></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1701060648/Global/Investor/events/shareholders-meetings/2023/br147_mid_en.pdf">Business report (interim period)</a></li></ul></div></div></div></div><div id="28f933212f1d" data-sb-field-path=".[2]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">146th Ordinary General Meeting of Shareholders(June 29, 2022)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><span class="text-primary" data-sb-field-path=".title"></span></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727586/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_01_en_1.pdf">Notice of convocation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727587/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_02_en.pdf">Items disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662725889/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_03_en_1.pdf">Message from Christophe Weber, President & CEO</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727590/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_04_en.pdf">Takeda's executive compensation overview</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727593/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_07_en.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_05_en.pdf">Notice of Resolutions</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_06_en.pdf">Results of the Exercise of Voting Rights</a></p></li></ul></div></div></div></div><div id="4b51947c6fd9ac34acb8eccb50da4af5" data-sb-field-path=".[3]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">146th Interim Report</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><span class="text-primary" data-sb-field-path=".title"></span></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1669795726/legacy-dotcom/siteassets/system/investors/report/business/br146_mid_en.pdf">Business report (interim period)</a></li></ul></div></div></div></div><div id="05b1931fbb0a" data-sb-field-path=".[4]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">145th Ordinary General Meeting of Shareholders (June 29, 2021)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_01_en.pdf">Notice of Convocation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_02_en.pdf">Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_03_en.pdf">Message from Christophe Weber, President & CEO</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727600/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_04_en_2.pdf">Takeda’s executive compensation overview</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727601/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_05_en.pdf">Partial Correction to the Notice of Convocation of the 145th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/shareholders-meetings/FY2021_GSM_28-June-2021_vF.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727603/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_06_en.pdf">Notice of Resolutions</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_07_en.pdf">Results of the Exercise of Voting Rights</a></p></li></ul></div></div></div></div><div id="161ab7cedacaa676379d8e74a246c18f" data-sb-field-path=".[5]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">145th Interim Report</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/report/business/br145_mid_en.pdf">Business report (interim period)</a></li></ul></div></div></div></div><div id="7643fab3-0d38-4869-9091-42e7ff9b53d3" data-sb-field-path=".[6]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">144th Ordinary General Meeting of Shareholders (June 24, 2020)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727605/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_01_en.pdf">Notice of Convocation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727607/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_02_en.pdf">Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727608/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_03_en.pdf">Message from Christophe Weber, President & CEO</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727609/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_04_en.pdf">Takeda's executive compensation overview</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4ab49c/siteassets/system/investors/shareholders-meetings/e_notice-of-amendment-to-be-posted-on-the-web.pdf">Partial Correction to the Items Disclosed via the Internet Concerning the Notice of Convocation of the 144th Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192637/legacy-dotcom/siteassets/system/investors/shareholders-meetings/cw2020_15min_gsm_presentation_1806.pdf">144th Ordinary General Meeting of Shareholders Christophe Weber</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4ab49c/siteassets/system/investors/shareholders-meetings/sm_144_05-en.pdf">Notice of Resolutions</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://www.takeda.com/4ab49f/siteassets/system/investors/shareholders-meetings/sm_144_06_en.pdf">Results of the Exercise of Voting Rights</a></p></li></ul></div></div></div></div><div id="11e8b94d50235150d60d6e4d211d556e" data-sb-field-path=".[7]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">144th Interim Report</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/business/br144_mid_en.pdf">Business report (interim period)</a></li></ul></div></div></div></div><div id="e81b402e-5a64-4fa2-ba04-39acfa0a3157" data-sb-field-path=".[8]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">143rd Ordinary General Meeting of Shareholders (June 27, 2019)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727611/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_01_en.pdf">Notice of Convocation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727612/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_02_en.pdf">Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1905_en.pdf">Message from Christophe Weber, President & CEO</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_03_en.pdf">Partial Correction to the Notice of Convocation of the 143rd Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727614/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_04_en.pdf">Supplemental Material for the Proposals at the 143rd Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727616/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_05_en.pdf">Summary of Takeda’s Modifications to the Executive Compensation Program and Future Considerations</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/shareholder-engagement-response-e-final-clean-v3.pdf">Takeda’s Recommendation to vote for Takeda’s Proposals at the 143rd Ordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sakane-san-message_e-with-attachment.pdf">A Statement of Confidence in the Leadership of Mr. Christophe Weber and Comments on the Proposals at the 143rd Ordinary General Meeting of Shareholders from Masahiro Sakane, the Chair of the Board of Directors Meeting of Takeda</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727621/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p01_en.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727622/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p02_en.pdf">Consolidated Financial Results for FY2018 and Guidance for FY2019</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1675192644/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_06-en.pdf">Notice of Resolutions</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727623/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_07_en.pdf">Results of the Exercise of Voting Rights</a></p></li></ul></div></div></div></div><div id="737f9d8976bb12fb2a934a59d7210155" data-sb-field-path=".[9]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">143rd Interim Report</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/report/business/br143_mid_en.pdf">Business report (interim period)</a></li></ul></div></div></div></div><div id="bec9ba37-fa09-44b8-9240-8aa714d59d08" data-sb-field-path=".[10]" class="last:border-b-[1px] border-t-[1px] border-b-dark-grey border-t-dark-grey"><button class="w-full flex transition justify-between px-8 py-6 max-xs:p-3 cursor-pointer text-dark-grey bg-white"><p data-sb-field-path=".title" class="font-bold mr-[20px] line-clamp-2 text-left">Extraordinary General Meeting of Shareholders (December 5, 2018)</p><div class="group"><span class="block w-[25px] h-[2px] transition-all mt-[50%] bg-primary group-hover:bg-primary-active rotate-90"></span><span class="block w-[25px] h-[2px] translate-y-[-2px] transition-all bg-primary group-hover:bg-primary-active"></span></div></button><div data-sb-field-path=".content" class="hidden overflow-hidden transition-all duration-500 bg-light-grey opacity-0 max-h-0"><div data-sb-field-path=".[0]" class="RTE_root__IAyax bg-light-grey px-8 pb-6 max-xs:p-3 max-xs:pt-0" data-testid="root"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><ul class="RTE_text__cqJOV" data-sb-field-path=".text"><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727624/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_01_en.pdf">Notice of Convocation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727625/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1811_en.pdf">Message from Christophe Weber, President & CEO, regarding the acquisition of Shire plc</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727626/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1115_en.pdf">Partial Correction to the Reference Document attached to the Notice of Convocation of the Extraordinary General Meeting of Shareholders</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727628/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_01_en.pdf">Presentation</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727629/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1205_en.pdf">Notice of Resolutions</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/raw/upload/v1662727630/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_02_en.pdf">Results of the Exercise of voting Rights</a></p></li><li><p><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" data-sb-link-ignore="false" href="/investors/overview/offer-for-shire/">Learn more about the Shire offer</a></p></li></ul></div></div></div></div></div></div></section><section data-section-position="9" data-sb-field-path="sections.9" data-section-name="<div id="retail-investor-events">## Retail Investor Events</div> " data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb bg-white flex flex-col justify-center border-none"><div class="Container_root__5fKNx"><div class="flex w-full max-w-screen-xl"><div class="w-1/1"><div data-sb-field-path=".title" class="TextBody_markdownTitleWrapper___IjAs"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="TextBody_markdownTitle__Qu08o text-dark-grey"><div id="retail-investor-events"><h2 id="Retail_Investor_Events">Retail Investor Events</h2></div></div></div><hr class="Divider_root__damfW bg-primary TextBody_divider__1W9pV"/></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="TextBody_markdownText__NAlzY" data-sb-field-path=".text"><h4 id="Online_information_session_for_retail_investors_Committed_to_Growth_Shareholder_Returns_in_Japanese_only">Online information session for retail investors: "Committed to Growth & Shareholder Returns" (in Japanese only)</h4><p>7:45 pm - 8:30 pm JST on February 22, 2024</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="true" rel="noreferrer" href="https://api01-platform.stream.co.jp/apiservice/plt3/NTk0NA%3d%3d%23NTI3Mg%3d%3d%23280%23168%23b%233FE2A0D9E400%23MDoyOjc6YTpmOzEwOzEwOzEw%23">Webcast<span class="Link_iconWrapper__DNWsB"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 24 24" class="" role="img" aria-hidden="false" data-testid="icon-LinkExternal"><title>Go to https://api01-platform.stream.co.jp/apiservice/plt3/NTk0NA%3d%3d%23NTI3Mg%3d%3d%23280%23168%23b%233FE2A0D9E400%23MDoyOjc6YTpmOzEwOzEwOzEw%23</title><path d="M19 19H5V5h7V3H3v18h18v-9h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"></path></svg></span></a></li><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1710384814/Global/Investor/events/2024/presentation_02222024.pdf">Presentation</a></li></ul><hr/><h4 id="Information_session_for_retail_investors_Better_health_for_people_Brighter_future_for_the_world">Information session for retail investors: "Better health for people, Brighter future for the world"</h4><p>February 22, 2023</p><ul><li><a class="text-primary hover:text-primary-active border-b border-primary hover:border-primary-active" target="_blank" data-sb-link-ignore="false" rel="noreferrer" href="https://assets-dam.takeda.com/image/upload/v1678160771/legacy-dotcom/siteassets/system/investors/investor--events/20230222_retail%20investor%20event_presentation.pdf">Presentation</a></li></ul><hr/></div></div></div></div></div></section><section data-section-position="10" data-sb-field-path="sections.10" data-section-name="## Sign up for our investors newsletter " data-exclude-from-nav="false" class="global-pt global-pb global-mt global-mb !mb-10 bg-dark-grey relative min-h-[300px]"><div class="flex flex-col items-center justify-center py-14"><div class="Markdown_root__pKQ5I" data-testid="root"><h2 id="Sign_up_for_our_investors_newsletter" class="!m-0 !font-light normal-case tracking-normal text-center text-white" data-sb-field-path=".title">Sign up for our investors newsletter</h2></div><p class="text-base text-center mt-3 text-white" data-sb-field-path=".subtitle">Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet</p><a class="ActionRedesign_root__v_xnN ActionRedesign_primary__WVDC3 ActionRedesign_large__WBUAx mt-6" role="button" aria-label="Sign up" data-sb-link-ignore="false" data-sb-field-path=".button" __metadata="[object Object]" type="Action" href="/investors/newsletter/"><span class="ActionRedesign_label__CNp0R" data-testid="label">Sign up</span></a></div></section><section data-section-position="11" data-sb-field-path="sections.11" data-section-name="## Explore " data-exclude-from-nav="true" class="global-pt global-pb global-mt global-mb bg-white"><div class="Container_root__5fKNx"><header class="SectionTitleContainer_root__XGH__ text-dark-grey" data-testid="sectionTitleContainer"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><h2 id="Explore" class="SectionWrapperWithTitle_title__pmQu0" data-sb-field-path=".title">Explore</h2></div><hr class="Divider_root__damfW bg-primary SectionWrapperWithTitle_titleBottomBorder__Gd46k"/></header><div data-sb-field-path=".items" class="" data-testid="root"><div class="Grid_grid__UAr5E !gap-x-9 !gap-y-9 max-md:!gap-y-9 !grid-cols-1 md:!grid-cols-2" style="grid-template-columns:repeat(auto-fill, minmax(max(250px, 47%), 1fr))" data-testid="grid"><div class="Grid_gridItemWrapper__3STn4" data-testid="gridItemWrapper"><a class="group flex h-full items-stretch border-l-[5px] cursor-pointer border-primary hover:border-primary-active bg-light-grey hover:bg-hover-grey transition" data-sb-link-ignore="false" data-sb-field-path=".0" href="/investors/financial-highlights/"><div class="flex-1 p-5 sm:p-7"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><h3 id="Financial_Highlights-sections.11-6b3dd4e3-2e80-4954-baab-b577657cd309" class="text-lg font-medium sm:text-xl text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Financial Highlights</h3></div><p class="mt-3 text-body-block text-dark-grey" data-sb-field-path=".description">The company’s most recent and important financial information</p></div><div class="flex items-end p-3"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to Financial Highlights page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div><div class="Grid_gridItemWrapper__3STn4" data-testid="gridItemWrapper"><a class="group flex h-full items-stretch border-l-[5px] cursor-pointer border-primary hover:border-primary-active bg-light-grey hover:bg-hover-grey transition" data-sb-link-ignore="false" data-sb-field-path=".1" href="/newsroom/press-releases/"><div class="flex-1 p-5 sm:p-7"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><h3 id="Newsroom-sections.11-a07a1da2-01aa-41f8-95de-e4605756cae8" class="text-lg font-medium sm:text-xl text-dark-grey group-hover:text-primary-active transition-colors !mb-0" data-sb-field-path=".linkLabel">Newsroom</h3></div><p class="mt-3 text-body-block text-dark-grey" data-sb-field-path=".description">Read our latest news</p></div><div class="flex items-end p-3"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" width="24" height="24" viewBox="0 0 24 24" class="w-[32px] h-[32px] text-primary group-hover:text-primary-active" role="img" aria-hidden="false" data-testid="icon-ChevronDefaultRight"><title>Go to Newsroom page</title><path d="M9.707 18.707l6-6c0.391-0.391 0.391-1.024 0-1.414l-6-6c-0.391-0.391-1.024-0.391-1.414 0s-0.391 1.024 0 1.414l5.293 5.293-5.293 5.293c-0.391 0.391-0.391 1.024 0 1.414s1.024 0.391 1.414 0z"></path></svg></div></a></div></div></div></div></section></div></div></main><footer data-sb-field-path="siteSettings:footer" class="Footer_footerRedesign__6eH8h"><div class="Container_root__5fKNx"><div class="Footer_wrapperRedesign__LkcA0"><div class="flex flex-wrap items-center gap-6 justify-between"><a class="flex items-center justify-center min-w-[44px] min-h-[44px]" data-sb-link-ignore="false" href="/"><span class="ImageBlock_root__p_rMO ImageBlock_rootFill__ts5qS ImageBlock_rootLimitWidth__EMprg Footer_logoRedesign__mN9V5" data-testid="root" style="aspect-ratio:720 / 256"><img data-sb-field-path=".logo.url" alt="Takeda logo" __metadata="[object Object]" fetchpriority="high" loading="eager" decoding="async" data-nimg="fill" class="ImageBlock_image__sHiB_ rounded-none" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;object-fit:cover;color:transparent;aspect-ratio:720 / 256" sizes="100vw" srcSet="https://assets-dam.takeda.com/image/upload/c_lfill,w_480/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 480w, https://assets-dam.takeda.com/image/upload/c_lfill,w_640/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 640w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1080/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1080w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1200/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1200w, https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257 1920w" src="https://assets-dam.takeda.com/image/upload/c_lfill,w_1920/v1/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257"/></span></a><ul class="flex items-center" data-sb-field-path="siteSettings:footer.socialLinks" role="list"><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".0" role="listitem"><a class="group link Social_root__FoqsP SocialRedesign_root__OocZz" target="_blank" aria-label="LinkedIn icon" data-sb-link-ignore="true" rel="noreferrer" __metadata="[object Object]" type="Social" href="https://www.linkedin.com/company/takeda-pharmaceuticals/"><div class="" data-testid="content"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 22 21" class="Social_icon__VdRn_ SocialRedesign_icon__UROjE" role="img" aria-hidden="false" __metadata="[object Object]" type="Icon" data-testid="icon-LinkedIn"><title>LinkedIn</title><path d="M 0.24739583333333331 6.173705722070846 L 4.544270833333333 6.173705722070846 L 4.544270833333333 19 L 0.24739583333333331 19 L 0.24739583333333331 6.173705722070846 Z M 4.153645833333333 0.627724795640327 C 4.587673611111112 1.0462079927338777 4.809027777777779 1.5747048138056288 4.817708333333333 2.2132152588555862 C 4.826388888888889 2.8430971843778368 4.607204861111112 3.3694368755676645 4.16015625 3.7922343324250676 C 3.713107638888889 4.2150317892824685 3.125 4.4264305177111725 2.3958333333333335 4.4264305177111725 L 2.3697916666666665 4.4264305177111725 C 1.6579861111111114 4.4264305177111725 1.0850694444444446 4.2150317892824685 0.6510416666666667 3.7922343324250676 C 0.21701388888888884 3.3694368755676645 0 2.8430971843778368 0 2.2132152588555862 C 0 1.5747048138056288 0.22352430555555552 1.0462079927338777 0.6705729166666667 0.627724795640327 C 1.117621527777778 0.20924159854677427 1.7013888888888893 0 2.421875 0 C 3.142361111111111 0 3.719618055555556 0.20924159854677427 4.153645833333333 0.627724795640327 Z M 18.645833333333332 7.345027247956403 C 19.54861111111111 8.32436421435059 20 9.758855585831062 20 11.648501362397822 L 20 19 L 15.716145833333332 19 L 15.716145833333332 12.140326975476839 C 15.716145833333332 11.23433242506812 15.540364583333332 10.524636693914623 15.188802083333332 10.011239782016348 C 14.837239583333332 9.497842870118072 14.288194444444446 9.241144414168938 13.541666666666668 9.241144414168938 C 12.994791666666668 9.241144414168938 12.53689236111111 9.389986376021797 12.16796875 9.68767029972752 C 11.799045138888891 9.985354223433243 11.5234375 10.354223433242508 11.341145833333332 10.794277929155314 C 11.245659722222223 11.053133514986376 11.197916666666668 11.40258855585831 11.197916666666668 11.842643051771118 L 11.197916666666668 19 L 6.9140625 19 C 6.931423611111112 15.557220708446865 6.940104166666666 12.76589464123524 6.940104166666666 10.626021798365123 C 6.940104166666666 8.486148955495004 6.935763888888889 7.209128065395094 6.927083333333334 6.794959128065395 L 6.9140625 6.173705722070846 L 11.197916666666668 6.173705722070846 L 11.197916666666668 8.037465940054496 L 11.171875 8.037465940054496 C 11.34548611111111 7.761353315168028 11.5234375 7.51975476839237 11.705729166666668 7.312670299727522 C 11.888020833333332 7.105585831062671 12.133246527777779 6.881244323342415 12.44140625 6.639645776566757 C 12.749565972222223 6.398047229791097 13.127170138888891 6.210376930063577 13.57421875 6.076634877384197 C 14.021267361111114 5.942892824704814 14.518229166666668 5.876021798365122 15.065104166666668 5.876021798365122 C 16.549479166666668 5.876021798365122 17.743055555555557 6.365690281562215 18.645833333333332 7.345027247956403 Z"></path></svg></div></a></li><li class="flex mr-[24px] max-xs:mr-[16px] last:mr-0" data-sb-field-path=".1" role="listitem"><a class="group link Social_root__FoqsP SocialRedesign_root__OocZz" target="_blank" aria-label="YouTube logo" data-sb-link-ignore="true" rel="noreferrer" __metadata="[object Object]" type="Social" href="https://www.youtube.com/takeda-pharmaceuticals"><div class="" data-testid="content"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" fill="currentColor" viewBox="0 0 310 310" class="Social_icon__VdRn_ SocialRedesign_icon__UROjE" role="img" aria-hidden="false" __metadata="[object Object]" type="Icon" data-testid="icon-YouTube"><title>YouTube</title><path d="M297.917 64.645c-11.19-13.302-31.85-18.728-71.306-18.728H83.386c-40.359 0-61.369 5.776-72.517 19.938C0 79.663 0 100.008 0 128.166v53.669c0 54.551 12.896 82.248 83.386 82.248h143.226c34.216 0 53.176-4.788 65.442-16.527C304.633 235.518 310 215.863 310 181.835v-53.669c0-29.695-.841-50.16-12.083-63.521zm-98.896 97.765-65.038 33.991a9.997 9.997 0 0 1-14.632-8.863v-67.764a10 10 0 0 1 14.609-8.874l65.038 33.772a10 10 0 0 1 .023 17.738z"></path></svg></div></a></li></ul></div></div><div class="Footer_footerNavigationWrapperRedesign__FWWQI"><ul data-sb-field-path="siteSettings:footer.navigationLinks" class="Footer_listRedesign__eV7Wq"><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg" aria-label="Locations" data-sb-link-ignore="false" data-sb-field-path="siteSettings:footer.navigationLinks.links.0" href="/worldwide/">Locations</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg" aria-label="Contact us" data-sb-link-ignore="false" data-sb-field-path="siteSettings:footer.navigationLinks.links.1" href="/contact-us/">Contact us</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg" aria-label="Careers" data-sb-link-ignore="false" data-sb-field-path="siteSettings:footer.navigationLinks.links.2" href="/careers/">Careers</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg" aria-label="Financial Highlights" data-sb-link-ignore="false" data-sb-field-path="siteSettings:footer.navigationLinks.links.3" href="/investors/financial-highlights/">Financial Highlights</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg" aria-label="HCPs" data-sb-link-ignore="false" data-sb-field-path="siteSettings:footer.navigationLinks.links.4" href="/hcps/">HCPs</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg" aria-label="Patients" data-sb-link-ignore="false" data-sb-field-path="siteSettings:footer.navigationLinks.links.5" href="/patients/">Patients</a></li></ul></div><div class="mt-11"><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="Footer_markdownContainer__Q4UBe" data-sb-field-path="siteSettings:footer.disclaimerText"><p>This website provides information about Takeda's worldwide business. For specific information about our local markets, please use the <a class="underline" data-sb-link-ignore="false" href="/worldwide/">country selector</a>.</p></div></div></div><div class="flex flex-wrap max-md:flex-col gap-11 justify-between mt-11"><div class="flex flex-wrap max-md:flex-col gap-6"><ul class="flex flex-wrap items-center max-md:flex-col max-md:items-start gap-6" data-sb-field-path="siteSettings:languages.-1"><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg text-[0.875rem] !leading-[17px]" aria-label="Terms and Conditions" data-sb-link-ignore="false" data-sb-field-path="siteSettings:languages.-1.additionalLinks.0" href="/terms-and-conditions/">Terms and Conditions</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg text-[0.875rem] !leading-[17px]" aria-label="Privacy Notice" data-sb-link-ignore="false" data-sb-field-path="siteSettings:languages.-1.additionalLinks.1" href="/privacy-notice/">Privacy Notice</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg text-[0.875rem] !leading-[17px]" aria-label="Cookie Policy" data-sb-link-ignore="false" data-sb-field-path="siteSettings:languages.-1.additionalLinks.2" href="/cookie-policy/">Cookie Policy</a></li><li class="Footer_linkItemRedesign__OAPZ9"><a class="Footer_linkRedesign__JYlTg text-[0.875rem] !leading-[17px]" aria-label="Accessibility Statement" data-sb-link-ignore="false" data-sb-field-path="siteSettings:languages.-1.additionalLinks.3" href="/global-accessibility-statement/">Accessibility Statement</a></li></ul></div><div class="MarkdownRedesign_root__YCuOn" data-testid="root"><div class="Footer_copyrightRedesign__PWlAO" data-sb-field-path="siteSettings:footer.copyrightText"><p>Copyright 1995-2024 Takeda Pharmaceutical Company Limited. All rights reserved.</p></div></div></div></div></footer></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"page":{"headerPosition":"sticky","slug":"/investors/events","theme":{"h1":{"fontLineHeight":"2.875rem","fontWeight":"300","fontLineHeightMobile":"","fontWeightMobile":"300","fontSize":"2.625rem","fontSizeMobile":"1.875rem"},"h5":{"fontLineHeight":"1.75rem","fontWeight":"700","fontLineHeightMobile":"1.75rem","fontWeightMobile":"700","fontSize":"1rem","fontSizeMobile":"1rem"},"colorSecondaryContrast":"#ffffff","h2":{"fontWeight":"300","fontLineHeightMobile":"2rem","fontWeightMobile":"300","fontSize":"2.25rem","fontSizeMobile":"1.5rem","fontLineHeight":"2.6875rem"},"colorDarkGreyContrast":"#ffffff","colorLightGreyContrast":"#333333","colorHoverGrey":"#DCE6E9","buttonSecondary":{"borderRadiusTopLeft":"","borderRadiusBottomLeft":"","borderRadiusTopRight":"","hoverBackgroundColor":"","borderRadiusBottomRight":"","textColor":"#333333","backgroundColor":""},"colorPrimaryActiveContrast":"#ffffff","spacings":{"marginTop":"0rem","marginTopFirstComponentMobile":"2.5rem","paddingBottomMobile":"0rem","marginBottom":"3.125rem","marginBottomMobile":"2.5rem","paddingTopMobile":"0rem","marginTopMobile":"0rem","paddingTop":"0rem","paddingBottom":"0rem","marginTopFirstComponent":"3.125rem"},"colorDarkGrey":"#333333","__i18n_lang":"en","quote":{"fontSize":"2rem","fontSizeMobile":"1.25rem","fontLineHeight":"2.75rem","fontWeight":"400","fontLineHeightMobile":"1.625rem","fontWeightMobile":"400"},"colorMediumGreyContrast":"#ffffff","colorMediumGrey":"#a1a4ac","cta":{"fontWeight":"700","fontLineHeightMobile":"1.625rem","fontWeightMobile":"700","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem"},"colorPrimaryContrast":"#ffffff","bodyBlock":{"fontWeightMobile":"400","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem","fontWeight":"400","fontLineHeightMobile":"1.625rem"},"colorPrimary":"#BD120A","colorSecondary":"#891515","globalImages":{"borderRadiusTopLeft":"","borderRadiusBottomLeft":"1.875rem","borderRadiusTopRight":"","borderRadiusBottomRight":""},"h3":{"fontLineHeight":"2rem","fontWeight":"500","fontLineHeightMobile":"1.75rem","fontWeightMobile":"500","fontSize":"1.5rem","fontSizeMobile":"1.25rem"},"colorLightGrey":"#edf2f4","textColor":"#333333","subHeading":{"fontWeight":"500","fontLineHeightMobile":"1.5rem","fontWeightMobile":"700","fontSize":"1.125rem","fontSizeMobile":"1rem","fontLineHeight":"1.25rem"},"colorPrimaryActive":"#891515","language":"en","h4":{"fontWeight":"500","fontLineHeightMobile":"1.75rem","fontWeightMobile":"500","fontSize":"1.25rem","fontSizeMobile":"1.125rem","fontLineHeight":"1.75rem"},"buttonPrimary":{"borderRadiusTopRight":"","hoverBackgroundColor":"#891515","borderRadiusBottomRight":"","textColor":"#ffffff","backgroundColor":"#BD120A","borderRadiusTopLeft":"","borderRadiusBottomLeft":"1.25rem"},"__metadata":{"key":"ThemeStyle2960","modelName":"ThemeStyle","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"siteTheme","createdAt":"2022-11-11T08:38:47Z","updatedAt":"2024-07-16T10:23:18Z"},"type":"ThemeStyle"},"sections":[{"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2220","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"navigationGroup":{"name":"Investor","links":[{"icon":"ArrowDefaultRight","iconPosition":"right","showIcon":false,"href":"/investors/overview","label":"Overview","elementId":"","altText":"Overview","__metadata":{"key":"d1bfc7a4-4542-459c-82d0-a26e82eec920","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"altText":"Financial Highlights","label":"Financial Highlights","href":"/investors/financial-highlights","elementId":"","icon":"ArrowDefaultRight","iconPosition":"right","__metadata":{"key":"7f85e07d-63dd-4c7e-abb2-9acef82e13bd","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","href":"/investors/financial-results/quarterly-results","elementId":"","showIcon":false,"altText":"Quarterly Results","label":"Quarterly Results","icon":"ArrowDefaultRight","__metadata":{"key":"1ede64f7-fa4e-4e02-aa61-d5d923c45edd","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","label":"Stock Information \u0026 Shareholder Returns","showIcon":false,"href":"/investors/stock-information","altText":"Stock Information \u0026 Shareholder Returns","icon":"ArrowDefaultRight","__metadata":{"key":"6ff79b52-acb8-4b0e-bc95-55df1ecb6883","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"href":"/investors/sec-filings-and-security-reports","label":"Securities Report \u0026 Form 20-F ","elementId":"","icon":"ArrowDefaultRight","iconPosition":"right","altText":"Securities Report \u0026 Form 20-F ","showIcon":false,"__metadata":{"key":"94b98148-8274-48d4-8687-35a81e3c2a8c","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"ArrowDefaultRight","href":"/investors/events/","showIcon":false,"label":"IR Events","elementId":"","altText":"IR Events","iconPosition":"right","__metadata":{"key":"a8b34324-e219-4b62-add3-08f7ca6573ff","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"__i18n_lang":"en","language":"en","__metadata":{"key":"NavigationGroup2964","modelName":"NavigationGroup","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"qJqFQIVNz2Uy6XYR7Ba1t0","createdAt":"2023-02-02T16:27:04Z","updatedAt":"2024-10-08T11:56:31Z"},"type":"NavigationGroup"},"displayName":"","overlayColor":{"color":"black","__metadata":{"key":"ThemeColorPicker2221","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"titleColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2222","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"elementId":"","backgroundImagePosition":"center","componentLayout":"takeda-com-redesign","margin":{"left":"","bottom":"0","right":"","top":""},"title":"# Investor Events\n\n","padding":{"top":"","left":"","bottom":"4","right":""},"overlayOpacity":0,"hideTitle":false,"backgroundImageAlt":"Glasses on newspaper","backgroundImage":{"access_mode":"public","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"type":"cloudinary.asset","created_at":"2022-09-07T15:34:03Z","uploaded_by":{"id":"553579438111562","type":"accesskey"},"secure_url":"https://assets-dam.takeda.com/image/upload/v1662564843/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900.jpg","url":"http://assets-dam.takeda.com/image/upload/v1662564843/siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900.jpg","public_id":"siteassets/jp/home/investors/report/consolidated-financial-statements/consolidated-financial-statements1600x900","bytes":908866,"height":900,"width":1600,"version":1662564843,"resource_type":"image","format":"jpg","created_by":{"id":"553579438111562","type":"accesskey"},"__metadata":{"key":"cloudinary.asset2945","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"isNavigationShown":true,"enableNoSnippet":false,"excludeFromNavigation":false,"__metadata":{"key":"a4ba64bc-4e9e-4ab9-8ca7-b6d3a14b9f0b","modelName":"PageBannerSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"PageBannerSection"},{"title":"Divider Section Redesign","enableNoSnippet":false,"padding":{"top":"4"},"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2223","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign","margin":{"top":"0","bottom":"0"},"hideTitle":true,"divider":{"dividerColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2248","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"Divider2400","modelName":"Divider","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Divider"},"displayName":"","excludeFromNavigation":true,"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2224","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"elementId":"","__metadata":{"key":"45672c48-6226-41ed-933d-87b18e1628a3","modelName":"DividerSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"DividerSection"},{"displayName":"","elementId":"","enableNoSnippet":false,"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2225","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"default","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2226","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"maxColumns":4,"padding":{"top":"4","bottom":"0"},"variant":"compact","title":"## Contents\n","excludeFromNavigation":false,"margin":{"right":"","top":"0","left":"","bottom":"0"},"hideTitle":false,"__metadata":{"key":"0444cfeb-8129-4e09-ac31-3e0fde13ece1","modelName":"QuickLinksSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksSection"},{"hideTitle":false,"elementId":"","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2227","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","title":"","enableNoSnippet":false,"padding":{"top":"","left":"","bottom":"","right":""},"margin":{"left":"","bottom":"0","right":"","top":"0"},"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2228","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"excludeFromNavigation":false,"rows":[{"gridGap":5,"cells":[{"components":[{"margin":{"bottom":"0","right":"14","top":"","left":""},"hideTitle":false,"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2652","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"enableNoSnippet":false,"maxColumns":4,"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2653","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"elementId":"","displayName":"","excludeFromNavigation":false,"items":[{"href":"#earnings-announcement-meetings--ir-events--broker-conferences","media":[{"elementId":"","altText":"chevron down","aspectRatio":"","priority":false,"url":{"bytes":437,"url":"http://assets-dam.takeda.com/image/upload/v1712129681/Global/Investor/Chevron.svg","resource_type":"image","public_id":"Global/Investor/Chevron","folder_id":"c37291215309430020114fb85e0c5a39da","_version":1,"created_at":"2024-04-03T07:34:41Z","access_mode":"public","created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"id":"41712a8983efef9a22ab203acb96d99a","height":41,"width":42,"format":"svg","version":1712129681,"secure_url":"https://assets-dam.takeda.com/image/upload/v1712129681/Global/Investor/Chevron.svg","type":"cloudinary.asset","uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"folder":"Global/Investor","__metadata":{"key":"0KH9vmNGcsBcwYsqUB8ia","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__metadata":{"key":"196ce365c18c","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAElBMVEXAIBnAIBnAIBnAIBnAIBnAIBm4tKS0AAAABnRSTlMjMBkMPROE4iCeAAAAPElEQVQIHRXBgQnAMAgAwdcJFDKACJlAOkDACSzZf5XSO+rHZOYmAAV3B1l9DOluI1YfZcRt8wT6UpO3PsI9BuYftIYnAAAAAElFTkSuQmCC"}],"linkLabel":"Earnings Announcement Meetings / IR Events / Broker Conferences","showDescription":false,"hideIcon":false,"iconColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2846","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"5813ddff95b5","modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"}],"__metadata":{"key":"9103de192262","modelName":"QuickLinksSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksSection"}],"__metadata":{"key":"c1d14933ac87","modelName":"ColumnsRowsSectionCell","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnsRowsSectionCell"},{"components":[{"elementId":"","titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2654","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"enableNoSnippet":false,"excludeFromNavigation":false,"padding":{"top":"","left":"","bottom":"","right":""},"displayName":"","hideTitle":false,"items":[{"iconColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2847","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"href":"#annual-shareholders-meetings","media":[{"aspectRatio":"","priority":false,"url":{"created_at":"2024-04-03T07:34:41Z","format":"svg","public_id":"Global/Investor/Chevron","height":41,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"_version":1,"id":"41712a8983efef9a22ab203acb96d99a","type":"cloudinary.asset","resource_type":"image","secure_url":"https://assets-dam.takeda.com/image/upload/v1712129681/Global/Investor/Chevron.svg","access_mode":"public","version":1712129681,"width":42,"uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"folder":"Global/Investor","folder_id":"c37291215309430020114fb85e0c5a39da","bytes":437,"url":"http://assets-dam.takeda.com/image/upload/v1712129681/Global/Investor/Chevron.svg","__metadata":{"key":"0KH9vmNGcsBcwYsqUB8ia","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"chevron down","__metadata":{"key":"196ce365c18c","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAElBMVEXAIBnAIBnAIBnAIBnAIBnAIBm4tKS0AAAABnRSTlMjMBkMPROE4iCeAAAAPElEQVQIHRXBgQnAMAgAwdcJFDKACJlAOkDACSzZf5XSO+rHZOYmAAV3B1l9DOluI1YfZcRt8wT6UpO3PsI9BuYftIYnAAAAAElFTkSuQmCC"}],"linkLabel":"Annual Shareholders Meetings","showDescription":false,"hideIcon":false,"__metadata":{"key":"5813ddff95b5","modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"}],"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2655","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"0"},"maxColumns":4,"__metadata":{"key":"9103de192262","modelName":"QuickLinksSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksSection"}],"__metadata":{"key":"bc05b85d21c90414d985dd42faef184e","modelName":"ColumnsRowsSectionCell","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnsRowsSectionCell"},{"components":[{"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2656","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"enableNoSnippet":false,"excludeFromNavigation":false,"maxColumns":4,"hideTitle":false,"items":[{"href":"#retail-investor-events","media":[{"altText":"chevron down","aspectRatio":"","priority":false,"url":{"height":41,"type":"cloudinary.asset","folder_id":"c37291215309430020114fb85e0c5a39da","created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"public_id":"Global/Investor/Chevron","secure_url":"https://assets-dam.takeda.com/image/upload/v1712129681/Global/Investor/Chevron.svg","_version":1,"metadata":{"epzciwdjuelllku8ngpo":["0001"]},"folder":"Global/Investor","bytes":437,"version":1712129681,"url":"http://assets-dam.takeda.com/image/upload/v1712129681/Global/Investor/Chevron.svg","format":"svg","created_at":"2024-04-03T07:34:41Z","uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"access_mode":"public","id":"41712a8983efef9a22ab203acb96d99a","resource_type":"image","width":42,"__metadata":{"key":"0KH9vmNGcsBcwYsqUB8ia","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","__metadata":{"key":"196ce365c18c","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock","blurDataURL":"data:image/webp;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKBAMAAAB/HNKOAAAAElBMVEXAIBnAIBnAIBnAIBnAIBnAIBm4tKS0AAAABnRSTlMjMBkMPROE4iCeAAAAPElEQVQIHRXBgQnAMAgAwdcJFDKACJlAOkDACSzZf5XSO+rHZOYmAAV3B1l9DOluI1YfZcRt8wT6UpO3PsI9BuYftIYnAAAAAElFTkSuQmCC"}],"linkLabel":"Retail Investor Events","showDescription":false,"hideIcon":false,"iconColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2848","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"5813ddff95b5","modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"}],"elementId":"","displayName":"","margin":{"top":"","left":"","bottom":"0"},"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2657","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"9103de192262","modelName":"QuickLinksSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksSection"}],"__metadata":{"key":"88ddf94a411ecc226f14681abc823bb9","modelName":"ColumnsRowsSectionCell","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnsRowsSectionCell"}],"gridType":"1-1-1","__metadata":{"key":"781e608051f9","modelName":"ColumnsRowsSectionRow","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnsRowsSectionRow"}],"__metadata":{"key":"6177850072eb","modelName":"ColumnsRowsSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ColumnsRowsSection"},{"componentLayout":"takeda-com-redesign","enableNoSnippet":false,"title":"Divider Section Redesign","hideTitle":true,"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2229","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2230","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","divider":{"dividerColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2249","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"Divider2401","modelName":"Divider","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Divider"},"margin":{"top":"4"},"excludeFromNavigation":true,"elementId":"","__metadata":{"key":"50adb9ba-d6e0-42ed-a06f-0b14d88a4792","modelName":"DividerSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"DividerSection"},{"enableNoSnippet":false,"tabs":[{"id":"tab-1","isDisabled":false,"title":"Upcoming Events","content":[{"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2402","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"default","text":"### R\u0026D Day: Focus on Late-Stage Pipeline and Market Opportunity\n\n(6:30pm ~ EST on December 12, 2024)\u003cbr\u003e\n*Duration: Approximately 5 hours \n\nPresentation material will be posted at 5:30pm EST on December 12th. (7:30am JST on December 13th)\n* [Webcast](https://zoom.us/webinar/register/WN_outURVqXT-aImrwATSefJw)\n\n* [Add to Calender](https://assets-dam.takeda.com/raw/upload/Global/Investor/events/2024/ics/r_d-day-focus-on-late-stage-pipeline-and-market-opportunity-en.ics)\n\n***\n\n#### Quarterly Results - Quarter 3 FY2024\n\n(January 30, 2025)\n\n***\n\n#### Quarterly Results - Quarter 4 FY2024\n\n(May 8, 2025)\n\n***\n","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2403","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"03af8763c33e","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"1388344bfe6f","modelName":"HorizontalTab","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"HorizontalTab"},{"isDisabled":false,"title":"FY2024 Past Events","content":[{"text":"\u003cdiv id=\"tab-3\"\u003e\n#### Quarterly Results - Quarter 2 FY2024\n\n(October 31, 2024)\n\n* [Read more](/investors/financial-results/quarterly-results/)\n\n***\n\n#### Quarterly Results - Quarter 1 FY2024\n\n(July 31, 2024)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results/)\n\n***\n\n#### TAK-861 Investor Call on Phase 2b Narcolepsy Type 1 Data\n\n(7:30pm- 8:30pm CDT, 8:30pm - 9:30pm EDT on June 3, 2024)\n\n* [Webcast](https://www.irwebcasting.com/20240604/4/index.html)\n\n* [Presentation](https://assets-dam.takeda.com/image/upload/v1717400991/Global/Investor/events/2024/tak-861-investor-call-en.pdf)\n\n***\n\n#### Quarterly Results - Quarter 4 FY2023\n\n(May 9, 2024)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2023/)\n\n***\n","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2404","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"right":"","top":"","left":"","bottom":""},"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2405","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"default","__metadata":{"key":"03af8763c33e","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"id":"tab-2","__metadata":{"key":"41fec6782cb1a9d8793d40c851979c45","modelName":"HorizontalTab","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"HorizontalTab"}],"activeTabColorPicker":{"color":"primary","__metadata":{"key":"ThemeColorPicker2231","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"\u003cdiv id=\"earnings-announcement-meetings--ir-events--broker-conferences\"\u003e## Earnings Announcement Meetings / IR Events / Broker Conferences","inactiveTabColorPicker":{"color":"white","__metadata":{"key":"ThemeColorPicker2232","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"padding":{"bottom":"","right":"","top":"","left":""},"componentLayout":"takeda-com-redesign","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2233","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","defaultActiveTabIndex":1,"hideTitle":false,"elementId":"","excludeFromNavigation":false,"margin":{"top":"","left":"","bottom":"","right":""},"__metadata":{"key":"d7937f61f7c0","modelName":"HorizontalTabsSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"HorizontalTabsSection"},{"enableNoSnippet":false,"excludeFromNavigation":false,"elementId":"","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2234","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"## Event Archive\n\n","enableOpenMultipleAccordions":false,"hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2235","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"takeda-com-redesign","accordions":[{"title":"FY2023 (April 2023-March 2024)","content":[{"text":"#### Cowen 44\u003csup\u003eth\u003c/sup\u003e Health Care Conference\n\n(9:50am – 10:20am EST on March 6, 2024)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 3 FY2023\n\n(February 1, 2024)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2023/)\n\n***\n\n#### 42nd Annual J.P. Morgan Healthcare Conference\n\n(5:15pm – 5:55pm PST on January 8, 2024)\n\n* This event was closed.\n\n***\n\n#### Plasma-Derived Therapies Investor Event\n\n(6:00 – 7:00pm EST on December 5, 2023)\n\n* [Webcast](https://www.irwebcasting.com/20231206/3/index.html)\n* [Presentation](https://assets-dam.takeda.com/image/upload/v1701756390/Global/Investor/events/2023/PDT_Presentation_2023_EN.pdf)\n\n***\n\n#### Jefferies London Healthcare Conference\n\n(4:00 – 4:25am EST on November 14, 2023)\n\n(9:00 – 9:25am GMT on November 14, 2023)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 2 FY2023\n\n(October 26, 2023)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2023/)\n\n***\n\n#### Morgan Stanley Healthcare Conference\n\n(3:35 – 4:05pm EDT on September 11, 2023)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 1 FY2023\n\n(July 27, 2023)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2023/)\n\n***\n\n#### Quarterly Results - Quarter 4 FY2022\n\n(May 11, 2023)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2022/)\n\n***\n","title":"\n\n","backgroundColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2406","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2407","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"default","__metadata":{"key":"c7adae47-23d2-4c83-9885-32444e6798a7","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"afa44aad7eb523e4b18d228a9e799ce2","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"FY2022 (April 2022-March 2023)","content":[{"title":"\n\n","backgroundColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2408","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2409","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"default","text":"#### TAK-279 (TYK2 inhibitor) Investor Call on Phase 2b Psoriasis Data\n\n(March 18, 2023)\n\n* [Webcast](https://www.irwebcasting.com/20230319/2/index.html)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1679175992/siteassets/system/investors/investor--events/TAK-279%20Investor%20Call_EN.pdf)\n\n***\n\n#### QDENGA Investor call\n\n(March 15, 2023)\n\n* [Webcast](https://www.irwebcasting.com/20230316/2/index.html)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1679624806/siteassets/system/investors/investor--events/Qdenga%20Presentation_EN.pdf)\n\n***\n\n#### Cowen 43rd Health Care Conference\n\n(March 6, 2023)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 3 FY2022\n\n(February 2, 2023)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2022/)\n\n***\n\n#### 41st Annual J.P. Morgan Healthcare Conference\n\n(January 9, 2023)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192363/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc23_presentation.pdf)\n\n***\n\n#### Conference call regarding acquisition of NDI-034858 From Nimbus Therapeutics\n\n(December 13, 2022)\n\n* [Presentation](https://www.takeda.com/4af01e/siteassets/system/investors/investor--events/takeda-ir-call_en.pdf)\n\n* [Webcast](https://www.irwebcasting.com/20221214/3/index.html)\n\n***\n\n#### Jefferies London Healthcare Conference\n\n(November 15, 2022)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 2 FY2022\n\n(October 27, 2022)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2022/)\n\n***\n\n#### Seminar: Investors and Analysts on Lysosomal Storage Diseases (LSD)\n\n(October 4, 2022)\n\n* [Presentation](https://www.takeda.com/4a7c83/siteassets/system/investors/investor--events/en_lsd-ir-disease-seminar.pdf)\n\n* [Webcast](https://www.irwebcasting.com/20221004/2/index.html)\n\n***\n\n#### Morgan Stanley Healthcare Conference\n\n(September 12, 2022)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 1 FY2022\n\n(July 28, 2022)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2022/)\n\n***\n\n#### Jefferies Healthcare Conference\n\n(June 9, 2022)\n\n* This event was closed.\n\n***\n\n#### Quarterly Results - Quarter 4 FY2021\n\n(May 11, 2022)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2021/)\n","__metadata":{"key":"c7adae47-23d2-4c83-9885-32444e6798a7","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"71f40cf2-a8dc-457a-a955-57f74eaac6ce","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2253","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2254","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"FY2021 (April 2021-March 2022)","content":[{"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2410","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Cowen 42\u003csup\u003end\u003c/sup\u003e Health Care Conference\n\n(2:50pm – 3:20pm EST on March 8, 2022)\n\n* This event was closed.\n\n***\n\n### Seminar: Investors and Analysts on Short Bowel Syndrome (SBS) and Complex Crohn’s Perianal Fistulas (CPF)\n\n(1:00pm JST on February 24, 2022)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_ir-disease-seminar_gi.pdf)\n\n* [Webcast](https://www.irwebcasting.com/20220224/2/index.html)\n\n***\n\n### Quarterly Results - Quarter 3 FY2021\n\n(Held on February 3, 2022)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2021/)\n\n***\n\n### 40\u003csup\u003eth \u003c/sup\u003eAnnual J.P. Morgan Healthcare Conference\n\n(4:30pm – 5:10pm EST on January 10, 2022)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192362/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc-presentation_2022.pdf)\n\n***\n\n### Takeda Management Call\n\n(6:00pm – 7:00pm EST on January 10, 2022)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_takeda-mgmt-call_jan-11.pdf)\n\n***\n\n### Plasma-Derived Therapies Investor Event\n\n(5:30pm – 7:30pm EST on November 17, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727524/legacy-dotcom/siteassets/system/investors/investor--events/IRDayPresentation_EN.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2021\n\n(Held on October 28, 2021)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2021/)\n\n***\n\n### Quarterly Results - Quarter 1 FY2021\n\n(Held on July 30, 2021)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2021/)\n\n***\n\n### Finance Investor Day\n\n(7:00pm – 9:00pm EDT on July 12, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192361/legacy-dotcom/siteassets/system/investors/investor--events/finance-investor-day_en.pdf)\n\n***\n\n### Oncology Strategic Update Call\n\n(6:30pm – 7:45pm EDT on June 8, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/asco-2021-ir-event_en.pdf)\n\n***\n\n### 2021 Biopharma CEO Investor Forum\n\n(8:00am – 8:50am EDT on June 7, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727530/legacy-dotcom/siteassets/system/investors/investor--events/Takeda_CECP_CEO.pdf)\n\n***\n\n### Wave 1 Pipeline Market Opportunity Call Part 2\n\n(8:00am – 10:30am EDT on April 6, 2021) \n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/Wave1MarketEventPart2_EN.pdf)\n\n* [R\\\u0026D Pipeline Factsheet](https://assets-dam.takeda.com/raw/upload/v1662727534/legacy-dotcom/siteassets/system/what-we-do/research-and-development-rd-in-takeda/our-pipeline/PipelineFactsheet_Apr_2021.pdf)\n\n***\n\n### Quarterly Results - Quarter 4 FY2020\n\n(Held on May 11, 2021)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2020/)","padding":{"right":"","top":"","left":"","bottom":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2411","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"__metadata":{"key":"81658ca6e303","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2255","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"c2e000a4-a4a3-4580-99bf-5787d4483829","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2256","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"FY2020 (April 2020-March 2021)","content":[{"padding":{"right":"","top":"","left":"","bottom":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2412","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"right":"","top":"","left":"","bottom":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2413","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Growth and Emerging Markets Strategic Update Call\n\n(6:30am-8:15am EST on March 11, 2021) \n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/GEM-IR-Day-Presentation.pdf)\n\n***\n\n### Seminar: Investors and Analysts on Takeda’s Japan Oncology Business and its oncology products and disease in Japan\n\n(1:00pm-2:45pm JST on February 25, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192359/legacy-dotcom/siteassets/system/investors/investor--events/20210225_japan-_oncology-event_en.pdf)\n\n***\n\n### Quarterly Results - Quarter 3 FY2020\n\n(Held on February 4, 2021)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2020/)\n\n***\n\n### World Conference on Lung Cancer (WCLC) Investor Event\n\n(5:00pm-6:00pm EST on January 29, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/investor--events/WCLC-2021-IR-Event.pdf)\n\n***\n\n### 39\u003csup\u003eth \u003c/sup\u003eAnnual J.P. Morgan Healthcare Conference\n\n(5:20pm-6:00pm EST on January 11, 2021)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/investor--events/JPMHC2021.pdf)\n\n***\n\n### Wave 1 Pipeline Market Opportunity Call\n\n(5:00pm-7:15pm EST on December 8, 2020)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727539/legacy-dotcom/siteassets/system/investors/investor--events/Wave1presentation_en.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2020\n\n(Held on October 29, 2020)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2020/)\n\n***\n\n### Seminar: Investors and Analysts on Inflammatory Bowel Disease\n\n(1:00pm JST on September 2, 2020)\n\n* [Presentation](https://www.takeda.com/4ab563/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200902_ibd_en.pdf)\n\n***\n\n### Quarterly Results - Quarter 1 FY2020\n\n(Held on July 31, 2020)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2020/)\n\n***\n\n### Seminar: Investors and Analysts on Hereditary Angioedema (HAE)\n\n(1:00pm JST on June 30, 2020) \n\n* [Presentation](https://www.takeda.com/4ab54d/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200630_p01_en.pdf)\n\n***\n\n### Oncology Focused Investor Call\n\n(8:00am EDT / 9:00pm JST on June 8, 2020)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192591/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2020/june-8-onc-investor-event-presentation-06.02.20-final.pdf)\n\n***\n\n### Quarterly Results - Quarter 4 FY2019\n\n(Held on May 13, 2020)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2019/)","__metadata":{"key":"ae4c1fea2359","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2257","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2258","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"b9e3a5e1-c426-4199-b636-cff97d1f9655","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2259","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2260","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"FY2019 (April 2019-March 2020)","content":[{"text":"### Quarterly Results - Quarter 3 FY2019\n\n(Held on February 4, 2020)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2019/)\n\n***\n\n### 38\u003csup\u003eth \u003c/sup\u003eAnnual J.P. Morgan Healthcare Conference\n\n(4:00pm-4:55pm PST on January 14, 2020)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/JPMHC_2020.pdf)\n\n***\n\n### R\\\u0026D Day and Plasma-Derived Therapies Day in Tokyo\n\n(11:00am-5:00pm JST on November 21, 2019)\n\n#### Plasma-Derived Therapies\n\n* Plasma-Derived Therapies Overview: Julie Kim, President, Plasma-Derived Therapies Business Unit\n\n* Plasma-Derived Therapies R\\\u0026D: Christopher Morabito, Head, R\\\u0026D, Plasma-Derived Therapies\n\n* [Click to Download](https://assets-dam.takeda.com/image/upload/v1729283799/Global/Investor/events/2019/pdt_day_tokyo.pdf) \n\n#### R\\\u0026D Day\n\n* [Click to Download the slides](https://assets-dam.takeda.com/raw/upload/v1675192582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_tokyo-rd-day_all-slides_final_20191121.pdf)\n\n* [Takeda: A Global Values-Based, R\\\u0026D-Driven Biopharmaceutical Leader: ](https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_0---takeda_rdday_intro_final.pdf)Christophe Weber, President \u0026 CEO\n\n* [Translating Science into Highly Innovative, Life-changing Medicines: ](https://assets-dam.takeda.com/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_1---andy-rd-day_final.pdf)Andy Plump, President, R\\\u0026D\n\n* [Oncology and Cell Therapies with Spotlight on CAR-NK: ](https://assets-dam.takeda.com/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_2---io-rd-day_final.pdf)Chris Arendt, Head, Oncology Drug Discovery Unit\n\n* [Spotlight on Oncology Opportunities TAK-788: ](https://assets-dam.takeda.com/raw/upload/v1675192575/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_3---tak-788-rd-day_final.pdf)Rachael Brake, Global Program Leader, Oncology\n\n* [Spotlight on Oncology Opportunities Pevonedistat: ](https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_4---tak-924-rd-day_final.pdf)Phil Rowlands, Head, Oncology Therapeutic Area Unit\n\n* [Rare Diseases \u0026 Gene Therapy: ](https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_5---rare-disease-rd-day_final.pdf)Dan Curran, Head, Rare Disease Therapeutic Area Unit\n\n* [Spotlight on Orexin2R agonists: ](https://assets-dam.takeda.com/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_6---ox2r-rd-day_final.pdf)Deborah Hartman, Global Program Leader, Neuroscience\n\n* [Therapeutic Area Focus in GI with Spotlight on Celiac Disease: ](https://assets-dam.takeda.com/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_7---gi-rd-days_final.pdf)Asit Parikh, Head, GI Therapeutic Area Unit\n\n* [Takeda R\\\u0026D Pipeline Narrative](https://assets-dam.takeda.com/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf)\n\n***\n\n### Plasma-Derived Therapies Day in Covington, Georgia\n\n(11:15am-3:45pm EST on November 15, 2019)\n\n* [All slides](https://assets-dam.takeda.com/raw/upload/v1662727582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/PDT_20191115.pdf)\n\n* Plasma-Derived Therapies Overview: Julie Kim, President, Plasma-Derived Therapies Business Unit\n\n* Plasma-Derived Therapies R\\\u0026D: Christopher Morabito, Head, R\\\u0026D, Plasma-Derived Therapies\n\n* Covington Site Introduction: Carlos Soto, Covington Site Head\n\n***\n\n### R\\\u0026D Day in New York\n\n(12:30pm-4:00pm EST on November 14, 2019)\n\n* [All slides](https://assets-dam.takeda.com/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/all-slides_20191114_vf.pdf)\n\n* Welcome and Opening Remarks: Sheelagh Cawley-Knopf, Head, R\\\u0026D Global Portfolio Strategy\n\n* [Takeda: A Global Values-Based, R\\\u0026D-Driven Biopharmaceutical Leader](https://assets-dam.takeda.com/raw/upload/v1675192572/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/0---christophe--slide-20191114_vf.pdf): Christophe Weber, President \u0026 CEO\n\n* [Translating Science into Highly Innovative, Life-changing Medicines](https://assets-dam.takeda.com/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/1_Andy_20191114.pdf): Andy Plump, President, R\\\u0026D\n\n* [Oncology and Cell Therapies with Spotlight on CAR-NK](https://assets-dam.takeda.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/2_IO_20191114.pdf): Chris Arendt, Head, Oncology Drug Discovery Unit\n\n* [Spotlight on Oncology Opportunities TAK-788](https://assets-dam.takeda.com/raw/upload/v1662727598/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/3_TAK788_20191114.pdf): Rachael Brake, Global Program Leader, Oncology\n\n* [Spotlight on Oncology Opportunities Pevonedistat](https://assets-dam.takeda.com/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/4_TAK924_20191114.pdf): Phil Rowlands, Head, Oncology Therapeutic Area Unit\n\n* [Rare Diseases \u0026 Gene Therapy](https://assets-dam.takeda.com/raw/upload/v1675192574/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/5_rare-disease_20191114_2.pdf): Dan Curran, Head, Rare Disease Therapeutic Area Unit\n\n* [Spotlight on Orexin2R agonists](https://assets-dam.takeda.com/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/6_OX2R_20191114.pdf): Deborah Hartman, Global Program Leader, Neuroscience\n\n* [Therapeutic Area Focus in GI with Spotlight on Celiac Disease](https://assets-dam.takeda.com/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/7_GI_20191114.pdf): Asit Parikh, Head, GI Therapeutic Area Unit\n\n* [Takeda R\\\u0026D Pipeline Narrative](https://assets-dam.takeda.com/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2019\n\n(Held on October 31, 2019)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2019/)\n\n***\n\n### IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit\n\n(Held on October 10, 2019)\n\n* This event was closed.\n\n***\n\n### Morgan Stanley Healthcare Conference\n\n(Held on September 10, 2019 ET)\n\n* This event was closed.\n\n***\n\n### Quarterly Results - Quarter 1 FY2019\n\n(Held on July 31, 2019)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2019/)\n\n***\n\n### IR Seminar “Plasma-Derived Therapies Business”\n\n(Held on July 12, 2019)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192570/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/20190712-ir-presentation-on-pdt_final_e.pdf)\n\n***\n\n### Quarterly Results - Quarter 4 FY2018\n\n(Held on May 14, 2019)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2018/)","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2414","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"left":"","bottom":"","right":"","top":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2415","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"2646ec5adaf7","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"d45a2a09-a8de-4f58-ba97-10981bed037e","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2261","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"FY2018 (April 2018-March 2019)","content":[{"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2416","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Quarterly Results - Quarter 3 FY2018\n\n(Held on February 1, 2019)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2018/)\n\n***\n\n### 37\u003csup\u003eth \u003c/sup\u003eAnnual J.P. Morgan Healthcare Conference\n\n(Held on January 8, 2019 PST)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727541/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/JPMHC2019-E.pdf)\n\n***\n\n### Meeting regarding Acquisition of Shire plc by Takeda\n\n(Held on January 7, 2019) \n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192566/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/shire-deal-close-announcement_en.pdf): A Global, Values-based, R\u0026D-driven Biopharmaceutical Leader\n\n* [More details on Takeda's offer to acquire Shire Plc.](https://www.takeda.com/investors/offer-for-shire/)\n\n***\n\n### Quarterly Results - Quarter 2 FY2018\n\n(Held on October 31, 2018)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2018/)\n\n***\n\n### Takeda’s R\u0026D Investor Day (Boston)\n\n(October 11, 2018)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727546/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULL_DECK_Boston_E.pdf): Delivering on our R\u0026D vision\n\n* Andy Plump, Chief Medical and Scientific Officer\n\n * [Oncology](https://assets-dam.takeda.com/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_Oncology_Boston_E.pdf)\n\n * [Gastroenterology](https://assets-dam.takeda.com/raw/upload/v1662727549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_DECK_Boston_E.pdf)\n\n * [Neuroscience](https://assets-dam.takeda.com/raw/upload/v1662727551/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_DECK_Boston_E.pdf)\n\n * [Vaccines](https://assets-dam.takeda.com/raw/upload/v1662727552/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VBU_DECK_Boston_E.pdf)\n\n***\n\n### Takeda’s R\u0026D Investor Day (Tokyo)\n\n(September 27, 2018)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULLDECK_E_rd_day.pdf): Delivering on our R\u0026D vision\n\n* Andy Plump, Chief Medical and Scientific Officer\n\n * [Oncology](https://assets-dam.takeda.com/raw/upload/v1662727555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_ONCOLOGY_E.pdf)\n\n * [Gastroenterology](https://assets-dam.takeda.com/raw/upload/v1662727557/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_E.pdf)\n\n * [Neuroscience](https://assets-dam.takeda.com/raw/upload/v1662727558/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_E.pdf)\n\n * [Vaccines](https://assets-dam.takeda.com/raw/upload/v1662727559/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VACCINE_E.pdf)\n\n * [Shonan iPark](https://assets-dam.takeda.com/raw/upload/v1662727560/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/5_IPARK_E.pdf)\n\n***\n\n### Quarterly Results - Quarter 1 FY2018\n\n(Held on July 31, 2018)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2018/)\n\n***\n\n### Quarterly Results - Quarter 4 FY2017\n\n(Held on May 14, 2018)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2017/)\n\n***\n\n### Conference Call Regarding Proposed Acquisition of Shire plc by Takeda\n\n(Held on May 8/9, 2018)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192569/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/takeda-to-acquire-shire-accelerating-takeda_s-transformation-to-deliver-more-for-patients.pdf): Takeda to Acquire Shire-Accelerating Takeda’s Transformation to Deliver More for Patients\n\n","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2417","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"a8476b42973e","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2262","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2263","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"b25dbc57-bc42-44fb-93bc-5005f99a117c","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"FY2017 (April 2017-March 2018)","content":[{"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2418","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"left":"","bottom":"","right":"","top":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2419","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Quarterly Results - Quarter 3 FY2017\n\n(Held on February 1, 2018)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2017/)\n\n***\n\n### 36\u003csup\u003eth \u003c/sup\u003eAnnual J.P. Morgan Healthcare Conference\n\n(Held on January 8, 2018 PST)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727540/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2017/36th-annual-j.p.-morgan-healthcare-conference-held-on-january-8-2018-pst/qr2017_q3_p01_en.pdf)\n\n***\n\n### Jefferies 2017 Global Healthcare Conference\n\n(Presented November 16, 2017, 10:00 GMT)\n\n* This event was closed.\n\n***\n\n### Quarterly Results - Quarter 2 FY2017\n\n(Held on November 1, 2017)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2017/)\n\n***\n\n### Quarterly Results - Quarter 1 FY2017\n\n(Held on July 28, 2017)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2017/)\n\n***\n\n### UBS Global Healthcare Conference\n\n(Released on May 23, 2017, 9:30 EDT)\n\n* This event was closed.\n\n***\n\n### Quarterly Results - Quarter 4 FY2016\n\n(Held on May 10, 2017)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2016/)","__metadata":{"key":"f017ead3d255","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"d4c06805-6a70-4d42-90ee-8528937fcf32","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"FY2016 (April 2016-March 2017)","content":[{"padding":{"right":"","top":"","left":"","bottom":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2420","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"left":"","bottom":"","right":"","top":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2421","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Quarterly Results - Quarter 3 FY2016\n\n(Held on February 1, 2017)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2016/)\n\n***\n\n### Conference Call on the Acquisition of ARIAD Pharmaceuticals\n\n(Released on January 10, 2017)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/conference-call-on-the-acquisition-of-ariad-pharmaceuticals-released-on-january-10-2017/takeda-to-acquire-ariad-pharmaceuticals.pdf)\n\n***\n\n### 35\u003csup\u003eth\u003c/sup\u003eAnnual J.P. Morgan Healthcare Conference\n\n(Held on January 9, 2017)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/35thannual-j.p.-morgan-healthcare-conference-held-on-january-9-2017/j.p.-morgan-healthcare-conference-presentation.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2016\n\n(Held on October 28, 2016)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2016/)\n\n***\n\n### Quarterly Results - Quarter 1 FY2016\n\n(Held on July 29, 2016)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2016/)\n\n***\n\n### Takeda IR Day\n\n(Held on June 9, 2016)\n\n1. [Takeda Oncology: ](https://assets-dam.takeda.com/raw/upload/v1675192554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/1.-takeda-oncology.pdf)Christophe Bianchi, President, Global Oncology Business Unit\n\n2. [Focused World Class R\u0026D New approaches to innovation: ](https://assets-dam.takeda.com/raw/upload/v1675192555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/2.-focused-world-class-r_d.pdf)Andrew Plump, Chief Medical \u0026 Scientific Officer\n\n***\n\n### Quarterly Results - Quarter 4 FY2015\n\n(Held on May 10, 2016)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2015/)","__metadata":{"key":"40285f8f9dd8","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"43ea30193f66","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"FY2015 (April 2015-March 2016)","content":[{"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2422","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"left":"","bottom":"","right":"","top":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2423","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Quarterly Results - Quarter 3 FY2015\n\n(Held on February 3, 2016)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2015/)\n\n***\n\n### 34th Annual J.P. Morgan Healthcare Conference\n\n(Held on January 12, 2016)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2015/34th-annual-j.p.-morgan-healthcare-conference-held-on-january-12-2016/qr2015_q3_p01_en.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2015\n\n(Held on October 30, 2015)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2015/)\n\n***\n\n### Quarterly Results - Quarter 1 FY2015\n\n(Held on July 30, 2015)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2015/)\n\n***\n\n### Quarterly Results - Quarter 4 FY2014\n\n(Held on May 15, 2015)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2014/)","__metadata":{"key":"e01849b5e601","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"93cad3cd0d2b","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"FY2014 (April 2014-March 2015)","content":[{"text":"### Takeda IR Event: A Global Leader in Gastroenterology\n\n(Held on March 9, 2015)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/takeda-ir-event--a-global-leader-in-gastroenterology-held-on-march-9-2015/qr2014_q3_p_en.pdf)\n\n***\n\n### Quarterly Results - Quarter 3 FY2014\n\n(Held on February 5, 2015)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2014/)\n\n***\n\n### 33\u003csup\u003erd\u003c/sup\u003e Annual J.P. Morgan Healthcare Conference\n\n(Held on January 13, 2015)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/33rd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2015/qr2014_q3_e01_en.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2014\n\n(Held on October 30, 2014)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2014/)\n\n***\n\n### Quarterly Results - Quarter 1 FY2014\n\n(Held on August 1, 2014)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2014/)\n\n***\n\n### Quarterly Results - Quarter 4 FY2013\n\n(Held on May 8, 2014)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2013/)","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2424","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"right":"","top":"","left":"","bottom":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2425","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"8f3785febbf8","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"c320bf2b58fb","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"FY2013 (April 2013-March 2014)","content":[{"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2426","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2427","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"### Quarterly Results - Quarter 3 FY2013\n\n(Held on February 5, 2014)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2013/)\n\n***\n\n### 32\u003csup\u003end\u003c/sup\u003e Annual J.P. Morgan Healthcare Conference\n\n(Held on January 13, 2014)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1675192534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2013/32nd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2014/j.p.-morgan-healthcare-conference-presentation.pdf)\n\n***\n\n### Quarterly Results - Quarter 2 FY2013\n\n(Held on October 31, 2013)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2013/)\n\n***\n\n### Quarterly Results - Quarter 1 FY2013\n\n(Held on July 31, 2013)\n\n* [Read more](https://www.takeda.com/investors/financial-results/quarterly-results-2013/)","padding":{"left":"","bottom":"","right":"","top":""},"__metadata":{"key":"0c0d92636420","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"cf7ad452a151","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"}],"displayName":"","__metadata":{"key":"1e3b90d2-e375-4cf7-a3ee-b20c9f90d0e2","modelName":"AccordionSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"AccordionSection"},{"text":"### 148th Ordinary General Meeting of Shareholders (June 26, 2024)\n\n* [Notice of Convocation of the 148th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1716784771/Global/Investor/events/shareholders-meetings/2024/sm_148_01_en.pdf)\n\n* [Other items which are provided electronically](https://assets-dam.takeda.com/image/upload/v1716771549/Global/Investor/events/shareholders-meetings/2024/sm_148_02_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO](https://www.takeda.com/investors/events/shareholder-letter-2024)\n\n* [Takeda’s executive compensation overview](https://assets-dam.takeda.com/image/upload/v1716782703/Global/Investor/events/shareholders-meetings/2024/sm_148_04_en.pdf)\n\n* [FY2023 Q4 Financial Results](https://www.takeda.com/investors/financial-results/quarterly-results/)\n\n* [Statement from Masami Iijima, Chair of the Board of Directors Meeting of Takeda, in Response to Institutional Shareholder Services Inc.’s Voting Recommendations Ahead of the 148th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1717730187/Global/Investor/events/shareholders-meetings/2024/iss-reactive-statement_en.pdf)\n\n* [Partial Correction to the Notice of Convocation of the 148th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1717986546/Global/Investor/events/shareholders-meetings/2024/sm_148_05_en.pdf)\n\n* [Presentation](https://assets-dam.takeda.com/image/upload/v1719479941/Global/Investor/events/shareholders-meetings/2024/sm_148_07_en.pdf)\n\n* [Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1718759459/Global/Investor/events/shareholders-meetings/2024/sm_148_06_en.pdf)\n\n* [Results of the Exercise of Voting Rights of the 148th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1719808017/Global/Investor/events/shareholders-meetings/2024/sm_148_08_en.pdf)\n\n* [The 148th Ordinary General Meeting of Shareholders (Video Recording)](https://bcove.video/3XNRk4n)\n","componentLayout":"takeda-com-redesign","elementId":"","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2236","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"enableNoSnippet":false,"excludeFromNavigation":false,"hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2237","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","title":"\u003cdiv id=\"annual-shareholders-meetings\"\u003e## Annual Shareholders Meetings\u003c/div\u003e\n","subtitle":"","__metadata":{"key":"43197853-b17a-4c6e-90f7-c2f41e07347f","modelName":"TextSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"TextSection"},{"title":"## Past Shareholder Events \u0026 Reports\n\n","componentLayout":"takeda-com-redesign","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2238","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"displayName":"","enableOpenMultipleAccordions":false,"accordions":[{"title":"147th Ordinary General Meeting of Shareholders(June 28, 2023)","content":[{"componentLayout":"default","title":"\n\n","margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2428","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Notice of Convocation of the 147th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1687414710/Global/Investor/events/shareholders-meetings/2023/sm_147_01-2_en.pdf)\n\n* [Other items which are provided electronically](https://assets-dam.takeda.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_02_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO](https://assets-dam.takeda.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_03_en.pdf)\n\n* [Takeda’s executive compensation overview](https://assets-dam.takeda.com/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_04_en.pdf)\n\n* [FY2022 Q4 Financial Results](https://www.takeda.com/investors/financial-results/quarterly-results/)\n\n* [Partial Correction to the Notice of Convocation of 147th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/image/upload/v1687409671/Global/Investor/events/shareholders-meetings/2023/Notice_of_Amendment_to_be_posted_on_the_WEB.pdf)\n\n* [Presentation](https://assets-dam.takeda.com/image/upload/v1688013747/Global/Investor/events/shareholders-meetings/2023/sm_147_07_en.pdf)\n\n* [Notice of Resolutions](https://assets-dam.takeda.com/image/upload/v1687488561/Global/Investor/events/shareholders-meetings/2023/sm_147_06_en.pdf)\n\n* [Results of the Exercise of Voting Rights](https://assets-dam.takeda.com/image/upload/v1688114712/Global/Investor/events/shareholders-meetings/2023/sm_147_08_en.pdf)\n","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2429","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"51c14d794d31","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"32199af8ccc0bc31aad7a0a1d8b58a97","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"147th Interim Report","content":[{"componentLayout":"default","text":"* [Business report (interim period)](https://assets-dam.takeda.com/image/upload/v1701060648/Global/Investor/events/shareholders-meetings/2023/br147_mid_en.pdf)\n\n","padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2430","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2431","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"\n\n","margin":{"right":"","top":"","left":"","bottom":""},"__metadata":{"key":"51c14d794d31","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"057d576b8bc0424837a40689333a399b","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"146th Ordinary General Meeting of Shareholders(June 29, 2022)","content":[{"margin":{"bottom":"","right":"","top":"","left":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2432","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Notice of convocation](https://assets-dam.takeda.com/raw/upload/v1662727586/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_01_en_1.pdf)\n\n* [Items disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727587/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_02_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO](https://assets-dam.takeda.com/raw/upload/v1662725889/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_03_en_1.pdf)\n\n* [Takeda's executive compensation overview](https://assets-dam.takeda.com/raw/upload/v1662727590/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_04_en.pdf)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727593/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_07_en.pdf)\n\n* [Notice of Resolutions](https://assets-dam.takeda.com/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_05_en.pdf)\n\n* [Results of the Exercise of Voting Rights](https://assets-dam.takeda.com/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_06_en.pdf)","title":"\n\n","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2433","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"componentLayout":"default","padding":{"right":"","top":"","left":"","bottom":""},"__metadata":{"key":"51c14d794d31","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"28f933212f1d","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"146th Interim Report","content":[{"title":"\n\n","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2434","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"padding":{"bottom":"","right":"","top":"","left":""},"margin":{"right":"","top":"","left":"","bottom":""},"componentLayout":"default","text":"* [Business report (interim period)](https://assets-dam.takeda.com/raw/upload/v1669795726/legacy-dotcom/siteassets/system/investors/report/business/br146_mid_en.pdf)\n\n","titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2435","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"51c14d794d31","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"4b51947c6fd9ac34acb8eccb50da4af5","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"145th Ordinary General Meeting of Shareholders (June 29, 2021)","content":[{"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2436","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2437","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Notice of Convocation](https://assets-dam.takeda.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_01_en.pdf)\n\n* [Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_02_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO](https://assets-dam.takeda.com/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_03_en.pdf)\n\n* [Takeda’s executive compensation overview](https://assets-dam.takeda.com/raw/upload/v1662727600/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_04_en_2.pdf)\n\n* [Partial Correction to the Notice of Convocation of the 145th Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727601/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_05_en.pdf)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/shareholders-meetings/FY2021_GSM_28-June-2021_vF.pdf)\n\n* [Notice of Resolutions](https://assets-dam.takeda.com/raw/upload/v1662727603/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_06_en.pdf)\n\n* [Results of the Exercise of Voting Rights](https://assets-dam.takeda.com/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_07_en.pdf)","__metadata":{"key":"80ba919d8526","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"05b1931fbb0a","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"title":"145th Interim Report","content":[{"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2438","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"left":"","bottom":"","right":"","top":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2439","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Business report (interim period)](https://assets-dam.takeda.com/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/report/business/br145_mid_en.pdf)\n\n","__metadata":{"key":"80ba919d8526","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"161ab7cedacaa676379d8e74a246c18f","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2264","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"144th Ordinary General Meeting of Shareholders (June 24, 2020)","content":[{"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2440","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Notice of Convocation](https://assets-dam.takeda.com/raw/upload/v1662727605/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_01_en.pdf)\n\n* [Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727607/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_02_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO](https://assets-dam.takeda.com/raw/upload/v1662727608/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_03_en.pdf)\n\n* [Takeda's executive compensation overview](https://assets-dam.takeda.com/raw/upload/v1662727609/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_04_en.pdf)\n\n* [Partial Correction to the Items Disclosed via the Internet Concerning the Notice of Convocation of the 144th Ordinary General Meeting of Shareholders](https://www.takeda.com/4ab49c/siteassets/system/investors/shareholders-meetings/e_notice-of-amendment-to-be-posted-on-the-web.pdf)\n\n* [144th Ordinary General Meeting of Shareholders Christophe Weber](https://assets-dam.takeda.com/raw/upload/v1675192637/legacy-dotcom/siteassets/system/investors/shareholders-meetings/cw2020_15min_gsm_presentation_1806.pdf)\n\n* [Notice of Resolutions](https://www.takeda.com/4ab49c/siteassets/system/investors/shareholders-meetings/sm_144_05-en.pdf)\n\n* [Results of the Exercise of Voting Rights](https://www.takeda.com/4ab49f/siteassets/system/investors/shareholders-meetings/sm_144_06_en.pdf)","padding":{"bottom":"","right":"","top":"","left":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2441","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"__metadata":{"key":"eefee5eb456e","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2265","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2266","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"7643fab3-0d38-4869-9091-42e7ff9b53d3","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2267","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2268","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2269","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"144th Interim Report","content":[{"padding":{"right":"","top":"","left":"","bottom":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2442","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2443","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Business report (interim period)](https://assets-dam.takeda.com/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/business/br144_mid_en.pdf)\n\n","__metadata":{"key":"eefee5eb456e","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"__metadata":{"key":"11e8b94d50235150d60d6e4d211d556e","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2270","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2271","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"143rd Ordinary General Meeting of Shareholders (June 27, 2019)","content":[{"padding":{"left":"","bottom":"","right":"","top":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2444","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2445","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Notice of Convocation](https://assets-dam.takeda.com/raw/upload/v1662727611/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_01_en.pdf)\n\n* [Items Disclosed via the Internet Concerning the Notice of Convocation of the Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727612/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_02_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO](https://assets-dam.takeda.com/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1905_en.pdf)\n\n* [Partial Correction to the Notice of Convocation of the 143rd Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_03_en.pdf)\n\n* [Supplemental Material for the Proposals at the 143rd Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727614/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_04_en.pdf)\n\n* [Summary of Takeda’s Modifications to the Executive Compensation Program and Future Considerations](https://assets-dam.takeda.com/raw/upload/v1662727616/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_05_en.pdf)\n\n* [Takeda’s Recommendation to vote for Takeda’s Proposals at the 143rd Ordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/shareholder-engagement-response-e-final-clean-v3.pdf)\n\n* [A Statement of Confidence in the Leadership of Mr. Christophe Weber and Comments on the Proposals at the 143rd Ordinary General Meeting of Shareholders from Masahiro Sakane, the Chair of the Board of Directors Meeting of Takeda](https://assets-dam.takeda.com/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sakane-san-message_e-with-attachment.pdf)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727621/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p01_en.pdf)\n\n* [Consolidated Financial Results for FY2018 and Guidance for FY2019](https://assets-dam.takeda.com/raw/upload/v1662727622/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p02_en.pdf)\n\n* [Notice of Resolutions](https://assets-dam.takeda.com/raw/upload/v1675192644/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_06-en.pdf)\n\n* [Results of the Exercise of Voting Rights](https://assets-dam.takeda.com/raw/upload/v1662727623/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_07_en.pdf)","__metadata":{"key":"23535755cc5f","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2272","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"e81b402e-5a64-4fa2-ba04-39acfa0a3157","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"collapsedTitleBgColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2273","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"143rd Interim Report","content":[{"padding":{"left":"","bottom":"","right":"","top":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2446","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"right":"","top":"","left":"","bottom":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2447","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Business report (interim period)](https://assets-dam.takeda.com/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/report/business/br143_mid_en.pdf)\n\n","__metadata":{"key":"23535755cc5f","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2274","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2275","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"737f9d8976bb12fb2a934a59d7210155","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"},{"contentBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2276","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"Extraordinary General Meeting of Shareholders (December 5, 2018)","content":[{"padding":{"top":"","left":"","bottom":"","right":""},"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2448","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"margin":{"top":"","left":"","bottom":"","right":""},"titleColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2449","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"text":"* [Notice of Convocation](https://assets-dam.takeda.com/raw/upload/v1662727624/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_01_en.pdf)\n\n* [Message from Christophe Weber, President \u0026 CEO, regarding the acquisition of Shire plc](https://assets-dam.takeda.com/raw/upload/v1662727625/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1811_en.pdf)\n\n* [Partial Correction to the Reference Document attached to the Notice of Convocation of the Extraordinary General Meeting of Shareholders](https://assets-dam.takeda.com/raw/upload/v1662727626/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1115_en.pdf)\n\n* [Presentation](https://assets-dam.takeda.com/raw/upload/v1662727628/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_01_en.pdf)\n\n* [Notice of Resolutions](https://assets-dam.takeda.com/raw/upload/v1662727629/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1205_en.pdf)\n\n* [Results of the Exercise of voting Rights](https://assets-dam.takeda.com/raw/upload/v1662727630/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_02_en.pdf)\n\n* [Learn more about the Shire offer](/investors/overview/offer-for-shire)\n\n","__metadata":{"key":"97c632532a4b","modelName":"RTE","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"RTE"}],"expandedTitleBgColor":{"color":"light-grey","__metadata":{"key":"ThemeColorPicker2277","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"bec9ba37-fa09-44b8-9240-8aa714d59d08","modelName":"Accordion","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Accordion"}],"hideTitle":false,"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2239","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"enableNoSnippet":false,"elementId":"","excludeFromNavigation":false,"__metadata":{"key":"66a4112a-de0b-4446-bfa4-3f90cd847e4e","modelName":"AccordionSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"AccordionSection"},{"hideTitle":false,"componentLayout":"takeda-com-redesign","backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2240","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"excludeFromNavigation":false,"title":"\u003cdiv id=\"retail-investor-events\"\u003e## Retail Investor Events\u003c/div\u003e\n\n\n\n","subtitle":"","elementId":"","titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2241","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"enableNoSnippet":false,"text":"#### Online information session for retail investors: \"Committed to Growth \u0026 Shareholder Returns\" (in Japanese only)\n\n7:45 pm - 8:30 pm JST on February 22, 2024\n\n* [Webcast](https://api01-platform.stream.co.jp/apiservice/plt3/NTk0NA%3d%3d%23NTI3Mg%3d%3d%23280%23168%23b%233FE2A0D9E400%23MDoyOjc6YTpmOzEwOzEwOzEw%23)\n* [Presentation](https://assets-dam.takeda.com/image/upload/v1710384814/Global/Investor/events/2024/presentation_02222024.pdf)\n\n***\n\n#### Information session for retail investors: \"Better health for people, Brighter future for the world\"\n\nFebruary 22, 2023\n\n* [Presentation](https://assets-dam.takeda.com/image/upload/v1678160771/legacy-dotcom/siteassets/system/investors/investor--events/20230222_retail%20investor%20event_presentation.pdf)\n\n***","displayName":"","__metadata":{"key":"b3c47d67-b0a5-4ae7-9b70-276c9b03da1e","modelName":"TextSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"TextSection"},{"enableNoSnippet":false,"heightVariants":"","title":"## Sign up for our investors newsletter\n\n","elementId":"","button":{"elementId":"","style":"primary","showIcon":false,"iconPosition":"right","href":"/investors/newsletter","size":"large","altText":"Sign up","label":"Sign up","__metadata":{"key":"Action2717","modelName":"Action","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Action"},"componentLayout":"takeda-com-redesign-rir","backgroundColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2242","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"subtitle":"Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet","displayName":"","excludeFromNavigation":false,"overlayOpacity":30,"hideTitle":false,"margin":{"top":"","left":"","bottom":"10","right":""},"titleColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2243","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"__metadata":{"key":"ced0de2f-7285-42d5-a83b-7c0f44c508d7","modelName":"BannerCTASection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"BannerCTASection"},{"items":[{"linkLabel":"###Financial Highlights ","showDescription":true,"hideIcon":true,"iconColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2278","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"description":"The company’s most recent and important financial information","href":"/investors/financial-highlights","__metadata":{"key":"6b3dd4e3-2e80-4954-baab-b577657cd309","modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"},{"iconColor":{"color":"primary","__metadata":{"key":"ThemeColorPicker2279","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"description":"Read our latest news","href":"/newsroom/press-releases","linkLabel":"###Newsroom","showDescription":true,"hideIcon":true,"__metadata":{"key":"a07a1da2-01aa-41f8-95de-e4605756cae8","modelName":"QuickLinksItem","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksItem"}],"titleColor":{"color":"dark-grey","__metadata":{"key":"ThemeColorPicker2244","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"variant":"compact","displayName":"","componentLayout":"takeda-com-redesign-left-aligned-title","excludeFromNavigation":true,"backgroundColor":{"color":"white","__metadata":{"key":"ThemeColorPicker2245","modelName":"ThemeColorPicker","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ThemeColorPicker"},"title":"## Explore\n\n","hideTitle":false,"enableNoSnippet":false,"elementId":"","__metadata":{"key":"2d9970ff-e14b-49ec-87f9-c4592c56363f","modelName":"QuickLinksSection","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"QuickLinksSection"}],"__i18n_lang":"en","visibleInListings":true,"keywords":"","description":"Find information and relevant documents on past and upcoming investor-related events, including the Annual Shareholders Meeting and broker conferences.","altPageLanguages":[{"slug":"investors/events","language":"en","isEnabled":true},{"slug":"/jp/investors/events/","language":"ja","isEnabled":true}],"title":"Investor Events","isBackToTopBtnEnabled":true,"metaDescription":"Find information and relevant documents on past and upcoming investor-related events, including the Annual Shareholders Meeting and broker conferences.","disableScrollRestoration":true,"metaTitle":"Investor Events and Presentations | Takeda Pharmaceuticals","noIndexNoFollow":false,"canonical":"","language":"en","enablePageNavigation":false,"addTitleSuffix":false,"locale":{"displayName":"Global English","languageCode":"en","slug":"/en","localeCode":"en","language":"en","isEnabled":true,"__metadata":{"key":"Locale2795","modelName":"Locale","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"BFBFMQqWvC2I3ByltLTeDy","createdAt":"2024-03-14T14:51:47Z","updatedAt":"2024-03-14T14:51:47Z"},"type":"Locale"},"__metadata":{"key":"ContentLayout2975","modelName":"ContentLayout","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"cOAqlEEzQiJUPTqIF5MboP","createdAt":"2023-03-03T10:14:12Z","updatedAt":"2024-11-21T10:56:33Z"},"type":"ContentLayout"},"configBySegment":{},"defaultTheme":{"h1":{"fontWeight":"300","fontLineHeightMobile":"","fontWeightMobile":"300","fontSize":"2.625rem","fontSizeMobile":"1.875rem","fontLineHeight":"2.875rem"},"h2":{"fontWeight":"300","fontLineHeightMobile":"2rem","fontWeightMobile":"300","fontSize":"2.25rem","fontSizeMobile":"1.5rem","fontLineHeight":"2.6875rem"},"quote":{"fontSizeMobile":"1.25rem","fontLineHeight":"2.75rem","fontWeight":"400","fontLineHeightMobile":"1.625rem","fontWeightMobile":"400","fontSize":"2rem"},"textColor":"#333333","colorPrimaryActive":"#891515","colorSecondaryContrast":"#ffffff","buttonSecondary":{"backgroundColor":"","borderRadiusTopLeft":"","borderRadiusBottomLeft":"","borderRadiusTopRight":"","hoverBackgroundColor":"","borderRadiusBottomRight":"","textColor":"#333333"},"globalImages":{"borderRadiusTopRight":"","borderRadiusBottomRight":"","borderRadiusTopLeft":"","borderRadiusBottomLeft":"1.875rem"},"colorMediumGreyContrast":"#ffffff","colorMediumGrey":"#a1a4ac","colorLightGrey":"#edf2f4","colorDarkGrey":"#333333","__i18n_lang":"en","colorSecondary":"#891515","colorPrimaryContrast":"#ffffff","colorHoverGrey":"#DCE6E9","language":"en","h3":{"fontWeightMobile":"500","fontSize":"1.5rem","fontSizeMobile":"1.25rem","fontLineHeight":"2rem","fontWeight":"500","fontLineHeightMobile":"1.75rem"},"colorPrimary":"#BD120A","colorPrimaryActiveContrast":"#ffffff","subHeading":{"fontSize":"1.125rem","fontSizeMobile":"1rem","fontLineHeight":"1.25rem","fontWeight":"500","fontLineHeightMobile":"1.5rem","fontWeightMobile":"700"},"h4":{"fontWeight":"500","fontLineHeightMobile":"1.75rem","fontWeightMobile":"500","fontSize":"1.25rem","fontSizeMobile":"1.125rem","fontLineHeight":"1.75rem"},"h5":{"fontSizeMobile":"1rem","fontLineHeight":"1.75rem","fontWeight":"700","fontLineHeightMobile":"1.75rem","fontWeightMobile":"700","fontSize":"1rem"},"bodyBlock":{"fontLineHeightMobile":"1.625rem","fontWeightMobile":"400","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem","fontWeight":"400"},"spacings":{"paddingTop":"0rem","marginTop":"0rem","paddingTopMobile":"0rem","paddingBottomMobile":"0rem","marginBottom":"3.125rem","marginTopFirstComponent":"3.125rem","marginBottomMobile":"2.5rem","marginTopFirstComponentMobile":"2.5rem","marginTopMobile":"0rem","paddingBottom":"0rem"},"cta":{"fontWeightMobile":"700","fontSize":"1rem","fontSizeMobile":"1rem","fontLineHeight":"1.625rem","fontWeight":"700","fontLineHeightMobile":"1.625rem"},"buttonPrimary":{"borderRadiusBottomLeft":"1.25rem","borderRadiusTopRight":"","hoverBackgroundColor":"#891515","borderRadiusBottomRight":"","textColor":"#ffffff","backgroundColor":"#BD120A","borderRadiusTopLeft":""},"colorDarkGreyContrast":"#ffffff","colorLightGreyContrast":"#333333","__metadata":{"key":"ThemeStyle2959","modelName":"ThemeStyle","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"siteTheme","createdAt":"2022-11-11T08:38:47Z","updatedAt":"2024-07-16T10:23:18Z"},"type":"ThemeStyle"},"currentLanguage":"en","site":{"brightcoveVideoSettings":{"accountId":"2299575749001","playerId":"Dep9YQixR"},"scripts":[{"loadingStrategy":"beforeInteractive","title":"EPD-3055 OneTrust Cookie","script":{"code":"\u003c!-- OneTrust Cookies Consent Notice start for takeda.com --\u003e\n\u003c!-- 20230526 --\u003e\n\n\u003cscript\n type=\"text/javascript\"\n src=\"https://cdn.cookielaw.org/consent/3625bb82-8e0e-4be8-80d3-257e4f469168/OtAutoBlock.js\"\n\u003e\u003c/script\u003e\n\n\u003cscript\n src=\"https://cdn.cookielaw.org/scripttemplates/otSDKStub.js\"\n data-document-language=\"true\"\n type=\"text/javascript\"\n charset=\"UTF-8\"\n data-domain-script=\"3625bb82-8e0e-4be8-80d3-257e4f469168\"\n\u003e\u003c/script\u003e\n\n\u003cscript type=\"text/javascript\"\u003e\n function OptanonWrapper() {}\n\u003c/script\u003e\n\n\u003c!-- OneTrust Cookies Consent Notice end for takeda.com --\u003e ","__metadata":{"key":"code2246","modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"key":"96fac00f-4962-4d0d-8c5f-5839536ed0ac","modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-3519 Schema Script","script":{"code":"\u003cscript type=\"application/ld+json\"\u003e{\"@context\": \"https://schema.org\",\"@type\":\"Organization\",\"name\": \"Takeda Pharmaceutical Company Limited\",\"url\": \"https://www.takeda.com\",\"logo\": \"https://www.takeda.com/4ab4e2/siteassets/system/top/howwework_logo_1600x900.jpg\",\"address\": {\"@type\": \"PostalAddress\",\"streetAddress\": \"2-ch?me-1-1 Nihonbashihonch?\",\"addressLocality\": \"Chuo City\",\"addressRegion\": \"Tokyo\",\"postalCode\": \"103-0023\",\"addressCountry\": \"Japan\"},\"contactPoint\": {\"@type\": \"ContactPoint\",\"contactType\": \"contact\",\"telephone\": \"+81 3-3278-2111\",\"email\": \"Media_Relations@takeda.com\"},\"sameAs\":[\"https://www.linkedin.com/company/takeda-pharmaceuticals/\",\"https://twitter.com/takedapharma\",\"https://www.youtube.com/takeda-pharmaceuticals\"]} \u003c/script\u003e","filename":"","language":"","__metadata":{"key":"code2387","modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"key":"63262da4-9c32-435b-80a5-67f5449f1352","modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-2855 GTM Script","script":{"language":"","code":"\u003c!-- Google Tag Manager --\u003e\n\u003cscript\u003e(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-5XBTH5B');\u003c/script\u003e\n\u003c!-- End Google Tag Manager --\u003e","filename":"","__metadata":{"key":"code2388","modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"key":"f11e0f99-ac48-43de-8fd1-3ff7332effea","modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-4037 Matomo Tag Manager","script":{"code":"\u003c!-- Matomo Tag Manager --\u003e\r\n\u003cscript\u003e\r\nvar _mtm = window._mtm = window._mtm || [];\r\n_mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'});\r\nvar d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];\r\ng.async=true; g.src='https://cdn.matomo.cloud/takeda.matomo.cloud/container_rTZNKGIx.js'; s.parentNode.insertBefore(g,s);\r\n\u003c/script\u003e\r\n\u003c!-- End Matomo Tag Manager --\u003e","language":"js","__metadata":{"key":"code2250","modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"key":"81654c8cf9a8","modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"},{"loadingStrategy":"beforeInteractive","title":"EPD-4268 Cookie Script Hack","script":{"code":"\u003cstyle type=\"text/css\"\u003e #onetrust-consent-sdk svg {display: inline;} \u003c/style\u003e","__metadata":{"key":"code2247","modelName":"code","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"code"},"__metadata":{"key":"b8b6fa15-4703-4000-9231-9d6f3cd26a9f","modelName":"Script","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Script"}],"exitDisclaimer":{"title":"You are leaving Takeda.com","cancelButtonTitle":"Cancel","okButtonTitle":"Continue","whitelistedUrls":["assets-dam.takeda.com","takeda.com","players.brightcove.net/2299575749001","takedajobs.com","jobs.takeda.com","takedaoncology.com","www.takeda.com","www.takedaoncology.com","clinicaltrials.takeda.com","www.takedajobs.com","www.jp.takedajobs.com"],"isEnabled":true,"description":"Links to sites outside of takeda.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. \n\nTo stay on the current website, select “Cancel”\n","__metadata":{"key":"ExitDisclaimer2935","modelName":"ExitDisclaimer","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ExitDisclaimer"},"noIndexNoFollow":false,"fallbackSocialImage":{"url":"http://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","format":"jpg","metadata":{"epzciwdjuelllku8ngpo":["0001"]},"resource_type":"image","_version":1,"access_mode":"public","uploaded_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"created_at":"2023-05-12T12:02:00Z","bytes":185717,"secure_url":"https://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg","version":1683892920,"created_by":{"id":"5c035dcf12017bdefe1298466d0c2f","type":"user"},"public_id":"Global/OG Logo","width":1200,"height":627,"type":"cloudinary.asset","__metadata":{"key":"jdDRKJnyuW8qunA0HPL3m","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"__i18n_lang":"en","footer":{"__i18n_lang":"en","language":"en","socialLinks":[{"icon":{"variant":"LinkedIn","__metadata":{"key":"Icon2251","modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"style":"link","href":"https://www.linkedin.com/company/takeda-pharmaceuticals/","label":"LinkedIn","elementId":"","altText":"LinkedIn icon","__metadata":{"key":"1f14579e-7c12-4849-be12-a7d196bfb058","modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"},{"style":"link","href":"https://www.youtube.com/takeda-pharmaceuticals","label":"YouTube","elementId":"","altText":"YouTube logo","icon":{"variant":"YouTube","__metadata":{"key":"Icon2252","modelName":"Icon","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Icon"},"__metadata":{"key":"e8bf8d4a-b399-456f-adf0-56a0e9326663","modelName":"Social","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Social"}],"footerInternalLabel":"Global Footer - EN","logo":{"altText":"Takeda logo","aspectRatio":"","navigationUrl":"/","priority":true,"url":{"type":"cloudinary.asset","version":1652260163,"created_at":"2022-05-11T09:09:23Z","height":256,"uploaded_by":{"id":"553579438111562","type":"accesskey"},"bytes":3692,"access_mode":"public","width":720,"resource_type":"image","created_by":{"id":"553579438111562","type":"accesskey"},"url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","tags":["Takeda Logo","Takeda","logo"],"context":{"custom":{"alt":"Takeda logo","caption":"Takeda logo","Language":"English"}},"secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","format":"svg","__metadata":{"key":"cloudinary.asset2938","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","__metadata":{"key":"Logo2944","modelName":"Logo","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Logo"},"additionalLinks":[{"label":"Terms and Conditions","href":"/terms-and-conditions","elementId":"","icon":"arrowRight","iconPosition":"right","showIcon":false,"altText":"Terms and Conditions","__metadata":{"key":"4006b6f4-1255-44f6-be1e-0cb8024a2a3d","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","altText":"Privacy Notice","label":"Privacy Notice","showIcon":false,"iconPosition":"right","href":"/privacy-notice","elementId":"","__metadata":{"key":"7383d8fe-456a-4fcd-9333-c3ae2dc817ab","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"icon":"arrowRight","href":"/cookie-policy/","altText":"Cookie Policy","iconPosition":"right","elementId":"","label":"Cookie Policy","__metadata":{"key":"26488e27-becd-41fe-a610-29b37bdcc88f","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","label":"Accessibility Statement","href":"/global-accessibility-statement","iconPosition":"right","showIcon":false,"altText":"Accessibility Statement","icon":"arrowRight","__metadata":{"key":"b517a103-c0d3-440f-97c8-beb8e332c240","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"componentLayout":"takeda-com-redesign","navigationLinks":[{"iconPosition":"right","href":"/worldwide","showIcon":false,"elementId":"","label":"Locations","altText":"Locations","icon":"arrowRight","__metadata":{"key":"e65af62b-5cd2-4cb2-9c6c-833457f05f56","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"elementId":"","icon":"arrowRight","href":"/contact-us","altText":"Contact us","iconPosition":"right","label":"Contact us","__metadata":{"key":"46599b59-9786-42e6-855e-0773ddcb6272","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Careers","icon":"arrowRight","elementId":"","showIcon":false,"iconPosition":"right","href":"/careers","altText":"Careers","__metadata":{"key":"fb33e210-d0d5-4ec0-9a1c-a382fa126440","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Financial Highlights","elementId":"","href":"/investors/financial-highlights/","iconPosition":"right","showIcon":false,"altText":"Financial Highlights","icon":"arrowRight","__metadata":{"key":"b1db2e7a-ae4b-480e-b66c-9827bbc21d3b","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","href":"/hcps","iconPosition":"right","icon":"arrowRight","label":"HCPs","showIcon":false,"altText":"HCPs","__metadata":{"key":"6809bfa4-bb1d-4490-a6c0-6f22d03cb72d","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"href":"/patients","iconPosition":"right","altText":"Patients","label":"Patients","showIcon":false,"elementId":"","icon":"arrowRight","__metadata":{"key":"9ef34c8e-eadc-494c-b14b-d19c2f28d0cc","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"disclaimerText":"This website provides information about Takeda's worldwide business. For specific information about our local markets, please use the [country selector](/worldwide).\n","copyrightText":"Copyright 1995-2024 Takeda Pharmaceutical Company Limited. All rights reserved.\n","__metadata":{"key":"Footer2955","modelName":"Footer","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"WDc9QDjXlGnV1qjB17rrhg-migrated","createdAt":"2023-01-17T14:10:06Z","updatedAt":"2024-10-08T10:45:02Z"},"type":"Footer"},"header":{"title":"Takeda - Global","navigationLinks":[{"href":"","altText":"about","showIcon":false,"elementId":"","icon":"arrowRight","iconPosition":"right","links":[{"iconPosition":"right","href":"/about/our-company/","label":"Our Company","showIcon":false,"altText":"Our Company","elementId":"","icon":"arrowRight","__metadata":{"key":"aa4a7088-05f4-408e-8f1d-51675afce470","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"href":"/about/leadership","showIcon":false,"elementId":"","icon":"arrowRight","label":"Leadership","altText":"Leadership","iconPosition":"right","__metadata":{"key":"f0220992-3cbc-4042-9351-9d2a351372c5","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"links":[{"label":"Corporate Sustainability","elementId":"","icon":"arrowRight","altText":"Corporate Sustainability","links":[{"altText":"Sustainability Approach","showIcon":false,"elementId":"","icon":"arrowRight","iconPosition":"right","href":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach","label":"Sustainability Approach","__metadata":{"key":"45cdd84b-b636-456e-9843-effa55122913","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"altText":"Access to Medicines","icon":"arrowRight","iconPosition":"right","href":"/about/corporate-responsibility/corporate-sustainability/access-to-medicine","elementId":"","label":"Access to Medicines","__metadata":{"key":"a205f933-9801-48fe-a9ec-4f314c9149b7","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","href":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/","elementId":"","label":"Sustainability Disclosures","altText":"Sustainability Disclosures","icon":"arrowRight","showIcon":false,"__metadata":{"key":"bf08ae00c264","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"iconPosition":"right","href":"","showIcon":false,"__metadata":{"key":"d290bb68-a155-4b1a-8811-c7816a189e65","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"altText":"Ethics","label":"Ethics \u0026 Disclosures","elementId":"","links":[{"icon":"arrowRight","label":"Ethics","elementId":"","href":"/about/corporate-responsibility/ethics-disclosures/ethics","altText":"Ethics","iconPosition":"right","showIcon":false,"__metadata":{"key":"328b2aaa-ecf3-4542-8c56-eec4f3e32b60","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"href":"/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/","elementId":"","iconPosition":"right","showIcon":false,"altText":"Transparency Disclosures","icon":"arrowRight","label":"Transparency Disclosures","__metadata":{"key":"9f3e0a04-e90d-4302-adbc-8969a4eff1ad","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"icon":"arrowRight","iconPosition":"right","href":"","__metadata":{"key":"3ddecbfe-aeff-446d-8475-9245e263f09a","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","elementId":"","label":"Positions","href":"/about/corporate-responsibility/positions/","icon":"arrowRight","showIcon":false,"altText":"Positions","__metadata":{"key":"57cbef5e-2866-4725-93d5-75ca4dd18efb","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","showIcon":false,"elementId":"","href":"/about/corporate-responsibility/corporate-giving","altText":"Corporate Giving","iconPosition":"right","label":"Corporate Giving","__metadata":{"key":"83c3a813-724b-47b0-ad14-c46d6eb6e340","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"icon":"arrowRight","elementId":"","altText":"Corporate Responsibility","href":"","label":"Corporate Responsibility","iconPosition":"right","__metadata":{"key":"17d2ad41-f5df-426b-b48b-74a4cefff292","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Corporate Governance","iconPosition":"right","links":[{"showIcon":false,"altText":"Governance Strategy","icon":"arrowRight","label":"Governance Strategy","iconPosition":"right","elementId":"","href":"/about/corporate-governance/strategy/","__metadata":{"key":"72af665b-569a-4670-9679-40081634978b","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"elementId":"","label":"Governance Structure","altText":"Governance Structure","icon":"arrowRight","iconPosition":"right","href":"/about/corporate-governance/governance-structure","__metadata":{"key":"7bb80e0c-c5ef-47aa-b05f-ac93b19e59c8","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","showIcon":false,"icon":"arrowRight","elementId":"","altText":"Charters and Reports","href":"/about/corporate-governance/charters-and-reports","label":"Charters and Reports","__metadata":{"key":"2a711927-050b-464a-8a85-2a38477ca165","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"icon":"arrowRight","label":"Corporate Governance","elementId":"","href":"/corporate-governance","__metadata":{"key":"fb54ce14-b3f6-4854-bff0-d07f154baf50","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"label":"About","__metadata":{"key":"095c4670-ee60-4202-b896-a2b91d5bc4e4","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"icon":"arrowRight","iconPosition":"right","altText":"science","links":[{"href":"/science/areas-of-focus/","showIcon":false,"elementId":"","iconPosition":"right","icon":"arrowRight","altText":"Areas of Focus","label":"Areas of Focus","__metadata":{"key":"8ab70fde-08f0-403d-9796-19d66e0302d5","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"href":"/science/research-and-development","label":"Research and Development","showIcon":false,"iconPosition":"right","elementId":"","altText":"Research and Development","icon":"arrowRight","__metadata":{"key":"49d309a9-6eaa-4d3a-8f52-eabca51ac616","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","showIcon":false,"icon":"arrowRight","label":"Pipeline","altText":"Pipeline","iconPosition":"right","href":"/science/pipeline","__metadata":{"key":"50d03863-1230-4e99-9b27-5a8291a1d44a","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","altText":"Products","icon":"arrowRight","iconPosition":"right","label":"Products","links":[{"elementId":"","label":"Our Products","showIcon":false,"iconPosition":"right","altText":"Our Products","icon":"arrowRight","href":"/science/products","__metadata":{"key":"1ca9b57c-41ce-41a4-b28d-e25029a1df32","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","elementId":"","icon":"arrowRight","label":"Manufacturing","showIcon":false,"altText":"Manufacturing","href":"/science/products/manufacturing","__metadata":{"key":"bdceea3e-44ae-452f-bb5a-455c4bc5cbb1","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Suppliers","altText":"Suppliers","href":"/science/products/suppliers","elementId":"","icon":"arrowRight","iconPosition":"right","showIcon":false,"__metadata":{"key":"205e2d6c-ac95-4070-a8e6-5595f440ce63","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"__metadata":{"key":"55983ed9-a027-4ff0-849b-39b7a4546f7e","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","elementId":"","iconPosition":"right","href":"/science/clinical-trials","label":"Clinical Trials","altText":"Clinical Trials","showIcon":false,"__metadata":{"key":"c11272fc-6017-47fd-89ae-3dec05cc66d6","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"href":"","elementId":"","label":"Science","__metadata":{"key":"435c8304-6ec5-4763-bd5d-59e13f4829d9","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","label":"Our Impact","altText":"Our Impact","links":[{"label":"Our Stories","elementId":"","iconPosition":"right","href":"/our-impact/our-stories","icon":"arrowRight","showIcon":false,"altText":"Our Stories","__metadata":{"key":"cbd8ffca-bc84-490c-b31c-8e8df96e434d","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"icon":"arrowRight","href":"","__metadata":{"key":"ff3dbd5e-2b1e-49b5-b3d0-2de4cfe278d6","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","href":"","showIcon":false,"icon":"arrowRight","altText":"Newsroom","links":[{"iconPosition":"right","href":"/newsroom/press-releases","showIcon":false,"elementId":"","altText":"Press Releases","icon":"arrowRight","label":"Press Releases","__metadata":{"key":"bb732da3-054b-4673-88ed-74539b14853f","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Statements","elementId":"","iconPosition":"right","showIcon":false,"icon":"arrowRight","href":"/newsroom/statements","label":"Statements","__metadata":{"key":"c152ae03-5e13-41a0-b30b-64d8c8a2fbfa","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Media Resources","showIcon":false,"elementId":"","iconPosition":"right","label":"Media Resources","icon":"arrowRight","href":"/newsroom/media-resources","__metadata":{"key":"1786f7a6-a242-4462-a1b9-3e9733edf891","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"label":"Newsroom","elementId":"","__metadata":{"key":"fe8f3911-b301-4985-9f61-843018373faf","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Investors","href":"","label":"Investors","showIcon":false,"links":[{"href":"/investors/overview","elementId":"","icon":"arrowRight","altText":"Overview","iconPosition":"right","label":"Overview ","showIcon":false,"__metadata":{"key":"4c3a2f13-601e-4bd4-aefe-536205605ec9","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Financial Results","iconPosition":"right","showIcon":false,"altText":"Financial Results","icon":"arrowRight","href":"/investors/financial-results/quarterly-results","elementId":"","__metadata":{"key":"79017a31-869a-40ab-bdc2-7c9bb5431abd","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","label":"Investor Events","icon":"arrowRight","elementId":"","altText":"Investor Events","href":"/investors/events","showIcon":false,"__metadata":{"key":"c8965460-f53f-4605-ad9f-b3301cd419d5","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","altText":"Investor Contact","label":"Investor Contact","icon":"arrowRight","href":"/investors/contact","showIcon":false,"elementId":"","__metadata":{"key":"e2bc33e9-99cc-4af3-bd08-f99d9158c7d9","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"iconPosition":"right","elementId":"","icon":"arrowRight","__metadata":{"key":"19cbc22a-1abe-414b-b986-979008fdf9ac","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","label":"Careers","showIcon":false,"href":"/careers","elementId":"","altText":"careers","iconPosition":"right","__metadata":{"key":"44c09c12-0667-4c5f-8c4d-4a6e1b3f5043","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"componentLayout":"takeda-com-redesign","globalNavDefaultState":"collapsed","searchLocationPlaceholder":"Search for a country","__i18n_lang":"en","logo":{"navigationUrl":"/","priority":true,"url":{"width":720,"url":"http://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","uploaded_by":{"id":"553579438111562","type":"accesskey"},"type":"cloudinary.asset","version":1652260163,"format":"svg","public_id":"migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257","height":256,"resource_type":"image","secure_url":"https://res.cloudinary.com/takeda/image/upload/v1652260163/migration/dd376054054162cb1dd2807ef9d39eee5effe406-720x257.svg","created_at":"2022-05-11T09:09:23Z","access_mode":"public","created_by":{"id":"553579438111562","type":"accesskey"},"bytes":3692,"tags":["Takeda Logo","Takeda","logo"],"context":{"custom":{"Language":"English","alt":"Takeda logo","caption":"Takeda logo"}},"__metadata":{"key":"cloudinary.asset2941","modelName":"cloudinary.asset","projectId":"djvoabi3","source":"sourcebit-source-sanity"}},"elementId":"","altText":"Takeda logo","aspectRatio":"","__metadata":{"key":"Logo2949","modelName":"Logo","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Logo"},"searchPlaceholder":"Search...","localNavDefaultState":"collapsed","searchPageUrl":"/search","headerInternalLabel":"Global Header - EN","enableGlobalNavCollapsing":true,"language":"en","__metadata":{"key":"Header2965","modelName":"Header","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"h5S8Zv8xPUpA8CF4ZOulY2-migrated","createdAt":"2023-02-06T13:44:06Z","updatedAt":"2024-10-08T10:45:51Z"},"type":"Header"},"globalLanguages":[{"languageCode":"en","languageUrl":"en","isDefault":true,"additionalLinks":[{"altText":"Terms and Conditions","icon":"arrowRight","label":"Terms and Conditions","showIcon":false,"elementId":"","iconPosition":"right","url":"/terms-and-conditions","__metadata":{"key":"4006b6f4-1255-44f6-be1e-0cb8024a2a3d","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","label":"Privacy Notice","elementId":"","showIcon":false,"altText":"Privacy Notice","icon":"arrowRight","url":"/privacy-notice","__metadata":{"key":"7383d8fe-456a-4fcd-9333-c3ae2dc817ab","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"url":"/cookie-policy/","elementId":"","label":"Cookie Policy","showIcon":false,"icon":"arrowRight","iconPosition":"right","altText":"Cookie Policy","__metadata":{"key":"26488e27-becd-41fe-a610-29b37bdcc88f","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Accessibility Statement","elementId":"","altText":"Accessibility Statement","iconPosition":"right","url":"/global-accessibility-statement","icon":"arrowRight","showIcon":false,"__metadata":{"key":"b517a103-c0d3-440f-97c8-beb8e332c240","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"displayName":"English","links":[{"icon":"arrowRight","iconPosition":"right","label":"About","altText":"about","url":"","showIcon":false,"links":[{"altText":"Our Company","showIcon":false,"iconPosition":"right","label":"Our Company","elementId":"","url":"/about/our-company/","icon":"arrowRight","__metadata":{"key":"aa4a7088-05f4-408e-8f1d-51675afce470","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"url":"/about/leadership","showIcon":false,"altText":"Leadership","label":"Leadership","elementId":"","icon":"arrowRight","iconPosition":"right","__metadata":{"key":"f0220992-3cbc-4042-9351-9d2a351372c5","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","altText":"Corporate Responsibility","icon":"arrowRight","links":[{"url":"","elementId":"","links":[{"elementId":"","showIcon":false,"altText":"Sustainability Approach","url":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach","iconPosition":"right","label":"Sustainability Approach","icon":"arrowRight","__metadata":{"key":"45cdd84b-b636-456e-9843-effa55122913","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/about/corporate-responsibility/corporate-sustainability/access-to-medicine","label":"Access to Medicines","icon":"arrowRight","iconPosition":"right","elementId":"","altText":"Access to Medicines","__metadata":{"key":"a205f933-9801-48fe-a9ec-4f314c9149b7","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","altText":"Sustainability Disclosures","icon":"arrowRight","showIcon":false,"label":"Sustainability Disclosures","url":"/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/","__metadata":{"key":"bf08ae00c264","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"altText":"Corporate Sustainability","icon":"arrowRight","label":"Corporate Sustainability","showIcon":false,"iconPosition":"right","__metadata":{"key":"d290bb68-a155-4b1a-8811-c7816a189e65","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"url":"","elementId":"","label":"Ethics \u0026 Disclosures","links":[{"url":"/about/corporate-responsibility/ethics-disclosures/ethics","altText":"Ethics","icon":"arrowRight","iconPosition":"right","label":"Ethics","showIcon":false,"elementId":"","__metadata":{"key":"328b2aaa-ecf3-4542-8c56-eec4f3e32b60","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","altText":"Transparency Disclosures","showIcon":false,"icon":"arrowRight","label":"Transparency Disclosures","url":"/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/","__metadata":{"key":"9f3e0a04-e90d-4302-adbc-8969a4eff1ad","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"icon":"arrowRight","altText":"Ethics","iconPosition":"right","__metadata":{"key":"3ddecbfe-aeff-446d-8475-9245e263f09a","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","elementId":"","showIcon":false,"url":"/about/corporate-responsibility/positions/","altText":"Positions","iconPosition":"right","label":"Positions","__metadata":{"key":"57cbef5e-2866-4725-93d5-75ca4dd18efb","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Corporate Giving","icon":"arrowRight","url":"/about/corporate-responsibility/corporate-giving","iconPosition":"right","showIcon":false,"altText":"Corporate Giving","elementId":"","__metadata":{"key":"83c3a813-724b-47b0-ad14-c46d6eb6e340","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"iconPosition":"right","label":"Corporate Responsibility","url":"","__metadata":{"key":"17d2ad41-f5df-426b-b48b-74a4cefff292","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","url":"/corporate-governance","elementId":"","icon":"arrowRight","showIcon":false,"links":[{"elementId":"","showIcon":false,"url":"/about/corporate-governance/strategy/","altText":"Governance Strategy","icon":"arrowRight","iconPosition":"right","label":"Governance Strategy","__metadata":{"key":"72af665b-569a-4670-9679-40081634978b","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"iconPosition":"right","label":"Governance Structure","altText":"Governance Structure","url":"/about/corporate-governance/governance-structure","icon":"arrowRight","elementId":"","__metadata":{"key":"7bb80e0c-c5ef-47aa-b05f-ac93b19e59c8","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","iconPosition":"right","label":"Charters and Reports","showIcon":false,"icon":"arrowRight","url":"/about/corporate-governance/charters-and-reports","altText":"Charters and Reports","__metadata":{"key":"2a711927-050b-464a-8a85-2a38477ca165","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"altText":"Corporate Governance","label":"Corporate Governance","__metadata":{"key":"fb54ce14-b3f6-4854-bff0-d07f154baf50","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"elementId":"","__metadata":{"key":"095c4670-ee60-4202-b896-a2b91d5bc4e4","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","label":"Science","url":"","links":[{"iconPosition":"right","url":"/science/areas-of-focus/","icon":"arrowRight","elementId":"","label":"Areas of Focus","showIcon":false,"altText":"Areas of Focus","__metadata":{"key":"8ab70fde-08f0-403d-9796-19d66e0302d5","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","iconPosition":"right","showIcon":false,"elementId":"","altText":"Research and Development","url":"/science/research-and-development","label":"Research and Development","__metadata":{"key":"49d309a9-6eaa-4d3a-8f52-eabca51ac616","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/science/pipeline","elementId":"","iconPosition":"right","label":"Pipeline","altText":"Pipeline","icon":"arrowRight","__metadata":{"key":"50d03863-1230-4e99-9b27-5a8291a1d44a","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","altText":"Products","icon":"arrowRight","showIcon":false,"iconPosition":"right","links":[{"label":"Our Products","url":"/science/products","elementId":"","icon":"arrowRight","iconPosition":"right","showIcon":false,"altText":"Our Products","__metadata":{"key":"1ca9b57c-41ce-41a4-b28d-e25029a1df32","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Manufacturing","label":"Manufacturing","showIcon":false,"url":"/science/products/manufacturing","icon":"arrowRight","iconPosition":"right","elementId":"","__metadata":{"key":"bdceea3e-44ae-452f-bb5a-455c4bc5cbb1","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Suppliers","icon":"arrowRight","elementId":"","iconPosition":"right","showIcon":false,"url":"/science/products/suppliers","altText":"Suppliers","__metadata":{"key":"205e2d6c-ac95-4070-a8e6-5595f440ce63","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"label":"Products","__metadata":{"key":"55983ed9-a027-4ff0-849b-39b7a4546f7e","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Clinical Trials","iconPosition":"right","icon":"arrowRight","showIcon":false,"elementId":"","altText":"Clinical Trials","url":"/science/clinical-trials","__metadata":{"key":"c11272fc-6017-47fd-89ae-3dec05cc66d6","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"altText":"science","elementId":"","icon":"arrowRight","showIcon":false,"__metadata":{"key":"435c8304-6ec5-4763-bd5d-59e13f4829d9","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","links":[{"url":"/our-impact/our-stories","icon":"arrowRight","showIcon":false,"iconPosition":"right","altText":"Our Stories","label":"Our Stories","elementId":"","__metadata":{"key":"cbd8ffca-bc84-490c-b31c-8e8df96e434d","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"elementId":"","iconPosition":"right","label":"Our Impact","showIcon":false,"url":"","altText":"Our Impact","__metadata":{"key":"ff3dbd5e-2b1e-49b5-b3d0-2de4cfe278d6","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","links":[{"elementId":"","altText":"Press Releases","icon":"arrowRight","iconPosition":"right","showIcon":false,"url":"/newsroom/press-releases","label":"Press Releases","__metadata":{"key":"bb732da3-054b-4673-88ed-74539b14853f","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Statements","showIcon":false,"url":"/newsroom/statements","altText":"Statements","elementId":"","icon":"arrowRight","iconPosition":"right","__metadata":{"key":"c152ae03-5e13-41a0-b30b-64d8c8a2fbfa","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"url":"/newsroom/media-resources","elementId":"","iconPosition":"right","altText":"Media Resources","label":"Media Resources","icon":"arrowRight","__metadata":{"key":"1786f7a6-a242-4462-a1b9-3e9733edf891","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"showIcon":false,"icon":"arrowRight","label":"Newsroom","url":"","elementId":"","altText":"Newsroom","__metadata":{"key":"fe8f3911-b301-4985-9f61-843018373faf","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"label":"Investors","icon":"arrowRight","showIcon":false,"url":"","altText":"Investors","links":[{"url":"/investors/overview","elementId":"","altText":"Overview","label":"Overview ","icon":"arrowRight","iconPosition":"right","showIcon":false,"__metadata":{"key":"4c3a2f13-601e-4bd4-aefe-536205605ec9","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"altText":"Financial Results","iconPosition":"right","label":"Financial Results","elementId":"","icon":"arrowRight","showIcon":false,"url":"/investors/financial-results/quarterly-results","__metadata":{"key":"79017a31-869a-40ab-bdc2-7c9bb5431abd","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"showIcon":false,"altText":"Investor Events","iconPosition":"right","elementId":"","icon":"arrowRight","label":"Investor Events","url":"/investors/events","__metadata":{"key":"c8965460-f53f-4605-ad9f-b3301cd419d5","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","label":"Investor Contact","elementId":"","showIcon":false,"url":"/investors/contact","altText":"Investor Contact","icon":"arrowRight","__metadata":{"key":"e2bc33e9-99cc-4af3-bd08-f99d9158c7d9","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"elementId":"","iconPosition":"right","__metadata":{"key":"19cbc22a-1abe-414b-b986-979008fdf9ac","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","label":"Careers","iconPosition":"right","showIcon":false,"elementId":"","altText":"careers","url":"/careers","__metadata":{"key":"44c09c12-0667-4c5f-8c4d-4a6e1b3f5043","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"__metadata":{"key":"0ccf9ae0719a","modelName":"GlobalLanguage","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"GlobalLanguage"},{"languageUrl":"jp","isDefault":false,"displayName":"Japanese","links":[{"url":"","label":"企業情報","iconPosition":"right","icon":"arrowRight","showIcon":false,"elementId":"","altText":"企業情報","__metadata":{"key":"02656de7-c49b-4283-9ae4-72bfa356e09c","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","label":"サイエンス","altText":"サイエンス","iconPosition":"right","showIcon":false,"url":"","elementId":"","__metadata":{"key":"a6d6c397-c6f6-4586-9913-b3063de22c5b","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"iconPosition":"right","label":"私たちのストーリー","elementId":"","icon":"arrowRight","altText":"私たちのストーリー","showIcon":false,"url":"","__metadata":{"key":"d7133969-6899-47e1-8cdf-105128f40936","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"icon":"arrowRight","elementId":"","url":"","altText":"ニュース","iconPosition":"right","label":"ニュース","showIcon":false,"__metadata":{"key":"b5aa79b7-beb6-40de-ac46-4ee147e03c44","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","url":"","showIcon":false,"icon":"arrowRight","iconPosition":"right","label":"IR情報","altText":"IR情報","__metadata":{"key":"f37f33ba-24d3-408c-b1f2-3c3c163c3d81","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"},{"elementId":"","altText":"採用情報","showIcon":false,"label":"採用情報","iconPosition":"right","icon":"arrowRight","url":"/","__metadata":{"key":"b5f85248-d909-4e37-a225-4cec02249d01","modelName":"Link","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Link"}],"languageCode":"ja","__metadata":{"key":"0e90a000-69a8-403d-b6fd-1e0bd9bc42b5","modelName":"GlobalLanguage","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"GlobalLanguage"}],"locations":[{"languages":[{"displayName":"Spanish","languageCode":"es","isDefault":false,"__metadata":{"key":"0c99cbf700cd","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2310","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ar","locationName":"Argentina","__metadata":{"key":"948b1b570929","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"au","locationName":"Australia","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"key":"8fb62d64-2efc-4b96-8944-e0d77ba05f6a","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"f8ea65a9-6c08-4957-a804-e8ce3e95755e","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":true,"displayName":"German","languageCode":"de","__metadata":{"key":"991a32326b68","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2311","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"at","locationName":"Austria","__metadata":{"key":"5052b2f2019d","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Belgium","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"key":"f84639b4c2768353407ab42ee083fe45","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2312","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"be","__metadata":{"key":"2414b53417b0","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"ba","locationName":"Bosnia Herzegovina","languages":[{"isDefault":false,"displayName":"Bosnian","languageCode":"bs","__metadata":{"key":"d17d14235909bd9bf60cf35d6ef95422","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2313","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"759f24745e31","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2314","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"br","locationName":"Brazil","languages":[{"languageCode":"pt","isDefault":false,"displayName":"Portuguese","__metadata":{"key":"b1702899e9a2bc28bcec6ec7cef8804e","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"4a83cf470cac","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"bg","locationName":"Bulgaria","languages":[{"languageCode":"bg","isDefault":false,"displayName":"Bulgarian","__metadata":{"key":"99d0e81fb856857587cff2d487ad7b3e","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2315","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"e8dd0bdf26df","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Canada","languages":[{"isDefault":true,"displayName":"English","languageCode":"en","__metadata":{"key":"2ea4e00aa7b4e9a16f35b1fcc37d73fa","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"languageCode":"fr","isDefault":false,"displayName":"French","__metadata":{"key":"b26a418ef0ad","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2316","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ca","__metadata":{"key":"d239fcdd1b08","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"altText":"altText of the image","aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2396","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"cl","locationName":"Chile","languages":[{"languageCode":"en","isDefault":true,"displayName":"English","__metadata":{"key":"f783c9f34bf7","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"isDefault":false,"displayName":"Spanish","languageCode":"es","__metadata":{"key":"26c4b9e18772a15915595aedaab4fc93","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"d80ea3282c82","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"cn","locationName":"Mainland China","languages":[{"isDefault":false,"displayName":"Chinese","languageCode":"zh","languageUrl":"https://takeda.info/takeda-china","__metadata":{"key":"c5309e01-d446-49f4-856c-b145e3b87a8a","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"f3d7aac7-df0b-471a-8ecb-1cb02559a4e2","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"co","locationName":"Colombia","languages":[{"isDefault":false,"displayName":"Spanish","languageCode":"es","__metadata":{"key":"db94b5d878cb","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2317","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"6ede577a45a4","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2318","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"hr","locationName":"Croatia","languages":[{"languageCode":"hr","isDefault":false,"displayName":"Croatian","__metadata":{"key":"5782ad4a8f53d55447d6105f77e9bb36","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"4bc918143d7c","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2319","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"cz","locationName":"Czech Republic","languages":[{"isDefault":false,"displayName":"Czech","languageCode":"cs","__metadata":{"key":"674d5f466dbd9327eda8551c62615a02","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"195a35d3eae4","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2320","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"dk","locationName":"Denmark","languages":[{"isDefault":false,"displayName":"Danish","languageCode":"da","__metadata":{"key":"56b09306acc498a419fb78b3b07d34f3","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"cfbc5255b3a2","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"displayName":"Spanish","languageCode":"es","isDefault":false,"__metadata":{"key":"b7b7bdf3b242fa5fb28a6a42e0a805d6","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2321","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ec","locationName":"Ecuador","__metadata":{"key":"c2499fe60b4e","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Estonia","languages":[{"languageCode":"et","isDefault":false,"displayName":"Estonian","__metadata":{"key":"7a578ed067171f8b98e5f25aaec6546d","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2322","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ee","__metadata":{"key":"9b107a62ff80","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":false,"displayName":"Finnish","languageCode":"fi","__metadata":{"key":"0de5a3e8a936006b6506edd0b2e734ae","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2323","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"fi","locationName":"Finland","__metadata":{"key":"fc60d263723e","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"fr","locationName":"France","languages":[{"isDefault":false,"displayName":"French","languageCode":"fr","__metadata":{"key":"9a51b9c941cb093935bc06b25da48457","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2324","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"2ed662381229","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Germany","languages":[{"isDefault":false,"displayName":"German","languageCode":"de","__metadata":{"key":"36755bd4b50755060fb44ca01b384544","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2325","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"de","__metadata":{"key":"3bd9a83ecc91","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":false,"displayName":"Greek","languageCode":"el","__metadata":{"key":"f84727f84581d50f73eeff99fab909b0","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2326","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"gr","locationName":"Greece","__metadata":{"key":"8ec2f153c4dd","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":true,"displayName":"English","languageCode":"en","__metadata":{"key":"40954b6e76d8","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"languageCode":"zh","isDefault":false,"displayName":"Chinese","__metadata":{"key":"454493affcd40cea7155f0b9fb293a98","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2327","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"hk","locationName":"Hong Kong SAR","__metadata":{"key":"50dce634d384","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Hungary","languages":[{"languageCode":"hu","isDefault":false,"displayName":"Hungarian","__metadata":{"key":"35c25211b310510226999ca16fbe5732","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2328","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"hu","__metadata":{"key":"3d8fe415cb2d","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2329","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"in","locationName":"India","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"key":"3d2bd74dbaf61d64a38f23ec6c09954d","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"d53941beaa80","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Indonesia","languages":[{"languageCode":"id","isDefault":false,"displayName":"Indonesian","__metadata":{"key":"e9e0f4508432bf5457e17c2085305334","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2330","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"id","__metadata":{"key":"b22ed6ad123c","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"ie","locationName":"Ireland","languages":[{"displayName":"English","languageCode":"en","isDefault":false,"__metadata":{"key":"52d738370cf0f52b0fa048d8a4f4d33f","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2331","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"3e311e501ef4","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Israel","languages":[{"languageCode":"he","isDefault":false,"displayName":"Hebrew","__metadata":{"key":"b87a2f6abcb9f74b945c5557c89b765d","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2332","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"il","__metadata":{"key":"09ca8169990d","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"displayName":"Italian","languageCode":"it","isDefault":false,"__metadata":{"key":"2ae0e155bddc09f8321c778d38f825d5","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2333","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"it","locationName":"Italy","__metadata":{"key":"c9a733b4a1b4","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Japan","languages":[{"isDefault":false,"displayName":"Japanese","languageCode":"ja","__metadata":{"key":"6f8af788ef5228f92ecabe2f8191bf29","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2334","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"jp","__metadata":{"key":"5c227b8eb366","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Kazakhstan","languages":[{"languageCode":"kk","isDefault":true,"displayName":"Kazakh","__metadata":{"key":"b1aaa674f94b9f9f5b82dab56f194b18","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"isDefault":false,"displayName":"Russian","languageCode":"ru","__metadata":{"key":"34fc4c88e09a","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2335","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"kz","__metadata":{"key":"fcab0b6bf271","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2336","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"kr","locationName":"Korea","languages":[{"languageCode":"ko","isDefault":false,"displayName":"Korean","__metadata":{"key":"d30f1f213fbab4f6962cd191e694e53c","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"882820b3cb78","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"lv","locationName":"Latvia","languages":[{"isDefault":false,"displayName":"Latvian","languageCode":"lv","__metadata":{"key":"571aac0ebd3d55c39de0ab783eb6fa54","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2337","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"19ab19b52d66","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2338","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"lt","locationName":"Lithuania","languages":[{"languageCode":"lt","isDefault":false,"displayName":"Lithuanian","__metadata":{"key":"c68510ec271b74880bc96d204c6fa01b","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"aee9c2c47de6","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Malaysia","languages":[{"languageCode":"en","languageUrl":"/en-my","isDefault":false,"displayName":"English","__metadata":{"key":"27143d3b-12d6-4515-b07f-371c1520d0ee","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"my","__metadata":{"key":"44b6d54a-2753-4148-a51d-96bd15c9bfe4","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Mexico","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"key":"807d211bc4bbd2b9451d8d5f7731b1af","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2339","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"mx","__metadata":{"key":"580505e6a0f1","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"nl","locationName":"Netherlands","languages":[{"isDefault":false,"displayName":"Dutch","languageCode":"nl","__metadata":{"key":"b74e118226d2cbea0f5db4c7e5063239","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2340","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"739def278fea","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2341","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"nz","locationName":"New Zealand","languages":[{"isDefault":false,"displayName":"English","languageCode":"en","__metadata":{"key":"0d4a84429a32e368e1e5326bdec7f3d9","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"7fe0fbd18aa5","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"no","languageUrl":"/nn-no","isDefault":false,"displayName":"Norweigan","__metadata":{"key":"971d1d8399a93d871a71e0619bbd09a5","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2342","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"no","locationName":"Norway","__metadata":{"key":"becc12e4c8bf","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"key":"dbfbfbf65b8af8a537b67b6bedd0370f","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2343","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"pe","locationName":"Peru","__metadata":{"key":"27a61f558e93","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"ph","locationName":"Philippines","languages":[{"isDefault":true,"displayName":"English","languageCode":"en","__metadata":{"key":"7895ba24-1391-4890-a519-c8ab2d186a04","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"a91fe2c4-6f44-4fbb-893b-ad46db5c8e85","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":false,"displayName":"Polish","languageCode":"pl","__metadata":{"key":"212f42416fd9917670d147909f2b4081","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2344","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"pl","locationName":"Poland","__metadata":{"key":"0b1a9b99e3d0","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"pt","locationName":"Portugal","languages":[{"languageCode":"pt","isDefault":false,"displayName":"Portuguese","__metadata":{"key":"e49fa3704dd5858f0ac29b46f1588699","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2345","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"32e45d965e32","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2346","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ro","locationName":"Romania","languages":[{"languageCode":"ro","isDefault":false,"displayName":"Romanian","__metadata":{"key":"5217a6a39613bd461f2fdca44a416c72","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"a68b3c484969","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Russia","languages":[{"languageCode":"ru","isDefault":false,"displayName":"Russian","__metadata":{"key":"9d002a8ee9316705443dd9f39119b05e","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2347","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ru","__metadata":{"key":"7fe262ffaafa","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Saudi Arabia","languages":[{"languageCode":"en","isDefault":true,"displayName":"English","__metadata":{"key":"28ff1681811b","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"isDefault":false,"displayName":"Arabic","languageCode":"ar","__metadata":{"key":"3ddedbe34b0e","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","altText":"altText of the image","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2397","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"sa","__metadata":{"key":"5dd86130988b","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"rs","locationName":"Serbia","languages":[{"languageCode":"sr","isDefault":false,"displayName":"Serbian","__metadata":{"key":"cfd6dffdd254daef6af52e78f19ecd34","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2348","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"0ed3666494de","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"sg","locationName":"Singapore","languages":[{"isDefault":true,"displayName":"English","languageCode":"en","__metadata":{"key":"cb4397bb-4ea5-4386-aed8-54c36a3c0321","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"3d950a4f-17c6-4274-9744-9df9d986af9d","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"sk","locationName":"Slovakia","languages":[{"languageCode":"sk","isDefault":false,"displayName":"Slovak","__metadata":{"key":"4b0ae0b44fa5","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2349","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"87ad980c0f9b","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"languageCode":"sl","isDefault":false,"displayName":"Slovenian","__metadata":{"key":"02f19af7d437","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"locationCode":"si","locationName":"Slovenia","__metadata":{"key":"c5754f0a-2e41-4cf8-aeb0-94496ed2294b","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"South Africa","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"key":"8808ec466c12c3cdb33cd554ff621ede","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"altText":"altText of the image","aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2398","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"za","__metadata":{"key":"dee6f6557ffd","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationCode":"es","locationName":"Spain","languages":[{"languageCode":"es","isDefault":false,"displayName":"Spanish","__metadata":{"key":"ea32876928965792936b149eed6cc575","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2350","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"__metadata":{"key":"eb6976cee9e3","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2351","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"se","locationName":"Sweden","languages":[{"languageCode":"sv","isDefault":false,"displayName":"Swedish","__metadata":{"key":"660e556b3bb9207b498512ad682394fc","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"6e587e4fe367","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2352","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ch","locationName":"Switzerland","languages":[{"languageCode":"de","isDefault":true,"displayName":"German","__metadata":{"key":"98849442a7dd81888ab4cbdea85921ed","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"},{"languageCode":"fr","isDefault":false,"displayName":"French","__metadata":{"key":"5731873303ed","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"43e55f0ec03a","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"languages":[{"isDefault":false,"displayName":"Chinese","languageCode":"zh","__metadata":{"key":"9298cddb36e9ec40cc9d7b2e9dd90597","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2353","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"tw","locationName":"Taiwan","__metadata":{"key":"ea71f4301625","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2354","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"th","locationName":"Thailand","languages":[{"languageCode":"th","isDefault":false,"displayName":"Thai","__metadata":{"key":"62e07053049af28cbecfec5cb4821c2b","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"98a4732e1754","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2355","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"tr","locationName":"Turkey","languages":[{"displayName":"Turkish","languageCode":"tr","isDefault":false,"__metadata":{"key":"523fc5e9cb25c71f896bf9a549b40fe6","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"6f8f610c6a6c","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"Ukraine","languages":[{"languageCode":"uk","isDefault":false,"displayName":"Ukrainian","__metadata":{"key":"a5e316cbf4b294a050c987aaa7e86684","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"priority":false,"elementId":"","aspectRatio":"","__metadata":{"key":"ImageBlock2356","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"ua","__metadata":{"key":"91462a371166","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"United Kingdom","languages":[{"languageCode":"en","isDefault":false,"displayName":"English","__metadata":{"key":"0a1ad6f1ee49050ea291dad6f8d356fa","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"elementId":"","aspectRatio":"","priority":false,"__metadata":{"key":"ImageBlock2357","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"gb","__metadata":{"key":"16b567975428","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"locationName":"United States","languages":[{"languageUrl":"","isDefault":false,"displayName":"English","languageCode":"en","__metadata":{"key":"0d009d2afbbcb36e4ac071882ed60b3b","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"flagImg":{"aspectRatio":"","priority":false,"elementId":"","altText":"altText of the image","__metadata":{"key":"ImageBlock2399","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"us","__metadata":{"key":"5009df8d65c3","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"},{"flagImg":{"aspectRatio":"","priority":false,"elementId":"","__metadata":{"key":"ImageBlock2358","modelName":"ImageBlock","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"ImageBlock"},"locationCode":"vn","locationName":"Vietnam","languages":[{"languageCode":"en","languageUrl":"/en-vi","isDefault":false,"displayName":"English","__metadata":{"key":"ae2031182d746c2e88215a0dea862024","modelName":"LanguageWithNavigation","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"LanguageWithNavigation"}],"__metadata":{"key":"ceb335a75a7a","modelName":"Location","projectId":"djvoabi3","source":"sourcebit-source-sanity"},"type":"Location"}],"configInternalLabel":"Site Configuration - EN","language":"en","__metadata":{"key":"Config2972","modelName":"Config","projectId":"djvoabi3","source":"sourcebit-source-sanity","id":"siteSettings","createdAt":"2022-11-11T08:38:36Z","updatedAt":"2024-10-24T08:31:25Z"},"type":"Config"}},"__N_SSG":true},"page":"/[[...slug]]","query":{"slug":["investors","events"]},"buildId":"sbbqT0Rrdp-Nb378BFVQE","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[40481,53270,60823,39202,38870,48909,3480,53780,8560,1711,62197,62590,20611,27192,80663,26586,73539,89686,67296,46359,74386,87037,25174,33079,55137,48437,39964,71572,35288,87758,57959,41305,64460,24969,87730,62788,43501,16233,37310,83519,55524,72045,45162,72438,60598,29291,77809,93781,98859,3730,19482,16823,69805,32737,23885,77093,57299,27002,80885,32790,83715],"gsp":true,"locale":"en","locales":["en","jp","en-ph","ar-sa","en-sg","es-es","es-cl","en-cl","en-au","en-nz","da-dk","sv-se","kk-kz","id-id","en-sa","hr-hr","en-my","pt-pt","ru-kz","es-ar","bg-bg","sr-rs","en-za","pl-pl","ro-ro","ms-my"],"defaultLocale":"en","scriptLoader":[]}</script></body></html>